Publikationen online

Sortieren nach:

Titel
Autor
Erscheinungsjahr

Suche in Publikationen:

Publikationen

  • 2017

    Synergistic effects of dendritic cell targeting and laser-microporation on enhancing epicutaneous skin vaccination efficacy.

    Machado, Y, Duinkerken, S, Hoepflinger, V, Mayr, M, Korotchenko, E, Kurtaj, A, Pablos, I, Steiner, M, Stoecklinger, A, Lübbers, J, Schmid, M, Ritter, U, Scheiblhofer, S, Ablinger, M, Wally, V, Hochmann, S, Raninger, AM, Strunk, D, van Kooyk, Y, Thalhamer, J, Weiss, R.
    J Control Release. 2017, 266:87-99.

    View this publication in the PUBMED database
  • 2017

    When the guardian sleeps: Reactivation of the p53 pathway in cancer.

    Merkel, O, Taylor, N, Prutsch, N, Staber, PB, Moriggl, R, Turner, SD, Kenner, L.
    Mutat Res. 2017, 773:1-13.

    View this publication in the PUBMED database
  • 2017

    Distribution and Metabolism of Lipocurc™ (Liposomal Curcumin) in Dog and Human Blood Cells: Species Selectivity and Pharmacokinetic Relevance.

    Bolger, GT, Licollari, A, Tan, AM, Greil, R, Vcelar, B, Majeed, M, Helson, L.
    ANTICANCER RES. 2017, 37(7): 3483-3492.

    View this publication in the PUBMED database
  • 2017

    Improvement of quality of life and psychological distress after inpatient cancer rehabilitation.

    Riedl, D, Giesinger, JM, Wintner, LM, Loth, FL, Rumpold, G, Greil, R, Nickels, A, Licht, T, Holzner, B.
    WIEN KLIN WOCHENSCHR. 2017, 129(19-20): 692-701.

    View this publication in the PUBMED database
  • 2017

    Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer.

    Gampenrieder, SP, Hufnagl, C, Brechelmacher, S, Huemer, F, Hackl, H, Rinnerthaler, G, Romeder, F, Monzo Fuentes, C, Morre, P, Hauser-Kronberger, C, Mlineritsch, B, Greil, R.
    Pharmacogenomics J. 2017, 17(4):344-350.

    View this publication in the PUBMED database
  • 2017

    Reactivation of dormant anti-tumor immunity - a clinical perspective of therapeutic immune checkpoint modulation.

    Greil, R, Hutterer, E, Hartmann, TN, Pleyer, L.
    Cell Commun Signal. 2017, 15(1):5.

    View this publication in the PUBMED database
  • 2017

    Azacitidine in adult patients with acute myeloid leukemia.

    Schuh, AC, Dohner, H, Pleyer, L, Seymour, JF, Fenaux, P, Dombreth, H.
    Crit Rev Oncol Hematol. 2017, 116:159-177.

    View this publication in the PUBMED database
  • 2017

    COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa.

    Hainzl, S, Peking, P, Kocher, T, Murauer, EM, Larcher, F, Del Rio, M, Duarte, B, Steiner, M, Klausegger, A, Bauer, JW, Reichelt, J, Koller, U.
    Mol Ther. 2017.

    View this publication in the PUBMED database
  • 2017

    Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experience.

    Leisch, M, Weiss, L, Lindlbauer, N, Jungbauer, C, Egle, A, Rohde, E, Greil, R, Grabmer, C, Pleyer, L.
    Leuk Res. 2017, 59:12-19.

    View this publication in the PUBMED database
  • 2017

    Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer.

    Gampenrieder, SP, Hufnagl, C, Brechelmacher, S, Huemer, F, Hackl, H, Rinnerthaler, G, Romeder, F, Monzo Fuentes, C, Morre, P, Hauser-Kronberger, C, Mlineritsch, B, Greil, R.
    Pharmacogenomics J. 2017, 17(4):344-350.

    View this publication in the PUBMED database
  • 2017

    Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.

    nnerthaler, G, Romeder, F, M.
    J Clin Oncol. 2017, 35(22):2473-2481.

    View this publication in the PUBMED database
  • 2017

    SABCS 2016: systemic therapy for metastatic breast cancer.

    Gampenrieder, SP, Rinnerthaler, G, Greil, R.
    MEMO-MAG EUR MED ONC. 2017, 10(2): 86-89.

    View this publication in the PUBMED database
  • 2017

    Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.

    Eisterer, W, Piringer, G, De Vries, A, Ofner, D, Greil, R, Tschmelitsch, J, Samonigg, H, Solkner, L, Gnant, M, Thaler, J.
    Anticancer Res. 2017, 37(5):2683-2691.

    View this publication in the PUBMED database
  • 2017

    The Human NADPH Oxidase, Nox4, Regulates Cytoskeletal Organization in Two Cancer Cell Lines, HepG2 and SH-SY5Y.

    Auer, S, Rinnerthaler, M, Bischof, J, Streubel, MK, Breitenbach-Koller, H, Geisberger, R, Aigner, E, Cadamuro, J, Richter, K, Sopjani, M, Haschke-Becher, E, Felder, TK, Breitenbach, M,
    Front Oncol. 2017, 7: 111.

    View this publication in the PUBMED database
  • 2017

    Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy.

    Magnes, T, Melchardt, T, Weiss, L, Mittermair, C, Neureiter, D, Klieser, E, Gampenrieder, S, Moser, G, Gaggl, A, Greil, R, Egle, A.
    PLoS One. 2017, 12(7):e0180995.

    View this publication in the PUBMED database
  • 2017

    The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab.

    Magnes, T, Melchardt, T, Hufnagl, C, Weiss, L, Mittermair, C, Neureiter, D, Klieser, E, Rinnerthaler, G, Roesch, S, Gaggl, A, Greil, R, Egle, A.
    Pharmacogenomics J. 2017.

    View this publication in the PUBMED database
  • 2017

    Differences in stem cell processing lead to distinct secretomes secretion - implications for differential results of previous clinical trials of stem cell therapy for myocardial infarction.

    Wernly, B, Gonçalves, I, Kiss, A, Paar, V, Mösenlechner, T, Leisch, M, Santer, D, Motloch, L, Klein, KU, Tretter, EV, Kretzschmar, D, Podesser, B, Jung, C, Hoppe, UC, Lichtenauer, M.
    Biotechnol J. 2017.

    View this publication in the PUBMED database
  • 2017

    Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study

    Almeida, AM, Prebet, T, Itzykson, R, Ramos, F, Al-Ali, H, Shammo, J, Pinto, R, Maurillo, L, Wetzel, J, Musto, P, Van De Loosdrecht, AA, Costa, MJ, Esteves, S, Burgstaller, S, Stauder, R, Autzinger, EM, Lang, A, Krippl, P, Geissler, D, Falantes, JF, Pedro, C, Bargay, J, Deben, G, Garrido, A, Bonanad, S, Diez-Campelo, M, Thepot, S, Ades, L, Sperr, WR, Valent, P, Fenaux, P, Sekeres, MA, Greil, R, Pleyer, L.
    INT J MOL SCI. 2017, 18(4): 837.

    View this publication in the PUBMED database
  • 2017

    Amb a 1 isoforms: unequal siblings with distinct immunological features.

    Wolf, M, Twaroch, TE, Huber, S, Reithofer, M, Steiner, M, Aglas, L, Hauser, M, Aloisi, I, Asam, C, Hofer, H, Parigiani, MA, Ebner, C, Bohle, B, Briza, P, Angela, N, Stolz, F, Jahn-Schmid, B, Wallner, M, Ferreira, F.
    Allergy. 2017.

    View this publication in the PUBMED database
  • 2017

    Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib.

    Kazianka, L, Drucker, C, Skrabs, C, Thomas, W, Melchardt, T, Struve, S, Bergmann, M, Staber, PB, Porpaczy, E, Einberger, C, Heinz, M, Hauswirth, A, Raderer, M, Pabinger, I, Thalhammer, R, Egle, A, Wendtner, CM, Follows, G, Hoermann, G, Quehenberger, P, Jilma, B, Jaeger, U.
    Leukemia. 2017, 31(5):1117-1122.

    View this publication in the PUBMED database
  • 2017

    The Human NADPH Oxidase, Nox4, Regulates Cytoskeletal Organization in Two Cancer Cell Lines, HepG2 and SH-SY5Y.

    Auer, S, Rinnerthaler, M, Bischof, J, Streubel, MK, Breitenbach-Koller, H, Geisberger, R, Aigner, E, Cadamuro, J, Richter, K, Sopjani, M, Haschke-Becher, E, Felder, TK, Breitenbach, M.
    Front Oncol. 2017, 7:111.

    View this publication in the PUBMED database
  • 2017

    Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.

    Eisterer, W, Piringer, G, De Vries, A, Ofner, D, Greil, R, Tschmelitsch, J, Samonigg, H, Solkner, L, Gnant, M, Thaler, J.
    Anticancer Res. 2017, 37(5):2683-2691.

    View this publication in the PUBMED database
  • 2017

    Milestones in Chronic Lymphocytic Leukemia: An exciting decade of progress-10th anniversary of memo.

    Egle, A.
    Memo. 2017, 10(1):8-12.

    View this publication in the PUBMED database
  • 2017

    Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group

    Pleyer, L, Dohner, H, Dombret, H, Seymour, JF, Schuh, AC, Beach, CL, Swern, AS, Burgstaller, S, Stauder, R, Girschikofsky, M, Sill, H, Schlick, K, Thaler, J, Halter, B, Spandl, SM, Zebisch, A, Pichler, A, Pfeilstocker, M, Autzinger, EM, Lang, A, Geissler, K, Voskova, D, Sperr, WR, Hojas, S, Rogulj, IM, Andel, J, Greil, R.
    INT J MOL SCI. 2017, 18(2): 415.

    View this publication in the PUBMED database
  • 2017

    Influence of body mass index on survival in indolent and mantle cell lymphomas: analysis of the StiL NHL1 trial.

    Weiss, L, Melchardt, T, Egle, A, Hopfinger, G, Hackl, H, Greil, R, Barth, J, Rummel, M.
    Ann Hematol. 2017.

    View this publication in the PUBMED database
  • 2017

    Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib-dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study.

    Ludwig, H, Weisel, K, Petrucci, MT, Leleu, X, Cafro, AM, Garderet, L, Leitgeb, C, Foa, R, Greil, R, Yakoub-Agha, I, Zboralski, D, Vauleon, S, Duemmler, T, Beyer, D, Kruschinski, A, Riecke, K, Baumann, M, Engelhardt, M.
    Leukemia. 2017, 31(4):997-1000.

    View this publication in the PUBMED database
  • 2017

    The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation.

    Wolff, F, Leisch, M, Greil, R, Risch, A, Pleyer, L.
    Cell Commun Signal. 2017, 15(1):13.

    View this publication in the PUBMED database
  • 2017

    Hemeoxygenase-1 as a Novel Driver in Ritonavir-Induced Insulin Resistance in HIV-1-Infected Patients.

    Taylor, N, Kremser, I, Auer, S, Hoermann, G, Greil, R, Haschke-Becher, E, Esterbauer, H, Kenner, L, Oberkofler, H.
    J Acquir Immune Defic Syndr. 2017, 75(1):e13-e20.

    View this publication in the PUBMED database
  • 2017

    Reactivation of dormant anti-tumor immunity - a clinical perspective of therapeutic immune checkpoint modulation.

    Greil, R, Hutterer, E, Hartmann, TN, Pleyer, L.
    Cell Commun Signal. 2017, 15(1): 5.

    View this publication in the PUBMED database
  • 2017

    A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma.

    Kiesewetter, B, Willenbacher, E, Willenbacher, W, Egle, A, Neumeister, P, Voskova, D, Mayerhoefer, ME, Simonitsch-Klupp, I, Melchardt, T, Greil, R, Raderer, M.
    Blood. 2017, 129(3):383-385.

    View this publication in the PUBMED database
  • 2017

    Acute myeloid leukemia - strategies and challenges for targeting oncogenic Hedgehog/GLI signaling.

    Aberger, F, Hutterer, E, Sternberg, C, Del Burgo, PJ, Hartmann, TN.
    Cell Commun Signal. 2017, 15(1): 8.

    View this publication in the PUBMED database
  • 2017

    T cell exhaustion: from pathophysiological basics to tumor immunotherapy.

    Catakovic, K, Klieser, E, Neureiter, D, Geisberger, R.
    Cell Commun Signal. 2017, 15(1):.

    View this publication in the PUBMED database
  • 2016

    Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial.

    Greil, R, Obrtlíková, P, Smolej, L, Kozák, T, Steurer, M, Andel, J, Burgstaller, S, Mikušková, E, Gercheva, L, Nösslinger, T, Papajík, T, Ladická, M, Girschikofsky, M, Hrubiško, M, Jäger, U, Fridrik, M, Pecherstorfer, M, Králiková, E, Burcoveanu, C, Spasov, E, Petzer, A, Mihaylov, G, Raynov, J, Oexle, H, Zabernigg, A, Flochová, E, Palášthy, S, Stehlíková, O, Doubek, M, Altenhofer, P, Pleyer, L, Melchardt, T, Klingler, A, Mayer, J, Egle, A.
    Lancet Haematol. 2016, 3(7): e317-e329.

    View this publication in the PUBMED database
  • 2016

    Basophil Reactivity as Biomarker in Immediate Drug Hypersensitivity Reactions-Potential and Limitations.

    Steiner, M, Harrer, A, Himly, M.
    Front Pharmacol. 2016, 7: 171.

    View this publication in the PUBMED database
  • 2016

    Bcl-2 proteins in development, health, and disease of the hematopoietic system.

    Kollek, M, MГјller, A, Egle, A, Erlacher, M.
    FEBS J. 2016, 283(15): 2779-2810.

    View this publication in the PUBMED database
  • 2016

    Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones.

    Melchardt, T, Hufnagl, C, Weinstock, DM, Kopp, N, Neureiter, D, Tränkenschuh, W, Hackl, H, Weiss, L, Rinnerthaler, G, Hartmann, TN, Greil, R, Weigert, O, Egle, A.
    Oncotarget. 2016, xx:.

    View this publication in the PUBMED database
  • 2016

    Panitumumab-Associated Encephalopathy after Accidental Intra-arterial Application through Dislocated Central Venous Access Device.

    Pikija, S, Pilz, G, Gschwandtner, G, Rösler, C, Schlick, K, Greil, R, Sellner, J.
    Front Neurol. 2016, 7:196.

    View this publication in the PUBMED database
  • 2016

    BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia.

    Haerzschel, A, Catusse, J, Hutterer, E, Paunovic, M, Zirlik, K, Eibel, H, Krenn, PW, Hartmann, TN, Burger, M.
    Ann Hematol. 2016, 95(12):197-1988.

    View this publication in the PUBMED database
  • 2016

    Hemeoxygenase-1 as a novel driver in ritonavir-induced insulin resistance in HIV-1-infected patients.

    Taylor, N, Kremser, I, Auer, S, Hoermann, G, Greil, R, Haschke-Becher, E, Esterbauer, H, Kenner, L, Oberkofler, H.
    J Acquir Immune Defic Syndr. 2016.

    View this publication in the PUBMED database
  • 2016

    NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.

    Prochazka, KT, Melchardt, T, Posch, F, Schlick, K, Deutsch, A, Beham-Schmid, C, Weiss, L, Gary, T, Neureiter, D, Klieser, E, Greil, R, Neumeister, P, Egle, A, Pichler, M.
    Br J Cancer. 2016, xx:.

    View this publication in the PUBMED database
  • 2016

    Epidermal-specific deletion of CD44 reveals a function in keratinocytes in response to mechanical stress.

    Shatirishvili, M, Burk, AS, Franz, CM, Pace, G, Kastilan, T, Breuhahn, K, Hinterseer, E, Dierich, A, Bakiri, L, Wagner, EF, Ponta, H, Hartmann, TN, Tanaka, M, Orian-Rousseau, V.
    Cell Death Dis. 2016, 7(11):e2461.

    View this publication in the PUBMED database
  • 2016

    CD44: More than a mere stem cell marker.

    Morath, I, Hartmann, TN, Orian-Rousseau, V.
    Int J Biochem Cell Biol. 2016.

    View this publication in the PUBMED database
  • 2016

    Assessment of Pharmacokinetic Interaction Between Capecitabine and Cetuximab in Metastatic Colorectal Cancer Patients.

    Rachar, V, Czejka, M, Kitzmueller, M, Buchner, P, Lichtneckert, M, Greil, R, Geiler, H, Dittrich, C.
    ANTICANCER RES. 2016, 36(9): 4715-4723.

    View this publication in the PUBMED database
  • 2016

    An international, multicenter, prospective, observational study of neutropenia in patients being treated with lenalidomide?+?dexamethasone for relapsed or relapsed/refractory multiple myeloma (RR-MM).

    "Leleu, X, Terpos, E, Sanz, RG, Cooney, J, O""Gorman, P, Minarik, J, Greil, R, Williams, C, Gray, D, Szabo, Z."
    AM J HEMATOL. 2016, 91(8): 806-811.

    View this publication in the PUBMED database
  • 2016

    Elevated Toll-Like Receptor-Induced CXCL8 Secretion in Human Blood Basophils from Allergic Donors Is Independent of Toll-Like Receptor Expression Levels.

    Steiner, M, Hawranek, T, Schneider, M, Ferreira, F, Horejs-Hoeck, J, Harrer, A, Himly, M.
    PLOS ONE. 2016, 11(2): e0149275.

    View this publication in the PUBMED database
  • 2016

    Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications.

    Pleyer, L, Burgstaller, S, Stauder, R, Girschikofsky, M, Sill, H, Schlick, K, Thaler, J, Halter, B, Machherndl-Spandl, S, Zebisch, A, Pichler, A, Pfeilstöcker, M, Autzinger, EM, Lang, A, Geissler, K, Voskova, D, Geissler, D, Sperr, WR, Hojas, S, Rogulj, IM, Andel, J, Greil, R.
    J HEMATOL ONCOL. 2016, 9: 39.

    View this publication in the PUBMED database
  • 2016

    Fluorouracil and Dihydropyrimidine Dehydrogenase Genotyping.

    Magnes, T, Melchardt, T, Weiss, L, Hufnagl, C, Greil, R, Egle, A.
    J Clin Oncol. 2016, 34(20): 2433-2434.

    View this publication in the PUBMED database
  • 2016

    Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis -Masters of Survival and Clonality?.

    Pleyer, L, Valent, P, Greil, R.
    INT J MOL SCI. 2016, 17(7): 1009.

    View this publication in the PUBMED database
  • 2016

    Panitumumab-Associated Encephalopathy after Accidental Intra-arterial Application through Dislocated Central Venous Access Device.

    Pikija, S, Pilz, G, Gschwandtner, G, Rösler, C, Schlick, K, Greil, R, Sellner, J.
    Front Neurol. 2016, 7:196.

    View this publication in the PUBMED database
  • 2016

    BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia.

    Haerzschel, A, Catusse, J, Hutterer, E, Paunovic, M, Zirlik, K, Eibel, H, Krenn, PW, Hartmann, TN, Burger, M.
    Ann Hematol. 2016, 95(12):197-1988.

    View this publication in the PUBMED database
  • 2016

    Hemeoxygenase-1 as a novel driver in ritonavir-induced insulin resistance in HIV-1-infected patients.

    Taylor, N, Kremser, I, Auer, S, Hoermann, G, Greil, R, Haschke-Becher, E, Esterbauer, H, Kenner, L, Oberkofler, H.
    J Acquir Immune Defic Syndr. 2016.

    View this publication in the PUBMED database
  • 2016

    Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia : A case report.

    Huemer, F, Dejaco, M, Grabmer, C, Melchardt, T, Neureiter, D, Mayer, G, Egle, A, Greil, R, Weiss, L.
    Wien Klin Wochenschr. 2016.

    View this publication in the PUBMED database
  • 2016

    Epidermal-specific deletion of CD44 reveals a function in keratinocytes in response to mechanical stress.

    Shatirishvili, M, Burk, AS, Franz, CM, Pace, G, Kastilan, T, Breuhahn, K, Hinterseer, E, Dierich, A, Bakiri, L, Wagner, EF, Ponta, H, Hartmann, TN, Tanaka, M, Orian-Rousseau, V.
    Cell Death Dis. 2016, 7(11):e2461.

    View this publication in the PUBMED database
  • 2016

    CD44: More than a mere stem cell marker.

    Morath, I, Hartmann, TN, Orian-Rousseau, V.
    Int J Biochem Cell Biol. 2016.

    View this publication in the PUBMED database
  • 2016

    NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.

    Benedetti, D, Tissino, E, Caldana, C, Dal Bo, M, Bomben, R, Marconi, D, Ganghammer, S, Zaja, F, Pozzato, G, Di Raimondo, F, Hartmann, TN, Del Poeta, G, VanMeter, A, Zucchetto, A, Espina, V, Liotta, L, Gattei, V.
    Leukemia. 2016, 30(2): 513-517.

    View this publication in the PUBMED database
  • 2016

    Assessment of Pharmacokinetic Interaction Between Capecitabine and Cetuximab in Metastatic Colorectal Cancer Patients.

    Steiner, M, Harrer, A, Himly, M.
    Front Pharmacol. 2016, 7:171.

    View this publication in the PUBMED database
  • 2016

    Ibrutinib Inhibits VLA-4-Dependent Adhesion in CLL-Letter.

    Rinnerthaler, G, Hackl, H, Gampenrieder, SP, Hamacher, F, Hufnagl, C, Hauser-Kronberger, C, Zehentmayr, F, Fastner, G, Sedlmayer, F, Mlineritsch, B, Greil, R.
    Int J Mol Sci. 2016, 17(2).

    View this publication in the PUBMED database
  • 2016

    Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial.

    Greil, R, Obrtlíková, P, Smolej, L, Kozák, T, Steurer, M, Andel, J, Burgstaller, S, Mikušková, E, Gercheva, L, Nösslinger, T, Papajík, T, Ladická, M, Girschikofsky, M, Hrubiško, M, Jäger, U, Fridrik, M, Pecherstorfer, M, Králiková, E, Burcoveanu, C, Spasov, E, Petzer, A, Mihaylov, G, Raynov, J, Oexle, H, Zabernigg, A, Flochová, E, Palášthy, S, Stehlíková, O, Doubek, M, Altenhofer, P, Pleyer, L, Melchardt, T, Klingler, A, Mayer, J, Egle, A.
    Lancet Haematol. 2016, 3(7):e317-e329.

    View this publication in the PUBMED database
  • 2016

    Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic HematopoiesisMasters of Survival and Clonality?.

    Zaborsky, N, Gassner, FJ, Asslaber, D, Reinthaler, P, Denk, U, Flenady, S, Hofbauer, JP, Danner, B, Rebhandl, S, Harrer, A, Geisberger, R, Greil, R, Egle, A.
    Oncotarget. 2016.

    View this publication in the PUBMED database
  • 2016

    An international, multicenter, prospective, observational study of neutropenia in patients being treated with lenalidomide + dexamethasone for relapsed or relapsed/refractory multiple myeloma (RR-MM).

    Kollek, M, MГјller, A, Egle, A, Erlacher, M.
    FEBS J. 2016, 283(15):2779-2810.

    View this publication in the PUBMED database
  • 2016

    Developing a cancer immunogene therapy approach for Epidermolysis bullosa-associated squamous cell carcinoma.

    Melchardt, T, Hufnagl, C, Weinstock, DM, Kopp, N, Neureiter, D, Tränkenschuh, W, Hackl, H, Weiss, L, Rinnerthaler, G, Hartmann, TN, Greil, R, Weigert, O, Egle, A.
    Oncotarget. 2016.

    View this publication in the PUBMED database
  • 2016

    Combining antisense molecules with splicing modulation for KRT14 repair in epidermolysis bullosa.

    Willenbacher, W, Thangavadivel, S, Greil, R, Willenbacher, E, Weger, R, Manzl, C, Jöhrer, K, Brunner, A.
    Leuk Lymphoma. 2016, 57(10):2330-2341.

    View this publication in the PUBMED database
  • 2016

    Targeting tumor metabolism in the therapy of aggressive squamous cell carcinoma in patients with epidermolysis bullosa.

    Boige, V, Vincent, M, Alexandre, P, Tejpar, S, Landolfi, S, Le Malicot, K, Greil, R, Cuyle, PJ, Yilmaz, M, Faroux, R, Matzdorff, A, Salazar, R, Lepage, C, Taieb, J, Laurent-Puig, P.
    JAMA Oncol. 2016.

    View this publication in the PUBMED database
  • 2016

    Evaluation of the immunogenicity of viral epitopes in a cancer immunogene therapy approach for squamous cell carcinoma in RDEB.

    Gampenrieder, SP, Hufnagl, C, Brechelmacher, S, Huemer, F, Hackl, H, Rinnerthaler, G, Romeder, F, Monzo Fuentes, C, Morre, P, Hauser-Kronberger, C, Mlineritsch, B, Greil, R.
    Pharmacogenomics J. 2016.

    View this publication in the PUBMED database
  • 2016

    CRISPR/Cas9-mediated gene repair in the COL7A1 gene.

    Prochazka, KT, Melchardt, T, Posch, F, Schlick, K, Deutsch, A, Beham-Schmid, C, Weiss, L, Gary, T, Neureiter, D, Klieser, E, Greil, R, Neumeister, P, Egle, A, Pichler, M.
    Br J Cancer. 2016.

    View this publication in the PUBMED database
  • 2016

    CDK4/6 inhibition in luminal breast cancer.

    Gampenrieder, SP, Rinnerthaler, G, Greil, R.
    MEMO-MAG EUR MED ONC. 2016, 9(2): 76-81.

    View this publication in the PUBMED database
  • 2016

    Bcl-2 proteins in development, health, and disease of the hematopoietic system.

    Kollek, M, MГјller, A, Egle, A, Erlacher, M.
    FEBS J. 2016, 283(15):2779-2810.

    View this publication in the PUBMED database
  • 2016

    Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications.

    Pleyer, L, Burgstaller, S, Stauder, R, Girschikofsky, M, Sill, H, Schlick, K, Thaler, J, Halter, B, Machherndl-Spandl, S, Zebisch, A, Pichler, A, Pfeilstocker, M, Autzinger, EM, Lang, A, Geissler, K, Voskova, D, Geissler, D, Sperr, WR, Hojas, S, Rogulj, IM, Andel, J, Greil, R.
    J Hematol Oncol. 2016, 9:39.

    View this publication in the PUBMED database
  • 2016

    Immune checkpoint blockade in ovarian cancer.

    Weiss, L, Huemer, F, Mlineritsch, B, Greil, R.
    Memo. 2016, 9:82-84.

    View this publication in the PUBMED database
  • 2016

    Adjuvant medical treatment for breast cancer in elderly and old women.

    Westphal, T, Rinnerthaler, G, Mlineritsch, B.
    MEMO-MAG EUR MED ONC. 2016, 9(1): 17-19.

    View this publication in the PUBMED database
  • 2016

    CD1d expression on chronic lymphocytic leukemia B cells affects disease progression and induces T cell skewing in CD8 positive and CD4CD8 double negative T cells.

    Zaborsky, N, Gassner, FJ, Asslaber, D, Reinthaler, P, Denk, U, Flenady, S, Hofbauer, JP, Danner, B, Rebhandl, S, Harrer, A, Geisberger, R, Greil, R, Egle, A.
    Oncotarget. 2016.

    View this publication in the PUBMED database
  • 2016

    FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis.

    Suker, M, Beumer, BR, Sadot, E, Marthey, L, Faris, JE, Mellon, EA, El-Rayes, BF, Wang-Gillam, A, Lacy, J, Hosein, PJ, Moorcraft, SY, Conroy, T, Hohla, F, Allen, P, Taieb, J, Hong, TS, Shridhar, R, Chau, I, van Eijck, CH, Koerkamp, BG.
    Lancet Oncol. 2016, 17(6):801-810.

    View this publication in the PUBMED database
  • 2016

    Fluorouracil and Dihydropyrimidine Dehydrogenase Genotyping.

    Magnes, T, Melchardt, T, Weiss, L, Hufnagl, C, Greil, R, Egle, A,.
    J Clin Oncol. 2016, 34(20):2433-2434.

    View this publication in the PUBMED database
  • 2016

    Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials.

    Böll, B, Goergen, H, Behringer, K, Bröckelmann, PJ, Hitz, F, Kerkhoff, A, Greil, R, von Tresckow, B, Eichenauer, DA, Bürkle, C, Borchmann, S, Fuchs, M, Diehl, V, Engert, A, Borchmann, P.
    Blood. 2016, 127(18):2189-2192.

    View this publication in the PUBMED database
  • 2016

    Persistent CD49d engagement in circulating CLL cells: a role for blood-borne ligands?.

    Benedetti, D, Tissino, E, Caldana, C, Dal Bo, M, Bomben, R, Marconi, D, Ganghammer, S, Zaja, F, Pozzato, G, Di Raimondo, F, Hartmann, TN, Del Poeta, G, VanMeter, A, Zucchetto, A, Espina, V, Liotta, L, Gattei, V.
    Leukemia. 2016, 30(2): 513-517.

    View this publication in the PUBMED database
  • 2016

    Fluorouracil and Dihydropyrimidine Dehydrogenase Genotyping.

    Magnes, T, Melchardt, T, Weiss, L, Hufnagl, C, Greil, R, Egle, A.
    J Clin Oncol. 2016.

    View this publication in the PUBMED database
  • 2016

    Standardization of allergen products: 2. Detailed characterization of GMP-produced recombinant Phl p 5.0109 as European Pharmacopoeia reference standard.

    Himly, M, Nandy, A, Kahlert, H, Thilker, M, Steiner, M, Briza, P, Neubauer, A, Klysner, S, van Ree, R, Buchheit, KH, Vieths, S, Ferreira, F,f.
    Allergy. 2016, 71(4):49-504.

    View this publication in the PUBMED database
  • 2016

    Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo.

    Hanna, BS, McClanahan, F, Yazdanparast, H, Zaborsky, N, Kalter, V, Rößner, PM, Benner, A, Dürr, C, Egle, A, Gribben, JG, Lichter, P, Seiffert, M.
    Leukemia. 2016, 30(3): 570-579.

    View this publication in the PUBMED database
  • 2016

    A diagnostic algorithm for the detection of inhibitors against coagulation Factor V.

    Cadamuro, J, Skocic, M, Meisl, B, Raggam, RB, Felder, TK, PrГјller, F, Reinstadler, K, Wiedemann, H, Mrazek, C.
    Clin Chem Lab Med. 2016, 54(7):e203-e206.

    View this publication in the PUBMED database
  • 2016

    The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma.

    Troppan, KT, Melchardt, T, Wenzl, K, Schlick, K, Deutsch, A, Bullock, MD, Reitz, D, Beham-Schmid, C, Weiss, L, Neureiter, D, Tränkenschuh, W, Greil, R, Neumeister, P, Egle, A, Pichler, M.
    J Clin Pathol. 2016, 69(4):326-330.

    View this publication in the PUBMED database
  • 2016

    ILK Induction in Lymphoid Organs by a TNFО±-NF-ОєB-Regulated Pathway Promotes the Development of Chronic Lymphocytic Leukemia.

    Krenn, PW, Hofbauer, SW, Pucher, S, Hutterer, E, Hinterseer, E, Denk, U, Asslaber, D, Ganghammer, S, Sternberg, C, Neureiter, D, Aberger, F, Wickström, SA, Egle, A, Greil, R, Hartmann, TN.
    Cancer Res. 2016, 76(8):2186-2196.

    View this publication in the PUBMED database
  • 2016

    The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells.

    Hofbauer, SW, Krenn, PW, PiГ±ПЊn Hofbauer, J, Pucher, S, Asslaber, D, Egle, A, Hartmann, TN, Greil, R.
    Br J Haematol. 2016, 172(5): 815-819.

    View this publication in the PUBMED database
  • 2016

    Elevated Toll-Like Receptor-Induced CXCL8 Secretion in Human Blood Basophils from Allergic Donors Is Independent of Toll-Like Receptor Expression Levels.

    Steiner, M, Hawranek, T, Schneider, M, Ferreira, F, Horejs-Hoeck, J, Harrer, A, Himly, M.
    PLoS One. 2016, 11(2):e0149275.

    View this publication in the PUBMED database
  • 2016

    Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).

    Fridrik, MA, Jaeger, U, Petzer, A, Willenbacher, W, Keil, F, Lang, A, Andel, J, Burgstaller, S, Krieger, O, Oberaigner, W, Sihorsch, K, Greil, R.
    Eur J Cancer. 2016, 58:112-121.

    View this publication in the PUBMED database
  • 2016

    Combined CXCR3/CXCR4 measurements are of high prognostic value in chronic lymphocytic leukemia due to negative co-operativity of the receptors.

    Ganghammer, S, Gutjahr, J, Hutterer, E, Krenn, PW, Pucher, S, Zelle-Rieser, C, Jöhrer, K, Wijtmans, M, Leurs, R, Smit, MJ, Gattei, V, Greil, R, Hartmann, TN.
    Haematologica. 2016, 101(3):e99-e102.

    View this publication in the PUBMED database
  • 2016

    A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study.

    "Rawstron, AC, Fazi, C, Agathangelidis, A, Villamor, N, Letestu, R, Nomdedeu, J, Palacio, C, Stehlikova, O, Kreuzer, KA, Liptrot, S, O""Brien, D, de Tute, RM, Marinov, I, Hauwel, M, Spacek, M, Dobber, J, Kater, AP, Gambell, P, Soosapilla, A, Lozanski, G, Brachtl, G, Lin, K, Boysen, J, Hanson, C, Jorgensen, JL, Stetler-Stevenson, M, Yuan, C, Broome, HE, Rassenti, L, Craig, F, Delgado, J, Moreno, C, Bosch, F, Egle, A, Doubek, M, Pospisilova, S, Mulligan, S, Westerman, D, Sanders, CM, Emerson, R, Robins, HS, Kirsch, I, Shanafelt, T, Pettitt, A, Kipps, TJ, Wierda, WG, Cymbalista, F, Hallek, M, Hillmen, P, Montserrat, E, Ghia, P."
    Leukemia. 2016, 30(4):929-936.

    View this publication in the PUBMED database
  • 2016

    Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer.

    Gampenrieder, SP, Hufnagl, C, Brechelmacher, S, Huemer, F, Hackl, H, Rinnerthaler, G, Romeder, F, Monzo Fuentes, C, Morre, P, Hauser-Kronberger, C, Mlineritsch, B, Greil, R.
    Pharmacogenomics J. 2016.

    View this publication in the PUBMED database
  • 2016

    Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones.

    Melchardt, T, Hufnagl, C, Weinstock, DM, Kopp, N, Neureiter, D, Tränkenschuh, W, Hackl, H, Weiss, L, Rinnerthaler, G, Hartmann, TN, Greil, R, Weigert, O, Egle, A.
    Oncotarget. 2016.

    View this publication in the PUBMED database
  • 2016

    Low Beclin-1 expression predicts improved overall survival in patients treated with immunomodulatory drugs for multiple myeloma and identifies autophagy inhibition as a promising potentially druggable new therapeutic target: an analysis from The Austrian Myeloma Registry (AMR).

    Willenbacher, W, Thangavadivel, S, Greil, R, Willenbacher, E, Weger, R, Manzl, C, Jöhrer, K, Brunner, A.
    Leuk Lymphoma. 2016, xx: -12.

    View this publication in the PUBMED database
  • 2016

    Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials.

    Böll, B, Goergen, H, Behringer, K, Bröckelmann, PJ, Hitz, F, Kerkhoff, A, Greil, R, von Tresckow, B, Eichenauer, DA, Bürkle, C, Borchmann, S, Fuchs, M, Diehl, V, Engert, A, Borchmann, P.
    Blood. 2016, 127(18):2189-2192.

    View this publication in the PUBMED database
  • 2016

    DPYD Genotyping to Predict Adverse Events Following Treatment With Flourouracil-Based Adjuvant Chemotherapy in Patients With Stage III Colon Cancer: A Secondary Analysis of the PETACC-8 Randomized Clinical Trial.

    Boige, V, Vincent, M, Alexandre, P, Tejpar, S, Landolfi, S, Le Malicot, K, Greil, R, Cuyle, PJ, Yilmaz, M, Faroux, R, Matzdorff, A, Salazar, R, Lepage, C, Taieb, J, Laurent-Puig, P.
    JAMA Oncol. 2016, xx.

    View this publication in the PUBMED database
  • 2016

    miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites.

    Rinnerthaler, G, Hackl, H, Gampenrieder, SP, Hamacher, F, Hufnagl, C, Hauser-Kronberger, C, Zehentmayr, F, Fastner, G, Sedlmayer, F, Mlineritsch, B, Greil, R.
    Int J Mol Sci. 2016, 17(2).

    View this publication in the PUBMED database
  • 2015

    Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial.

    Jaeger, U, Trneny, M, Melzer, H, Praxmarer, M, Nawarawong, W, Ben Yehuda, D, Goldstein, D, Mihaljevic, B, Ilhan, O, Ballova, V, Hedenus, M, Hsiao, LT, Au, WY, Burgstaller, S, Weidinger, G, Keil, F, Dittrich, C, Skrabs, C, Klingler, A, Chott, A, Fridrik, MA, Greil, R.
    Haematologica. 2015, 100(7): 955-963.

    View this publication in the PUBMED database
  • 2015

    Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5-year follow-up.

    Ludwig, H, Greil, R, Masszi, T, Spicka, I, Shpilberg, O, Hajek, R, Dmoszynska, A, Paiva, B, Vidriales, MB, Esteves, G, Stoppa, AM, Robinson, D, Chaturvedi, S, Ataman, O, Enny, C, Feng, H, van de Velde, H, Viterbo, L.
    Br J Haematol. 2015, 171(3): 3-54.

    View this publication in the PUBMED database
  • 2015

    The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial.

    Fitzal, F, Filipits, M, Rudas, M, Greil, R, Dietze, O, Samonigg, H, Lax, S, Herz, W, Dubsky, P, Bartsch, R, Kronenwett, R, Gnant, M.
    Br J Cancer. 2015, 112(8): 1405-1410.

    View this publication in the PUBMED database
  • 2015

    The Role of CD44 in the Pathophysiology of Chronic Lymphocytic Leukemia.

    Gutjahr, JC, Greil, R, Hartmann, TN.
    FRONT IMMUNOL. 2015, 6: 177.

    View this publication in the PUBMED database
  • 2015

    The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients.

    Troppan, KT, Melchardt, T, Deutsch, A, Schlick, K, Stojakovic, T, Bullock, MD, Reitz, D, Beham-Schmid, C, Weiss, L, Neureiter, D, Wenzl, K, Greil, R, Neumeister, P, Egle, A, Pichler, M.
    Eur J Haematol. 2015, 95(6): 538-544.

    View this publication in the PUBMED database
  • 2015

    Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study.

    Leierer, G, Grabmeier-Pfistershammer, K, Steuer, A, Geit, M, Sarcletti, M, Haas, B, Kanatschnig, M, Rappold, M, Zangerle, R, Ledergerber, B, Taylor, N.
    PLOS ONE. 2015, 10(11).

    View this publication in the PUBMED database
  • 2015

    Treatment of Patients With Myelodysplastic Syndrome With Lenalidomide in Clinical Routine in Austria.

    Aschauer, G, Greil, R, Linkesch, W, Nösslinger, T, Stauder, R, Burgstaller, S, Fiegl, M, Fridrik, M, Girschikofsky, M, Keil, F, Petzer, A.
    Clin Lymphoma Myeloma Leuk. 2015, 15(11): e143-e149.

    View this publication in the PUBMED database
  • 2015

    Renaissance eines alten Bekannten - Bedeutung des Androgenrezeptors beim Mammakarzinom.

    Rinnerthaler, G.
    Wiener klinisches Magazin. 2015, 18(6).

    View this publication in the PUBMED database
  • 2015

    AID/APOBEC deaminases and cancer.

    Rebhandl, S, Huemer, M, Greil, R, Geisberger, R.
    Oncoscience. 2015, 2(4): 320-333.

    View this publication in the PUBMED database
  • 2015

    CD4+ T cells, but not non-classical monocytes, are dispensable for the development of chronic lymphocytic leukemia in the TCL1-tg murine model.

    Kocher, T, Asslaber, D, Zaborsky, N, Flenady, S, Denk, U, Reinthaler, P, Ablinger, M, Geisberger, R, Bauer, JW, Seiffert, M, Hartmann, TN, Greil, R, Egle, A, Hofbauer, JP.
    Leukemia. 2015, xx.

    View this publication in the PUBMED database
  • 2015

    Lessons from gain- and loss-of-function models of pro-survival Bcl2 family proteins: implications for targeted therapy.

    Sochalska, M, Tuzlak, S, Egle, A, Villunger, A.
    FEBS J. 2015, 282(5): 834-849.

    View this publication in the PUBMED database
  • 2015

    Non-pegylated liposomal doxorubicin in lymphoma: patterns of toxicity and outcome in a large observational trial.

    Wasle, I, Gamerith, G, Kocher, F, Mondello, P, Jaeger, T, Walder, A, Auberger, J, Melchardt, T, Linkesch, W, Fiegl, M, Mian, M.
    Ann Hematol. 2015, 94(4): 593-601.

    View this publication in the PUBMED database
  • 2015

    Azacitidine frontline therapy for unfit acute myeloid leukemia patients: Clinical use and outcome prediction.

    Ramos, F, ThГ©pot, S, Pleyer, L, Maurillo, L, Itzykson, R, Bargay, J, Stauder, R, Venditti, A, Seegers, V, MartГ­nez-Robles, V, Burgstaller, S, RГ©cher, C, DebГ©n, G, Gaidano, G, Gardin, C, Musto, P, Greil, R, SГЎnchez-Guijo, F, Fenaux, P.
    Leuk Res. 2015, 39(3): 296-306.

    View this publication in the PUBMED database
  • 2015

    Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study.

    Nachbaur, D, Angelova, O, Orth-Holler, D, Ditlbacher, A, Lackner, M, Auberger, J, Lass-Florl, C.
    EUR J HAEMATOL. 2015, 94(3): 258-264.

    View this publication in the PUBMED database
  • 2015

    Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry.

    Kocher, F, Hilbe, W, Seeber, A, Pircher, A, Schmid, T, Greil, R, Auberger, J, Nevinny-Stickel, M, Sterlacci, W, Tzankov, A, Jamnig, H, Kohler, K, Zabernigg, A, Frotscher, J, Oberaigner, W, Fiegl, M.
    LUNG CANCER. 2015, 87(2): 193-200.

    View this publication in the PUBMED database
  • 2015

    Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study.

    Tiede, A, Klamroth, R, Scharf, RE, Trappe, RU, Holstein, K, Huth-Kühne, A, Gottstein, S, Geisen, U, Schenk, J, Scholz, U, Schilling, K, Neumeister, P, Miesbach, W, Manner, D, Greil, R, von Auer, C, Krause, M, Leimkühler, K, Kalus, U, Blumtritt, J, Werwitzke, S, Budde, E, Koch, A, Knöbl, P.
    Blood. 2015, 125(7): 1091-1097.

    View this publication in the PUBMED database
  • 2015

    Lenalidomide and dexamethasone for acute light chain-induced renal failure: a phase II study.

    Ludwig, H, Rauch, E, Kuehr, T, Adam, Z, Weissmann, A, Kasparu, H, Autzinger, EM, Heintel, D, Greil, R, Poenisch, W, MГјldГјr, E, Zojer, N.
    Haematologica. 2015, 100(3):385-391.

    View this publication in the PUBMED database
  • 2015

    10th anniversary of the Austrian MDS Platform: aims and ongoing projects.

    Burgstaller, S, Bettelheim, P, Krieger, O, Machherndl-Spandl, S, Nösslinger, T, Pleyer, L, Sill, H, Sperr, WR, Stauder, R, Valent, P, Pfeilstöcker, M.
    Wien Klin Wochenschr. 2015, 127(1-2): 12-15.

    View this publication in the PUBMED database
  • 2015

    A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and ОІ2 -microglobulin.

    Melchardt, T, Troppan, K, Weiss, L, Hufnagl, C, Neureiter, D, Tränkenschuh, W, Hopfinger, G, Magnes, T, Deutsch, A, Neumeister, P, Hackl, H, Greil, R, Pichler, M, Egle, A.
    Br J Haematol. 2015, 168(2):239-245.

    View this publication in the PUBMED database
  • 2015

    Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients.

    Blank, PR, Filipits, M, Dubsky, P, Gutzwiller, F, Lux, MP, Brase, JC, Weber, KE, Rudas, M, Greil, R, Loibl, S, Szucs, TD, Kronenwett, R, Schwenkglenks, M, Gnant, M.
    Pharmacoeconomics. 2015, 33(2): 179-190.

    View this publication in the PUBMED database
  • 2015

    VLA-4 and CXCR4 overexpression in bone marrow of an aleukemic B-cell acute lymphoblastic leukemia presenting with osteolytic bone lesions.

    Hinterseer, E, Stiefel, O, Neureiter, D, Kandler, G, Vogt, S, Hutter, J, Strasser, G, Greil, R, Hartmann, TN, Hopfinger, G.
    Leuk Lymphoma. 2015, 56(8): 2465-2467.

    View this publication in the PUBMED database
  • 2015

    Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases.

    Berghoff, AS, Ilhan-Mutlu, A, Dinhof, C, Magerle, M, Hackl, M, Widhalm, G, Hainfellner, JA, Dieckmann, K, Pichler, J, Hutterer, M, Melchardt, T, Bartsch, R, Zielinski, CC, Birner, P, Preusser, M.
    Neuropathol Appl Neurobiol. 2015, 41(2):e41-e55.

    View this publication in the PUBMED database
  • 2015

    Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeutics.

    Melchardt, T, Weiss, L, Hufnagl, C, Neureiter, D, Kemmerling, R, Morre, P, Boekstegers, A, Hopfinger, G, Auberger, J, Steinkirchner, S, Pleyer, L, Greil, R, Egle, A.
    Leuk Lymphoma. 2015, 56(2):353-360.

    View this publication in the PUBMED database
  • 2015

    Relations of vitamin D status, gender and type 2 diabetes in middle-aged Caucasians.

    Stadlmayr, A, Aigner, E, Huber-Schönauer, U, Niederseer, D, Zwerina, J, Husar-Memmer, E, Hohla, F, Schett, G, Patsch, W, Datz, C.
    Acta Diabetol. 2015, 52(1):39-46.

    View this publication in the PUBMED database
  • 2015

    A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with advanced solid tumors.

    Dittrich, C, Fridrik, MA, Koenigsberg, R, Lee, C, Goeldner, R, Hilbert, J, Greil, R.
    Invest New Drugs. 2015, 33(2): 409-422.

    View this publication in the PUBMED database
  • 2015

    Adipocyte-derived players in hematologic tumors: useful novel targets?.

    Jöhrer, K, Ploner, C, Thangavadivel, S, Wuggenig, P, Greil, R.
    Expert Opin Biol Ther. 2015, 15(1): 61-77.

    View this publication in the PUBMED database
  • 2015

    A patient diagnosed with BRAF-mutated non-small cell lung cancer and hairy cell leukemia: at last, which entity is really carrying the BRAF mutation?.

    Schlick, K, Troch, M, Placher-Sorko, G, Faber, V, Neureiter, D, Berghoff, AS, Preusser, M, Greil, R, Hopfinger, G.
    Ann Hematol. 2015, 94(2): 345-346.

    View this publication in the PUBMED database
  • 2015

    Lapatinib-plus-Pegylated Liposomal Doxorubicin in Advanced HER2-positive Breast Cancer Following Trastuzumab: A Phase II Trial.

    Pircher, M, Mlineritsch, B, Fridrik, MA, Dittrich, C, Lang, A, Petru, E, Weltermann, A, Thaler, J, Hufnagl, C, Gampenrieder, SP, Rinnerthaler, G, Ressler, S, Ulmer, H, Greil, R.
    Anticancer Res. 2015, 35(1): 517-521.

    View this publication in the PUBMED database
  • 2015

    IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer-Results of a case series after 5-year follow-up.

    Fastner, G, Reitsamer, R, Ziegler, I, Zehentmayr, F, Fussl, C, Kopp, P, Peintinger, F, Greil, R, Fischer, T, Deutschmann, H, Sedlmayer, F.
    Int J Cancer. 2015, 136(5): 1193-1201.

    View this publication in the PUBMED database
  • 2015

    Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12.

    Gnant, M, Mlineritsch, B, Stoeger, H, Luschin-Ebengreuth, G, Knauer, M, Moik, M, Jakesz, R, Seifert, M, Taucher, S, Bjelic-Radisic, V, Balic, M, Eidtmann, H, Eiermann, W, Steger, G, Kwasny, W, Dubsky, P, Selim, U, Fitzal, F, Hochreiner, G, Wette, V, Sevelda, P, Ploner, F, Bartsch, R, Fesl, C, Greil, R.
    Ann Oncol. 2015, 26(2):313-320.

    View this publication in the PUBMED database
  • 2015

    "Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin""s lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial."

    Behringer, K, Goergen, H, Hitz, F, Zijlstra, JM, Greil, R, Markova, J, Sasse, S, Fuchs, M, Topp, MS, Soekler, M, Mathas, S, Meissner, J, Wilhelm, M, Koch, P, Lindemann, H, Schalk, E, Semrau, R, Kriz, J, Vieler, T, Bentz, M, Lange, E, Mahlberg, R, Hassler, A, Vogelhuber, M, Hahn, D, Mezger, J, Krause, SW, Skoetz, N, Böll, B, von Tresckow, B, Diehl, V, Hallek, M, Borchmann, P, Stein, H, Eich, H, Engert, A.
    Lancet. 2015, 385(9976):1418-1427.

    View this publication in the PUBMED database
  • 2015

    Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg-proline-interferon alpha-2b.

    Them, NC, Bagienski, K, Berg, T, Gisslinger, B, Schalling, M, Chen, D, Buxhofer-Ausch, V, Thaler, J, Schloegl, E, Gastl, GA, Wolf, D, Strecker, K, Egle, A, Melchardt, T, Burgstaller, S, Willenbacher, E, Zagrijtschuk, O, Klade, C, Greil, R, Gisslinger, H, Kralovics, R.
    Am J Hematol. 2015, 90(4): 288-294.

    View this publication in the PUBMED database
  • 2015

    CD18 (ITGB2) expression in chronic lymphocytic leukaemia is regulated by DNA methylation-dependent and -independent mechanisms.

    Hutterer, E, Asslaber, D, Caldana, C, Krenn, PW, Zucchetto, A, Gattei, V, Greil, R, Hartmann, TN.
    Br J Haematol. 2015, 169(2):286-289.

    View this publication in the PUBMED database
  • 2015

    Hedgehog/GLI and PI3K signaling in the initiation and maintenance of chronic lymphocytic leukemia.

    Kern, D, Regl, G, Hofbauer, SW, Altenhofer, P, Achatz, G, Dlugosz, A, Schnidar, H, Greil, R, Hartmann, TN, Aberger, F.
    Oncogene. 2015, 34(42): 5341-5351.

    View this publication in the PUBMED database
  • 2015

    B-cell receptor usage correlates with the sensitivity to CD40 stimulation and the occurrence of CD4+ T-cell clonality in chronic lymphocytic leukemia.

    Zaborsky, N, Holler, C, Geisberger, R, Asslaber, D, Gassner, FJ, Egger, V, PiГ±Гіn-Hofbauer, J, Kocher, T, Hartmann, TN, Greil, R, Egle, A.
    Haematologica. 2015, 100(8): e307-e310.

    View this publication in the PUBMED database
  • 2015

    [Therapie des Patienten mit Radioiod-refraktärem, differenziertem Schilddrüsenkarzinom. Ein Konsensusstatement].

    Lindner, C, Dierneder, J, Pall, G, Pirich, C, Hoffmann, M, Raderer, M, Becherer, A, Niederle, B, Lipp, R, Lind, P, Gallowitsch, H, Romeder, F, Virgolini, I.
    Nuklearmedizin. 2015, 54(3): 125-130.

    View this publication in the PUBMED database
  • 2015

    Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2,5) translocation.

    Merkel, O, Hamacher, F, Griessl, R, Grabner, L, Schiefer, AI, Prutsch, N, Baer, C, Egger, G, Schlederer, M, Krenn, PW, Hartmann, TN, Simonitsch-Klupp, I, Plass, C, Staber, PB, Moriggl, R, Turner, SD, Greil, R, Kenner, L.
    J Pathol. 2015, 236(4): 44-56.

    View this publication in the PUBMED database
  • 2015

    Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype.

    Gnant, M, Sestak, I, Filipits, M, Dowsett, M, Balic, M, Lopez-Knowles, E, Greil, R, Dubsky, P, Stoeger, H, Rudas, M, Jakesz, R, Ferree, S, Cowens, JW, Nielsen, T, Schaper, C, Fesl, C, Cuzick, J.
    ANN ONCOL. 2015, 26(8): 1685-1691.

    View this publication in the PUBMED database
  • 2015

    AIDing cancer treatment: Reducing AID activity via HSP90 inhibition.

    Rebhandl, S, Geisberger, R.
    Eur J Immunol. 2015, 45(8): 2208-2211.

    View this publication in the PUBMED database
  • 2015

    Chronic lymphocytic leukaemia induces an exhausted T cell phenotype in the TCL1 transgenic mouse model.

    Gassner FJ, Zaborsky N, Catakovic K, Rebhandl S, Huemer M, Egle A, Hartmann TN, Greil R, Geisberger R.
    Br J Haematol. 2015 Aug,170(4):515-22. doi: 10.1111/bjh.13467. Epub 2015 May 4.

    View this publication in the PUBMED database
  • 2015

    Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.

    Gnant, M, Pfeiler, G, Dubsky, PC, Hubalek, M, Greil, R, Jakesz, R, Wette, V, Balic, M, Haslbauer, F, Melbinger, E, Bjelic-Radisic, V, Artner-Matuschek, S, Fitzal, F, Marth, C, Sevelda, P, Mlineritsch, B, Steger, GG, Manfreda, D, Exner, R, Egle, D, Bergh, J, Kainberger, F, Talbot, S, Warner, D, Fesl, C, Singer, CF.
    LANCET. 2015, 386(9992): 433-443.

    View this publication in the PUBMED database
  • 2015

    CXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21.

    Ganghammer, S, Hutterer, E, Hinterseer, E, Brachtl, G, Asslaber, D, Krenn, PW, Girbl, T, Berghammer, P, Geisberger, R, Egle, A, Zucchetto, A, Kruschinski, A, Gattei, V, Chigaev, A, Greil, R, Hartmann, TN.
    Oncotarget. 2015, 6(14): 12048-12060.

    View this publication in the PUBMED database
  • 2015

    CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer.

    Melchardt, T, Hufnagl, C, Magnes, T, Weiss, L, Hutarew, G, Neureiter, D, Schlattau, A, Moser, G, Gaggl, A, Tränkenschuh, W, Greil, R, Egle, A.
    BMC Cancer. 2015, 15:725.

    View this publication in the PUBMED database
  • 2015

    "Digging deep into ""dirty"" drugs - modulation of the methylation machinery."

    Pleyer, L, Greil, R.
    Drug Metab Rev. 2015, 47(2): 252-279.

    View this publication in the PUBMED database
  • 2015

    Cytomegalovirus reactivation and its clinical impact in patients with solid tumors.

    Schlick, K, Grundbichler, M, Auberger, J, Kern, JM, Hell, M, Hohla, F, Hopfinger, G, Greil, R.
    INFECT AGENTS CANCER. 2015, 10:.

    View this publication in the PUBMED database
  • 2015

    Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI.

    Melchardt, T, Troppan, K, Weiss, L, Hufnagl, C, Neureiter, D, Tränkenschuh, W, Schlick, K, Huemer, F, Deutsch, A, Neumeister, P, Greil, R, Pichler, M, Egle, A.
    J Natl Compr Canc Netw. 2015, 13(12):1501-1508.

    View this publication in the PUBMED database
  • 2015

    Ropeginterferon alfa-2b, a novel IFNО±-2b, induces high response rates with low toxicity in patients with polycythemia vera.

    Gisslinger, H, Zagrijtschuk, O, Buxhofer-Ausch, V, Thaler, J, Schloegl, E, Gastl, GA, Wolf, D, Kralovics, R, Gisslinger, B, Strecker, K, Egle, A, Melchardt, T, Burgstaller, S, Willenbacher, E, Schalling, M, Them, NC, Kadlecova, P, Klade, C, Greil, R.
    Blood. 2015, 126(15): 1762-1769.

    View this publication in the PUBMED database
  • 2015

    Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck Cancer.

    Huemer, F, Melchardt, T, Tränkenschuh, W, Neureiter, D, Moser, G, Magnes, T, Weiss, L, Schlattau, A, Hufnagl, C, Ricken, G, Höftberger, R, Greil, R, Egle, A.
    BMC Cancer. 2015, 15:996.

    View this publication in the PUBMED database
  • 2015

    Response to comment by P. Vassilakopoulos and colleagues.

    Jaeger, U, Praxmarer, M, Greil, R.
    Haematologica. 2015, 100(11): e482.

    View this publication in the PUBMED database
  • 2015

    Interessante PraМ€sentationen am europaМ€ischen Krebskongress: Neue Daten beim Mammakarzinom.

    Gampenrieder, SP.
    Spectrum Onkologie. 2015. 05: 34-36.

    View this publication in the PUBMED database
  • 2014

    Chemotherapy-induced augmentation of T cells expressing inhibitory receptors is reversed by treatment with lenalidomide in chronic lymphocytic leukemia.

    Gassner FJ, Zaborsky N, Neureiter D, Huemer M, Melchardt T, Egle A, Rebhandl S, Catakovic K, Hartmann TN, Greil R, Geisberger R.
    Haematologica. 2014 May,99(5):67-9. doi: 10.3324/haematol.2013.098459. Epub 2014 Feb 21.

    View this publication in the PUBMED database
  • 2014

    AID induces intraclonal diversity and genomic damage in CD86(+) chronic lymphocytic leukemia cells.

    Huemer M, Rebhandl S, Zaborsky N, Gassner FJ, Hainzl S, Weiss L, Hebenstreit D, Greil R, Geisberger R.
    Eur J Immunol. 2014 Dec,44(12):3747-57. doi: 10.1002/eji.201344421. Epub 2014 Oct 18.

    View this publication in the PUBMED database
  • 2014

    APOBEC3 signature mutations in chronic lymphocytic leukemia.

    Rebhandl S, Huemer M, Gassner FJ, Zaborsky N, Hebenstreit D, Catakovic K, Grössinger EM, Greil R, Geisberger R.
    Leukemia. 2014 Sep,28(9):1929-32. doi: 10.1038/leu.2014.160. Epub 2014 May 20.

    View this publication in the PUBMED database
  • 2014

    Alternative splice variants of AID are not stoichiometrically present at the protein level in chronic lymphocytic leukemia.

    Rebhandl S, Huemer M, Zaborsky N, Gassner FJ, Catakovic K, Felder TK, Greil R, Geisberger R.
    Eur J Immunol. 2014 Jul,44(7):2175-87. doi: 10.1002/eji.201343853. Epub 2014 Apr 15.

    View this publication in the PUBMED database
  • 2014

    Targeting proliferation of chronic lymphocytic leukemia (CLL) cells through KCa3.1 blockade.

    Grössinger EM, Weiss L, Zierler S, Rebhandl S, Krenn PW, Hinterseer E, Schmölzer J, Asslaber D, Hainzl S, Neureiter D, Egle A, Piñón-Hofbauer J, Hartmann TN, Greil R, Kerschbaum HH.
    Leukemia. 2014 Apr,28(4):954-8. doi: 10.1038/leu.2014.37. Epub 2014 Jan 20.

    View this publication in the PUBMED database
  • 2014

    VLA-4 and CXCR4 overexpression in bone marrow of an aleukemic B-cell acute lymphoblastic leukemia presenting with osteolytic bone lesions.

    Hinterseer E, Stiefel O, Neureiter D, Kandler G, Vogt S, Hutter J, Strasser G, Greil R, Hartmann TN, Hopfinger G.
    Leuk Lymphoma. 2015 Feb 9:1-3. [Epub ahead of print]

    View this publication in the PUBMED database
  • 2014

    Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12.

    Gnant, M, Mlineritsch, B, Stoeger, H, Luschin-Ebengreuth, G, Knauer, M, Moik, M, Jakesz, R, Seifert, M, Taucher, S, Bjelic-Radisic, V, Balic, M, Eidtmann, H, Eiermann, W, Steger, G, Kwasny, W, Dubsky, P, Selim, U, Fitzal, F, Hochreiner, G, Wette, V, Sevelda, P, Ploner, F, Bartsch, R, Fesl, C, Greil, R
    Ann Oncol. 2015 Feb,26(2):313-20. doi: 10.1093/annonc/mdu544

    View this publication in the PUBMED database
  • 2014

    CD18 (ITGB2) expression in chronic lymphocytic leukaemia is regulated by DNA methylation-dependent and -independent mechanisms.

    Hutterer E, Asslaber D, Caldana C, Krenn PW, Zucchetto A, Gattei V, Greil R, Hartmann TN.
    Br J Haematol. 2015 Apr,169(2):286-9. doi: 10.1111/bjh.13188. Epub 2014 Oct 17.

    View this publication in the PUBMED database
  • 2014

    "The CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by on-demand"" addition of plerixafor to granulocyte-colony-stimulating factor."""

    Girbl T, Lunzer V, Greil R, Namberger K, Hartmann TN.
    Transfusion. 2014 Sep,54(9):2325-35. doi: 10.1111/trf.12632. Epub 2014 Mar 28.

    View this publication in the PUBMED database
  • 2014

    Tiam1/Rac1 signals contribute to the proliferation and chemoresistance, but not motility of chronic lymphocytic leukemia cells.

    Hofbauer SW, Krenn PW, Ganghammer S, Asslaber D, Pichler U, Oberascher K, Henschler R, Wallner M, Kerschbaum H, Greil R, Hartmann TN.
    Blood. 2014 Apr 3,123(14):2181-8. doi: 10.1182/blood-2013-08-523563. Epub 2014 Feb 5.

    View this publication in the PUBMED database
  • 2014

    Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24).

    Steger GG, Greil R, Lang A, Rudas M, Fitzal F, Mlineritsch B, Hartmann BL, Bartsch R, Melbinger E, Hubalek M, Stoeger H, Dubsky P, Ressler S, Petzer AL, Singer CF, Muss C, Jakesz R, Gampenrieder SP, Zielinski CC, Fesl C, Gnant M
    Ann Oncol. 2014 Feb,25(2):366-71. doi: 10.1093/annonc/mdt508. Epub 2013 Dec 16.

    View this publication in the PUBMED database
  • 2014

    The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia.

    Brachtl G, PiГ±Гіn Hofbauer J, Greil R, Hartmann TN.
    Ann Hematol. 2014 Mar,93(3):361-74. doi: 10.1007/s00277-013-1967-y. Epub 2013 Nov 28.

    View this publication in the PUBMED database
  • 2014

    Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg-proline-interferon alpha-2b.

    Them NC, Bagienski K, Berg T, Gisslinger B, Schalling M, Chen D, Buxhofer-Ausch V, Thaler J, Schloegl E, Gastl GA, Wolf D, Strecker K, Egle A, Melchardt T, Burgstaller S, Willenbacher E, Zagrijtschuk O, Klade C, Greil R, Gisslinger H, Kralovics R.
    Am J Hematol. 2015 Apr,90(4):288-94. doi: 10.1002/ajh.23928. Epub 2015 Mar 2.

    View this publication in the PUBMED database
  • 2014

    A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and ГЋВІ(2) -microglobulin.

    Melchardt T, Troppan K, Weiss L, Hufnagl C, Neureiter D, Tränkenschuh W, Hopfinger G, Magnes T, Deutsch A, Neumeister P, Hackl H, Greil R, Pichler M, Egle A.
    Br J Haematol. 2015 Jan,168(2):239-45. doi: 10.1111/bjh.13116. Epub 2014 Sep 19.

    View this publication in the PUBMED database
  • 2014

    Kasabach-Merritt phenomenon in hepatic angiosarcoma.

    Habringer S, Boekstegers A, Weiss L, Hopfinger G, Meissnitzer T, Melchardt T, Egle A, Greil R.
    Br J Haematol. 2014 Dec,167(5):716-8. doi: 10.1111/bjh.13049. Epub 2014 Jul 24.

    View this publication in the PUBMED database
  • 2014

    C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.

    Troppan KT, Schlick K, Deutsch A, Melchardt T, Egle A, Stojakovic T, Beham-Schmid C, Weiss L, Neureiter D, Wenzl K, Greil R, Neumeister P, Pichler M.
    Br J Cancer. 2014 Jul 8,111(1):55-60. doi: 10.1038/bjc.2014.277. Epub 2014 May 29.

    View this publication in the PUBMED database
  • 2014

    Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeutics.

    Melchardt T, Weiss L, Hufnagl C, Neureiter D, Kemmerling R, Morre P, Boekstegers A, Hopfinger G, Auberger J, Steinkirchner S, Pleyer L, Greil R, Egle A.
    Leuk Lymphoma. 2015 Feb,56(2):353-60. doi: 10.3109/10428194.2014.916798. Epub 2014 Jun 25.

    View this publication in the PUBMED database
  • 2014

    Liver toxicity during temozolomide chemotherapy caused by Chinese herbs.

    Melchardt T, Magnes T, Weiss L, Grundbichler M, Strasser M, Hufnagl C, Moik M, Greil R, Egle A.
    BMC Complement Altern Med. 2014 Mar 30,14:115. doi: 10.1186/1472-6882-14-115.

    View this publication in the PUBMED database
  • 2014

    Human immunodeficiency virus type 2 infections in Austria.

    Taylor N, Kern JM, Prammer W, Lang A, Haas B, Gisinger M, Zangerle R, Egle A, Greil R, Oberkofler H, Eberle J.
    Wien Klin Wochenschr. 2014 Apr,126(7-8):212-6. doi: 10.1007/s00508-013-0493-1. Epub 2014 Jan 18.

    View this publication in the PUBMED database
  • 2014

    Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial.

    Hopfinger G, Nösslinger T, Lang A, Linkesch W, Melchardt T, Weiss L, Egle A, Greil R.
    Ann Hematol. 2014 Mar,93(3):459-62. doi: 10.1007/s00277-014-2009-0. Epub 2014 Jan 18.

    View this publication in the PUBMED database
  • 2014

    Increased body mass index is associated with improved overall survival in diffuse large B-cell lymphoma.

    Weiss L, Melchardt T, Habringer S, Boekstegers A, Hufnagl C, Neureiter D, Hopfinger G, Greil R, Egle A.
    Ann Oncol. 2014 Jan,25(1):171-6. doi: 10.1093/annonc/mdt481. Epub 2013 Dec 3.

    View this publication in the PUBMED database
  • 2014

    Pleural decortication of a marginal zone lymphoma.

    Melchardt T, Weiss L, Namberger K, Pretsch I, Hutter J, Rettenbacher L, Neureiter D, Troch M, Greil R, Egle A.
    Ann Hematol. 2014 Jul,93(7):1253-4. doi: 10.1007/s00277-013-1960-5. Epub 2013 Nov 22.

    View this publication in the PUBMED database
  • 2014

    Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.

    Behringer K, Goergen H, Hitz F, Zijlstra JM, Greil R, Markova J, Sasse S, Fuchs M, Topp MS, Soekler M, Mathas S, Meissner J, Wilhelm M, Koch P, Lindemann H, Schalk E, Semrau R, Kriz J, Vieler T, Bentz M, Lange E, Mahlberg R, Hassler A, Vogelhuber M, Hahn D, Mezger J, Krause SW, Skoetz N, Böll B, von Tresckow B, Diehl V, Hallek M, Borchmann P, Stein H, Eich H, Engert A, on behalf of the German Hodgkin Study Group, the Swiss Group for Clinical Cancer Research, the Österreichische Arbeitsgemeinschaft für Klinische Pharmakologie und Therapie.
    Lancet. 2015 Apr 11,385(9976):1418-27. doi: 10.1016/S0140-6736(14)61469-0. Epub 2014 Dec 22.

    View this publication in the PUBMED database
  • 2014

    A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with advanced solid tumors.

    Dittrich C, Fridrik MA, Koenigsberg R, Lee C, Goeldner R, Hilbert J, Greil R.
    Invest New Drugs. 2015 Apr,33(2):409-22. doi: 10.1007/s10637-014-0201-7. Epub 2014 Dec 23.

    View this publication in the PUBMED database
  • 2014

    Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study.

    Tiede A, Klamroth R, Scharf RE, Trappe RU, Holstein K, Huth-Kühne A, Gottstein S, Geisen U, Schenk J, Scholz U, Schilling K, Neumeister P, Miesbach W, Manner D, Greil R,von Auer C, Krause M, Leimkühler K, Kalus U, Blumtritt J, Werwitzke S, Budde E, Koch A, Knöbl P.
    Blood. 2015 Feb 12,125(7):1091-7. doi: 10.1182/blood-2014-07-587089. Epub 2014 Dec 18.

    View this publication in the PUBMED database
  • 2014

    Cost-Effectiveness Analysis of Prognostic Gene Expression Signature-Based Stratification of Early Breast Cancer Patients.

    Blank PR, Filipits M, Dubsky P, Gutzwiller F, Lux MP, Brase JC, Weber KE, Rudas M, Greil R, Loibl S, Szucs TD, Kronenwett R, Schwenkglenks M, Gnant M.
    Pharmacoeconomics. 2015 Feb,33(2):179-90. doi: 10.1007/s40273-014-0227-x.

    View this publication in the PUBMED database
  • 2014

    Lenalidomide and dexamethasone for acute light chain-induced renal failure: a phase II study.

    Ludwig H, Rauch E, Kuehr T, Adam Z, Weissmann A, Kasparu H, Autzinger EM, Heintel D, Greil R, Poenisch W, MГјldГјr E, Zojer N.
    Haematologica. 2015 Mar,100(3):385-91. doi: 10.3324/haematol.2014.115204. Epub 2014 Nov 14.

    View this publication in the PUBMED database
  • 2014

    Preoperative Treatment with Capecitabine, Cetuximab and Radiotherapy for Primary Locally Advanced Rectal Cancer - A Phase II Clinical Trial.

    Eisterer W, DE Vries A, Ofner D, Rabl H, Koplmüller R, Greil R, Tschmelitsch J, Schmid R, Kapp K, Lukas P, Sedlmayer F, Höfler G, Gnant M, Thaler J
    Anticancer Res. 2014 Nov,34(11):6767-73.

    View this publication in the PUBMED database
  • 2014

    Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses.

    Brodowicz T, Lang I, Kahan Z, Greil R, Beslija S, Stemmer SM, Kaufman B, Petruzelka L, Eniu A, Anghel R, Koynov K, Vrbanec D, Pienkowski T, Melichar B, Spanik S, Ahlers S, Messinger D, Inbar MJ, Zielinski C.
    Br J Cancer. 2014 Nov 25,111(11):2051-7. doi: 10.1038/bjc.2014.504. Epub 2014 Sep 30.

    View this publication in the PUBMED database
  • 2014

    Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma.

    Benboubker L, Dimopoulos MA, Dispenzieri A, Catalano J, Belch AR, Cavo M, Pinto A, Weisel K, Ludwig H, Bahlis N, Banos A, Tiab M, Delforge M, Cavenagh J, Geraldes C, Lee JJ, Chen C, Oriol A, de la Rubia J, Qiu L, White DJ, Binder D, et al.
    N Engl J Med. 2014 Sep 4,371(10):906-17. doi: 10.1056/NEJMoa1402551.

    View this publication in the PUBMED database
  • 2014

    A randomized, open-label multicentre phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine cyclophosphamide and rituximab versus fludarabine cyclophosphamide and rituximab versus fludarabine cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia.

    Awan FT, Hillmen P, Hellmann A, Robak T, Hughes SG, Trone D, Shannon M, Flinn IW, Byrd JC
    Br J Haematol. 2014 Nov,167(4):466-77. doi: 10.1111/bjh.13061. Epub 2014 Aug 8.

    View this publication in the PUBMED database
  • 2014

    MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis.

    Benner A, Mansouri L, Rossi D, Majid A, Willander K, Parker A, Bond G, Pavlova S, Nückel H, Merkel O, Ghia P, Montserrat E, Kaderi MA, Rosenquist R, Gaidano G, Dyer MJ, Söderkvist P, Linderholm M, Oscier D, Tvaruzkova Z, Pospisilova S, Dührsen U, Greil R, Döhner H, Stilgenbauer S, Zenz T, European Research Initiative on CLL (ERIC)
    Haematologica. 2014 Aug,99(8):1285-91. doi: 10.3324/haematol.2013.101170.

    View this publication in the PUBMED database
  • 2014

    A patient diagnosed with BRAF-mutated non-small cell lung cancer and hairy cell leukemia: at last, which entity is really carrying the BRAF mutation?

    Schlick K, Troch M, Placher-Sorko G, Faber V, Neureiter D, Berghoff AS, Preusser M, Greil R, Hopfinger G.
    Ann Hematol. 2015 Feb,94(2):345-6. doi: 10.1007/s00277-014-2162-5. Epub 2014 Jul 24.

    View this publication in the PUBMED database
  • 2014

    Multicenter phase II study evaluating docetaxel and cisplatin as neoadjuvant induction regimen prior to surgery or radiochemotherapy with docetaxel, followed by adjuvant docetaxel therapy in chemonaive patients with NSCLC stage II IIIA and IIIB (TAX-AT 1.203 Trial).

    Kocher F, Pircher A, Mohn-Staudner A, Romeder F, Duller W, Steinmaurer M, Eckmayr J, Schmid T, Hilbe W, Fiegl M, Greil R.
    Lung Cancer. 2014 Sep,85(3):395-400. doi: 10.1016/j.lungcan.2014.06.019. Epub 2014 Jul 3.

    View this publication in the PUBMED database
  • 2014

    Assessment of TP53 functionality in chronic lymphocytic leukaemia by different assays, an ERIC-wide approach.

    Te Raa GD, MalДЌikovГЎ J, Mraz M, Trbusek M, Le Garff-Tavernier M, Merle-BГ©ral H, Greil R, Merkel O, PospГ­ЕЎilovГЎ S, Lin K, Pettitt AR, Stankovic T, van Oers MH, Eldering E, Stilgenbauer S, Zenz T, Kater AP
    Br J Haematol. 2014 Nov,167(4):565-9. doi: 10.1111/bjh.13006. Epub 2014 Jun 30.

    View this publication in the PUBMED database
  • 2014

    Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.

    Pleyer L, Burgstaller S, Girschikofsky M, Linkesch W, Stauder R, Pfeilstocker M, Schreder M, Tinchon C, Sliwa T, Lang A, Sperr WR, Krippl P, Geissler D, Voskova D, Schlick K, Thaler J, Machherndl-Spandl S, Theiler G, EckmГјllner O, Greil R.
    Ann Hematol. 2014 Nov,93(11):1825-38. doi: 10.1007/s00277-014-2126-9. Epub 2014 Jun 21.

    View this publication in the PUBMED database
  • 2014

    Oxaliplatin, fluorouracil and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label randomised phase 3 trial.

    Taieb J, Tabernero J, Mini E, Subtil F, Folprecht G, Van Laethem JL, Thaler J, Bridgewater J, Petersen LN, Blons H, Collette L, Van Cutsem E, Rougier P, Salazar R, Bedenne L, Emile JF, Laurent-Puig P, Lepage C
    Lancet Oncol. 2014 Jul,15(8):862-73. doi: 10.1016/S1470-2045(14)70227-X. Epub 2014 Jun 11.

    View this publication in the PUBMED database
  • 2014

    Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.

    Byrd JC, Brown JR, O'Brien S, Barrientos JC, Kay NE, Reddy NM, Coutre S, Tam CS, Mulligan SP, Jaeger U, Devereux S, Barr PM, Furman RR, Kipps TJ, Cymbalista F, Pocock C, Thornton P, Caligaris-Cappio F, Robak T, Delgado J, Schuster SJ, Montillo M, et al.
    N Engl J Med. 2014 Jul 17,371(3):213-23. doi: 10.1056/NEJMoa1400376. Epub 2014 May 31.

    View this publication in the PUBMED database
  • 2014

    Targeted therapy in advanced metastatic colorectal cancer: current concepts and perspectives.

    Hohla F, Winder T, Greil R, Rick FG, Block NL, Schally AV.
    World J Gastroenterol. 2014 May 28,20(20):6102-12. doi: 10.3748/wjg.v20.i20.6102.

    View this publication in the PUBMED database
  • 2014

    Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients.

    Tassara M, Döhner K, Brossart P, Held G, Götze K, Horst HA, Ringhoffer M, Köhne CH, Kremers S, Raghavachar A, Wulf G, Kirchen H, Nachbaur D, Derigs HG, Wattad M, Koller E, Brugger W, Matzdorff A, Greil R, Heil G, Paschka P, Gaidzik VI, et al.
    Blood. 2014 Jun 26,123(26):4027-36. doi: 10.1182/blood-2013-12-546283. Epub 2014 May 5.

    View this publication in the PUBMED database
  • 2014

    Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.

    EBCTCG (Early Breast Cancer Trialists' Collaborative Group), McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R, Whelan T, Wang Y, Wang Z, Darby S.
    Lancet. 2014 Jun 21,383(9935):2127-35. doi: 10.1016/S0140-6736(14)60488-8. Epub 2014 Mar 19.

    View this publication in the PUBMED database
  • 2014

    Azacitidine in CMML: matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival.

    Pleyer L, Germing U, Sperr WR, Linkesch W, Burgstaller S, Stauder R, Girschikofsky M, Schreder M, Pfeilstocker M, Lang A, Sliwa T, Geissler D, Schlick K, Placher-Sorko G, Theiler G, Thaler J, Mitrovic M, Neureiter D, Valent P, Greil R.
    Leuk Res. 2014 Apr,38(4):475-83. doi: 10.1016/j.leukres.2014.01.006. Epub 2014 Jan 18.

    View this publication in the PUBMED database
  • 2014

    The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer.

    Filipits M, Nielsen TO, Rudas M, Greil R, Stöger H, Jakesz R, Bago-Horvath Z, Dietze O, Regitnig P, Gruber-Rossipal C, Müller-Holzner E, Singer CF, Mlineritsch B, Dubsky P, Bauernhofer T, Hubalek M, Knauer M, Trapl H, Fesl C, Schaper C, Ferree S, Liu S, et al.
    Clin Cancer Res. 2014 Mar 1,20(5):1298-305. doi: 10.1158/1078-0432.CCR-13-1845. Epub 2014 Feb 11.

    View this publication in the PUBMED database
  • 2014

    Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study.

    Guglielmelli P, Biamonte F, Rotunno G, Artusi V, Artuso L, Bernardis I, Tenedini E, Pieri L, Paoli C, Mannarelli C, Fjerza R, Rumi E, Stalbovskaya V, Squires M, Cazzola M, Manfredini R, Harrison C, Tagliafico E, Vannucchi AM
    Blood. 2014 Apr 3,123(14):2157-60. doi: 10.1182/blood-2013-11-536557. Epub 2014 Jan 23.

    View this publication in the PUBMED database
  • 2014

    Performance characteristics of the COBAS Ampliprep/COBAS TaqMan v2.0 and the Abbott RealTime hepatitis C assays - implications for response-guided therapy in genotype 1 infections.

    Taylor N, Haschke-Becher E, Greil R, Strasser M, Oberkofler H.
    Antivir Ther. 2014,19(5):449-54. doi: 10.3851/IMP2723. Epub 2014 Jan 16.

    View this publication in the PUBMED database
  • 2014

    Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: results from a retrospective matched-pair analysis.

    Gampenrieder SP, Romeder F, MuГџ C, Pircher M, Ressler S, Rinnerthaler G, Bartsch R, Sattlberger C, Mlineritsch B, Greil R.
    Anticancer Res. 2014 Jan,34(1):227-33.

    View this publication in the PUBMED database
  • 2014

    Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.

    Gnant M, Filipits M, Greil R, Stoeger H, Rudas M, Bago-Horvath Z, Mlineritsch B, Kwasny W, Knauer M, Singer C, Jakesz R, Dubsky P, Fitzal F, Bartsch R, Steger G, Balic M, Ressler S, Cowens JW, Storhoff J, Ferree S, Schaper C, Liu S, et al.
    Ann Oncol. 2014 Feb,25(2):339-45. doi: 10.1093/annonc/mdt494. Epub 2013 Dec 16.

    View this publication in the PUBMED database
  • 2014

    Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind phase 3 trial.

    Butts C, Socinski MA, Mitchell PL, Thatcher N, Havel L, Krzakowski M, Nawrocki S, Ciuleanu TE, Bosquée L, Trigo JM, Spira A, Tremblay L, Nyman J, Ramlau R, Wickart-Johansson G, Ellis P, Gladkov O, Pereira JR, Eberhardt WE, Helwig C, Schröder A, Shepherd FA
    Lancet Oncol. 2014 Jan,15(1):59-68. doi: 10.1016/S1470-2045(13)70510-2. Epub 2013 Dec 9.

    View this publication in the PUBMED database
  • 2014

    Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC and UCHL1.

    Heitzer E, Artl M, Filipits M, Resel M, Graf R, Weißenbacher B, Lax S, Gnant M, Wrba F, Greil R, Dietze O, Hofbauer F, Böhm G, Höfler G, Samonigg H, Schaberl-Moser R, Balic M, Dandachi N.
    Mod Pathol. 2014 Jun,27(6):906-15. doi: 10.1038/modpathol.2013.204. Epub 2013 Dec 6.

    View this publication in the PUBMED database
  • 2014

    Alemtuzumab in chronic lymphocytic leukemia: final results of a large observational multicenter study in mostly pretreated patients.

    Fiegl M, Stauder R, Steurer M, Mian M, Hopfinger G, Brychtova Y, Skrabs C, Zabernigg A, Schmid F, Haslbaur F, Winder G, Walder A, Lang A, Voskova D, Greil R, Mayer J, Gastl G
    Ann Hematol. 2014 Feb,93(2):267-77. doi: 10.1007/s00277-013-1966-z. Epub 2013 Nov 30.

    View this publication in the PUBMED database
  • 2014

    Sensitive testing of plasma HIV-1 RNA and Sanger sequencing of cellular HIV-1 DNA for the detection of drug resistance prior to starting first-line antiretroviral therapy with etravirine or efavirenz.

    Geretti AM, Conibear T, Hill A, Johnson JA, Tambuyzer L, Thys K, Vingerhoets J, Van Delft Y
    J Antimicrob Chemother. 2014 Apr,69(4):1090-7. doi: 10.1093/jac/dkt474. Epub 2013 Nov 27.

    View this publication in the PUBMED database
  • 2014

    Female gender may predict response to FOLFIRINOX in patients with unresectable pancreatic cancer: a single institution retrospective review.

    Hohla F, Hopfinger G, Romeder F, Rinnerthaler G, Bezan A, Stättner S, Hauser-Kronberger C, Ulmer H, Greil R.
    Int J Oncol. 2014 Jan,44(1):319-26. doi: 10.3892/ijo.2013.2176. Epub 2013 Nov 15.

    View this publication in the PUBMED database
  • 2014

    Overcoming resistance against HER2-targeting agents in fifth-line therapy: is there still a place for bevacizumab in HER2+ breast cancer?

    Huemer F, Gampenrieder SP, Schlattau A, Greil R.
    Clin Breast Cancer. 2014 Feb,14(1):e17-20. doi: 10.1016/j.clbc.2013.09.009. Epub 2013 Sep 28.

    View this publication in the PUBMED database
  • 2014

    Bendamustine-bortezomib-dexamethasone is an active and well-tolerated regimen in patients with relapsed or refractory multiple myeloma.

    Ludwig H, Kasparu H, Leitgeb C, Rauch E, Linkesch W, Zojer N, Greil R, Seebacher A, Pour L, WeiГџmann A, Adam Z.
    Blood. 2014 Feb 13,123(7):985-91. doi: 10.1182/blood-2013-08-521468. Epub 2013 Nov 13.

    View this publication in the PUBMED database
  • 2014

    Bone-Targeted Therapy in Metastatic Breast Cancer - All Well-Established Knowledge?

    Gampenrieder, SP, Rinnerthaler, G, Greil, R
    Breast Care (Basel). 2014 Oct,9(5):323-30. doi: 10.1159/000368710.

    View this publication in the PUBMED database
  • 2014

    Azacitidine frontline therapy for unfit acute myeloid leukemia patients: Clinical use and outcome prediction.

    Ramos, F, ThГ©pot, S, Pleyer, L, Maurillo, L, Itzykson, R, Bargay, J, Stauder, R, Venditti, A, Seegers, V, MartГ­nez-Robles, V, Burgstaller, S, RГ©cher, C, DebГ©n, G, Gaidano, G, Gardin, C, Musto, P, Greil, R, SГЎnchez-Guijo, F, Fenaux, P,
    Leuk Res. 2015 Mar,39(3):296-306. doi: 10.1016/j.leukres.2014.12.013. Epub 2014 Dec 31.

    View this publication in the PUBMED database
  • 2014

    Malignant Lymphoblasts in T Cell Acute Lymphoblastic Leukemia Express High Levels of Kv1.3

    Groessinger, E, Weiss, L, Chen, MY, Wulff, H, Greil, R, Kerschbaum, H
    BIOPHYS J. 2014, 106(2): 551A-551A.

    View this publication in the PUBMED database
  • 2014

    A PHASE II STUDY OF RITUXIMAB PLUS LENALIDOMIDE IN PATIENTS WITH EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA OF THE MUCOSA-ASSOCIATED LYMPHOID TISSUE (MALT LYMPHOMA)

    Raderer, M, Kiesewetter, B, Willenbacher, W, Neumeister, P, Fridrik, M, Greil, R
    HAEMATOLOGICA. 2014, 99: 226-226.

    View this publication in the PUBMED database
  • 2014

    AN INTERNATIONAL, MULTICENTER, PROSPECTIVE, OBSERVATIONAL STUDY OF NEUTROPENIA IN PATIENTS BEING TREATED WITH LENALIDOMIDE plus DEXAMETHASONE FOR RELAPSED OR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RR-MM)

    Leleu, X, Terpos, E, Sanz, RG, Cooney, J, OxxxGorman, P, Minarik, J, Greil, R, Williams, C, Gray, D, Szabo, Z
    HAEMATOLOGICA. 2014, 99: 368-368.

    View this publication in the PUBMED database
  • 2014

    INTERIM RESULTS FROM A PHASE IIA STUDY OF THE ANTI-CXCL12 SPIEGELMER OLAPTESED PEGOL (NOX-A12) IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH MULTIPLE MYELOMA

    Ludwig, H, Weisel, K, Petrucci, MT, Leleu, X, Cafro, AM, Kropff, M, Greil, R, Zojer, N, Dummler, T, Kruschinski, A, Riecke, K, Foa, R, Yakoub-Agha, I, Engelhardt, M
    HAEMATOLOGICA. 2014, 99: 115-116.

    View this publication in the PUBMED database
  • 2014

    Updated report of the Austrian CML registry

    Schmidt, S, Sill, H, Greil, R, Burgstaller, S, Sliwa, T, Petzer, A, Lang, A, Weltermann, A, Voskova, D, Mitterer, M, Valent, P, Eberhard, N, Walder, A, Geissler, K, Andel, J, Hausler, C, Ludescher, C, Oexle, H, Korger, M, Schnallinger, M, Schreieck, S, Krippl, P, Pober, M, Woell, E, Geissler, D, Rochau, U, Siebert, U, Thaler, J, Gastl, G
    ONCOL RES TREAT. 2014, 37: 57-58.

    View this publication in the PUBMED database
  • 2014

    Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck

    Keil, F, Selzer, E, Berghold, A, Reinisch, S, de Vries, A, Greil, R, Bachtiary, B, Tinchon, C, Anderhuber, W, Burian, M, Kasparek, AK, Elsasser, W, Kainz, H, Riedl, R, Kapp, K, Kopp, M, Kornek, G
    ONCOL RES TREAT. 2014, 37: 273-273. Ebenfalls in Pubmed gefunden: Eur J Cancer. 2013 Jan,49(2):352-9. doi: 10.1016/j.ejca.2012.08.004. Epub 2012 Sep 14.

    View this publication in the PUBMED database
  • 2014

    Bevacizumab (BEV) plus chemotherapy (CT) continued beyond first disease progression (PD) in patients with metastatic colorectal cancer (mCRC) previously treated with BEV-based therapy: Outcomes according to KRAS status and first-line CT backbone in the ML18147 study.

    Kubicka, S, Greil, R, Andre, T, Bennouna, J, Sastre, J, Van Cutsem, E, Von Moos, R, Osterlund, PJ, Hegde, P, Sersch, MA, Osborne, S, Hermann, F, Arnold, D
    J CLIN ONCOL. 2014, 32(3):

    View this publication in the PUBMED database
  • 2014

    UPDATED REPORT OF THE AUSTRIAN CML REGISTRY

    Schmidt, S, Sill, H, Greil, R, Burgstaller, S, Schlogl, E, Petzer, A
    HAEMATOLOGICA. 2014, 99: 341-341.

    View this publication in the PUBMED database
  • 2014

    CLL cells under flow.

    Hartmann TN
    Blood. 2014 Jun 5,123(23):3533-4. doi: 10.1182/blood-2014-04-565358. Development and characterization of a physiologically relevant model of lymphocyte migration in chronic lymphocytic leukemia. [Blood. 2014]

    View this publication in the PUBMED database
  • 2014

    "Old and new news in CLL: ""It""s the pathway, stupid!""."

    Egle, A,
    Blood. 2014 Aug 14,124(7):989-90. doi: 10.1182/blood-2014-05-574145.

    View this publication in the PUBMED database
  • 2014

    How does lenalidomide target the chronic lymphocytic leukemia microenvironment?

    Kater, AP, Tonino, SH, Egle, A, Ramsay, AG,
    Blood. 2014 Oct 2,124(14):2184-9. doi: 10.1182/blood-2014-05-578286. Epub 2014 Aug 26.

    View this publication in the PUBMED database
  • 2013

    Lenalidomide/Rituximab Maintenance After Induction With Fludarabine/Rituximab In Combination With Escalating Doses Of Lenalidomide In Previously Untreated Chronic Lymphocytic Leukemia (CLL): The Revlirit CLL5 AGMT Phase I/II Study, Final Results

    Vornamen sind ausgeschrieben-Г¤ndern? Alexander Egle, Michael Steurer, Franz Josef Gassner, Roland Geisberger, Thomas Melchardt, Lisa Pleyer, Lukas Weiss, Michael A. Fridrik, Josef Thaler, Alois Lang, Richard Greil,
    Blood (ASH Annual Meeting Abstracts). 2013. #4164:

    View this publication in the PUBMED database
  • 2013

    A modified Phenol-chloroform extraction method for isolating circulating cell free DNA of tumor patients.

    Hufnagl C, Stöcher M, Moik M, Geisberger R, Greil R.
    Journal of Nucleic Acids Investigation. 2013. DOI: 10.4081/jnai.2013.e1

    View this publication in the PUBMED database
  • 2013

    Blockade of the Potassium Channel KCa3.1 inhibits proliferation in Chronic Lymphocytic Leukemia

    Grossinger, EM, Weiss, L, Zierler, S, Hinterseer, E, Schmolzer, J, Asslaber, D, Hainzl, S, Egle, A, Pinon, JD, Hartmann, TN, Greil, R, Kerschbaum, HH
    ONKOLOGIE. 2013, 36: 191-192.

    View this publication in the PUBMED database
  • 2013

    The transcription factor IRF-4 is related to prognosis in Chronic Lymphocytic Leukemia (CLL) and involved in proliferation and survival

    Asslaber, D, Hofbauer, JP, Zaborsky, N, Kocher, T, Hartmann, TN, Greil, R, Egle, A
    ONKOLOGIE. 2013, 36: 222-223.

    View this publication in the PUBMED database
  • 2013

    Mimicking the microenvironment in chronic lymphocytic leukaemia - where does the journey go?

    Asslaber D, Grössinger EM, Girbl T, Hofbauer SW, Egle A, Weiss L, Greil R, Hartmann TN.
    Br J Haematol. 2013 Mar,160(5):711-4. doi: 10.1111/bjh.12151. Epub 2012 Dec 4.

    View this publication in the PUBMED database
  • 2013

    Antiapoptotic effects of p21 regarding its subcellular localization in arsenic trioxide induced apoptosis in CLL

    Sifft, E, Hofbauer, JP, Asslaber, D, Hartmann, TN, Merkel, O, Greil, R
    ONKOLOGIE. 2013, 36: 222-222.

    View this publication in the PUBMED database
  • 2013

    CXCR3 modulates CXCL12-mediated cellular responses in chronic lymphocytic leukemia

    Ganghammer, S, Hinterseer, E, Johrer, K, Greil, R, Hartmann, TN
    CYTOKINE. 2013, 63(3): 264-264.

    View this publication in the PUBMED database
  • 2013

    Tiam1/Rac1 signals contribute to CLL cell proliferation and chemoresistance

    Hofbauer, SW, Krenn, PW, Ganghammer, S, Asslaber, D, Pichler, U, Wallner, M, Henschler, R, Greil, R, Hartmann, TN
    ONKOLOGIE. 2013, 36: 56-56.

    View this publication in the PUBMED database
  • 2013

    CD40-mediated activation of chronic lymphocytic leukemia cells promotes their CD44-dependent adhesion to hyaluronan and restricts CCL21-induced motility.

    Girbl T, Hinterseer E, Grössinger EM, Asslaber D, Oberascher K, Weiss L, Hauser-Kronberger C, Neureiter D, Kerschbaum H, Naor D, Alon R, Greil R, Hartmann TN.
    Cancer Res. 2013 Jan 15,73(2):561-70. doi: 10.1158/0008-5472.CAN-12-2749. Epub 2012 Nov 1.

    View this publication in the PUBMED database
  • 2013

    Complications of 5-azacytidine: Three cases of severe ischemic colitis in elderly patients with myelodysplastic syndrome.

    Melchardt T, Weiss L, Pleyer L, Steinkirchner S, Auberger J, Hopfinger G, Greil R, Egle A.
    Oncol Lett. 2013 Dec,6(6):1756-1758. Epub 2013 Oct 15.

    View this publication in the PUBMED database
  • 2013

    Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level.

    Taylor N, Grabmeier-Pfistershammer K, Egle A, Greil R, Rieger A, Ledergerber B, Oberkofler H.
    PLoS One. 2013 Aug 30,8(8):e74024. doi: 10.1371/journal.pone.0074024. eCollection 2013.

    View this publication in the PUBMED database
  • 2013

    Azacitidine in patients with WHO-defined AML - results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group.

    Pleyer L, Stauder R, Burgstaller S, Schreder M, Tinchon C, Pfeilstocker M, Steinkirchner S, Melchardt T, Mitrovic M, Girschikofsky M, Lang A, Krippl P, Sliwa T, Egle A, Linkesch W, Voskova D, Angermann H, Greil R.
    J Hematol Oncol. 2013 Apr 29,6:32. doi: 10.1186/1756-8722-6-32.

    View this publication in the PUBMED database
  • 2013

    Use of romiplostim allows for hepatitis C therapy in a HIV/HCV coinfected patient.

    Taylor N, Melchardt T, Grundbichler M, Strasser M, Egle A, Greil R.
    Ann Hematol. 2013 Jul,92(7):1001-2. doi: 10.1007/s00277-012-1659-z. Epub 2012 Dec 28.

    View this publication in the PUBMED database
  • 2013

    Viral infections and their management in patients with chronic lymphocytic leukemia.

    Melchardt T, Weiss L, Greil R, Egle A.
    Leuk Lymphoma. 2013 Aug,54(8):1602-13. doi: 10.3109/10428194.2012.755178. Epub 2013 Jan 3.

    View this publication in the PUBMED database
  • 2013

    What’s new in Hodgkin’s lymphoma: ASH 2012 and more

    Melchardt, T, Weiss, L, Greil, R, Egle, A,
    Magazine of European Medical Oncology. 2013, Volume 6, Issue 3: 193-196.

    View this publication in the PUBMED database
  • 2013

    Influence of Body Mass Index on survival in indolent and Mantle-cell Lymphomas: Analysis of the StiL1 trial

    Weiss, L, Melchardt, T, Egle, A, Hopfinger, G, Greil, R, Barth, J, Rummel, M
    ONKOLOGIE. 2013, 36: 31-32.

    View this publication in the PUBMED database
  • 2013

    Everolimus in postmenopausal, hormone receptor-positive advanced breast cancer: summary and results of an austrian expert panel discussion.

    Gnant M, Greil R, Hubalek M, Steger G.
    Breast Care (Basel). 2013 Aug,8(4):293-9. doi: 10.1159/000354121. Review.

    View this publication in the PUBMED database
  • 2013

    Systemic effect of catumaxomab in a patient with metastasized colorectal cancer: a case report.

    Bezan A, Hohla F, Meissnitzer T, Greil R.
    BMC Cancer. 2013 Dec 31,13:618. doi: 10.1186/1471-2407-13-618.

    View this publication in the PUBMED database
  • 2013

    The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients.

    Dubsky P, Brase JC, Jakesz R, Rudas M, Singer CF, Greil R, Dietze O, Luisser I, Klug E, Sedivy R, Bachner M, Mayr D, Schmidt M, Gehrmann MC, Petry C, Weber KE, Fisch K, Kronenwett R, Gnant M, Filipits M
    Br J Cancer. 2013 Dec 10,109(12):2959-64. doi: 10.1038/bjc.2013.671. Epub 2013 Oct 24.

    View this publication in the PUBMED database
  • 2013

    [71-year old woman with neutropenic fever during chemotherapy].

    Schlick K, Datz L, Hohla F, Greil R, Hopfinger G.
    Dtsch Med Wochenschr. 2013 Oct,138(41):2091-2. doi: 10.1055/s-0033-1349528. Epub 2013 Oct 1.

    View this publication in the PUBMED database
  • 2013

    [Successful cancer therapy: chance and challenges].

    Greil R, Hiddemann W.
    Dtsch Med Wochenschr. 2013 Oct,138(41):2083. doi: 10.1055/s-0033-1349623. Epub 2013 Oct 1.

    View this publication in the PUBMED database
  • 2013

    Neoadjuvant chemotherapy and targeted therapy in breast cancer: past, present and future.

    Gampenrieder SP, Rinnerthaler G, Greil R.
    J Oncol. 2013,2013:732047. doi: 10.1155/2013/732047. Epub 2013 Aug 20.

    View this publication in the PUBMED database
  • 2013

    The clinical potential of temsirolimus in second or later lines of treatment for metastatic renal cell carcinoma.

    Stenner-Liewen F, GrГјnwald V, Greil R, Porta C.
    Expert Rev Anticancer Ther. 2013 Sep,13(9):1021-33. doi: 10.1586/14737140.2013.833684. Epub 2013 Sep 12.

    View this publication in the PUBMED database
  • 2013

    The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial.

    Gnant M, Pfeiler G, Stöger H, Mlineritsch B, Fitzal F, Balic M, Kwasny W, Seifert M, Stierer M, Dubsky P, Greil R, Steger G, Samonigg H, Fesl C, Jakesz R.
    Br J Cancer. 2013 Aug 6,109(3):589-96. doi: 10.1038/bjc.2013.367. Epub 2013 Jul 18.

    View this publication in the PUBMED database
  • 2013

    Phase III trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patients with pretreated metastatic breast cancer.

    Crown JP, DiГ©ras V, Staroslawska E, Yardley DA, Bachelot T, Davidson N, Wildiers H, Fasching PA, Capitain O, Ramos M, Greil R, Cognetti F, Fountzilas G, Blasinska-Morawiec M, Liedtke C, Kreienberg R, Miller WH Jr, Tassell V, Huang X, Paolini J, Kern KA, Romieu G.
    J Clin Oncol. 2013 Aug 10,31(23):2870-8. doi: 10.1200/JCO.2012.43.3391. Epub 2013 Jul 15.

    View this publication in the PUBMED database
  • 2013

    Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings.

    Kubicka S, Greil R, AndrГ© T, Bennouna J, Sastre J, Van Cutsem E, von Moos R, Osterlund P, Reyes-Rivera I, MГјller T, Makrutzki M, Arnold D
    Ann Oncol. 2013 Sep,24(9):2342-9. doi: 10.1093/annonc/mdt231. Epub 2013 Jul 12.

    View this publication in the PUBMED database
  • 2013

    Circulating tumor DNA to monitor metastatic breast cancer.

    Weiss L, Hufnagl C, Greil R.
    N Engl J Med. 2013 Jul 4,369(1):93. doi: 10.1056/NEJMc1306040#SA2.

    View this publication in the PUBMED database
  • 2013

    Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer.

    Baselga J, GГіmez P, Greil R, Braga S, Climent MA, Wardley AM, Kaufman B, Stemmer SM, PГЄgo A, Chan A, Goeminne JC, Graas MP, Kennedy MJ, Ciruelos Gil EM, Schneeweiss A, Zubel A, Groos J, MelezГ­nkovГЎ H, Awada A.
    J Clin Oncol. 2013 Jul 10,31(20):2586-92. doi: 10.1200/JCO.2012.46.2408. Epub 2013 Jun 3.

    View this publication in the PUBMED database
  • 2013

    Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG).

    Gaidzik VI, Schlenk RF, Paschka P, Stölzle A, Späth D, Kuendgen A, von Lilienfeld-Toal M, Brugger W, Derigs HG, Kremers S, Greil R, Raghavachar A, Ringhoffer M, Salih HR, Wattad M, Kirchen HG, Runde V, Heil G, Petzer AL, Girschikofsky M, Heuser M, Kayser S, et al.
    Blood. 2013 Jun 6,121(23):4769-77. doi: 10.1182/blood-2012-10-461624. Epub 2013 Apr 30.

    View this publication in the PUBMED database
  • 2013

    AVEREL: a randomized phase III Trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer.

    Gianni L, Romieu GH, Lichinitser M, Serrano SV, Mansutti M, Pivot X, Mariani P, Andre F, Chan A, Lipatov O, Chan S, Wardley A, Greil R, Moore N, Prot S, Pallaud C, Semiglazov V.
    J Clin Oncol. 2013 May 10,31(14):1719-25. doi: 10.1200/JCO.2012.44.7912. Epub 2013 Apr 8.

    View this publication in the PUBMED database
  • 2013

    Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial.

    Pfeiler G, Stöger H, Dubsky P, Mlineritsch B, Singer C, Balic M, Fitzal F, Moik M, Kwasny W, Selim U, Renner K, Ploner F, Steger GG, Seifert M, Hofbauer F, Sandbichler P, Samonigg H, Jakesz R, Greil R, Fesl C, Gnant M
    Br J Cancer. 2013 Apr 16,108(7):1408-14. doi: 10.1038/bjc.2013.114. Epub 2013 Mar 19.

    View this publication in the PUBMED database
  • 2013

    ABVD in older patients with early-stage Hodgkin lymphoma treated within the German Hodgkin Study Group HD10 and HD11 trials.

    Böll B, Görgen H, Fuchs M, Pluetschow A, Eich HT, Bargetzi MJ, Weidmann E, Junghanß C, Greil R, Scherpe A, Schmalz O, Eichenauer DA, von Tresckow B, Rothe A, Diehl V, Engert A, Borchmann P.
    J Clin Oncol. 2013 Apr 20,31(12):1522-9. doi: 10.1200/JCO.2012.45.4181. Epub 2013 Mar 18.

    View this publication in the PUBMED database
  • 2013

    Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label non-inferiority phase 3 TURANDOT trial.

    Lang I, Brodowicz T, Ryvo L, Kahan Z, Greil R, Beslija S, Stemmer SM, Kaufman B, Zvirbule Z, Steger GG, Melichar B, Pienkowski T, Sirbu D, Messinger D, Zielinski C
    Lancet Oncol. 2013 Feb,14(2):125-33. doi: 10.1016/S1470-2045(12)70566-1. Epub 2013 Jan 10.

    View this publication in the PUBMED database
  • 2013

    A case of long-term remission with ofatumumab maintenance therapy in multiply relapsed and rituximab-refractory chronic lymphocytic leukaemia with deletion 17p.

    Namberger K, Weiss L, Krause B, Melchardt T, Greil R.
    Eur J Haematol. 2013 Apr,90(4):349-50. doi: 10.1111/ejh.12065. Epub 2013 Feb 14.

    View this publication in the PUBMED database
  • 2013

    Utility of PCR in diagnosis of invasive fungal infections: real-life data from a multicenter study.

    Lass-Flörl C, Mutschlechner W, Aigner M, Grif K, Marth C, Girschikofsky M, Grander W, Greil R, Russ G, Cerkl P, Eller M, Kropshofer G, Eschertzhuber S, Kathrein H, Schmid S, Beer R, Lorenz I, Theurl I, Nachbaur D.
    J Clin Microbiol. 2013 Mar,51(3):863-8. doi: 10.1128/JCM.02965-12. Epub 2012 Dec 26.

    View this publication in the PUBMED database
  • 2013

    Topical evening primrose oil for reduction of bortezomib-induced skin reactions.

    Auberger J, Vogt S, Hopfinger G, Clausen J, Greil R.
    Ann Hematol. 2013 Jul,92(7):995-6. doi: 10.1007/s00277-012-1656-2. Epub 2012 Dec 22.

    View this publication in the PUBMED database
  • 2013

    CYP2D6 metabolism and patient outcome in the Austrian Breast and Colorectal Cancer Study Group trial (ABCSG) 8.

    Goetz MP, Suman VJ, Hoskin TL, Gnant M, Filipits M, Safgren SL, Kuffel M, Jakesz R, Rudas M, Greil R, Dietze O, Lang A, Offner F, Reynolds CA, Weinshilboum RM, Ames MM, Ingle JN.
    Clin Cancer Res. 2013 Jan 15,19(2):500-7. doi: 10.1158/1078-0432.CCR-12-2153. Epub 2012 Dec 4.

    View this publication in the PUBMED database
  • 2013

    Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.

    Bennouna J, Sastre J, Arnold D, Г–sterlund P, Greil R, Van Cutsem E, von Moos R, ViГ©itez JM, BouchГ© O, Borg C, Steffens CC, Alonso-OrduГ±a V, Schlichting C, Reyes-Rivera I, Bendahmane B, AndrГ© T, Kubicka S
    Lancet Oncol. 2013 Jan,14(1):29-37. doi: 10.1016/S1470-2045(12)70477-1. Epub 2012 Nov 16.

    View this publication in the PUBMED database
  • 2013

    Randomized phase II study of bortezomib, thalidomide and dexamethasone with or without cyclophosphamide as induction therapy in previously untreated multiple myeloma.

    Ludwig H, Viterbo L, Greil R, Masszi T, Spicka I, Shpilberg O, Hajek R, Dmoszynska A, Paiva B, Vidriales MB, Esteves G, Stoppa AM, Robinson D Jr, Ricci D, Cakana A, Enny C, Feng H, van de Velde H, Harousseau JL.
    J Clin Oncol. 2013 Jan 10,31(2):247-55. doi: 10.1200/JCO.2011.39.5137. Epub 2012 Oct 22.

    View this publication in the PUBMED database
  • 2013

    EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer.

    Dubsky P, Filipits M, Jakesz R, Rudas M, Singer CF, Greil R, Dietze O, Luisser I, Klug E, Sedivy R, Bachner M, Mayr D, Schmidt M, Gehrmann MC, Petry C, Weber KE, Kronenwett R, Brase JC, Gnant M
    Ann Oncol. 2013 Mar,24(3):640-7. doi: 10.1093/annonc/mds334. Epub 2012 Oct 3.

    View this publication in the PUBMED database
  • 2013

    Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie.

    Troch M, Kiesewetter B, Willenbacher W, Willenbacher E, Zebisch A, Linkesch W, Fridrik M, MГјllauer L, Greil R, Raderer M.
    Haematologica. 2013 Feb,98(2):264-8. doi: 10.3324/haematol.2012.072587. Epub 2012 Sep 14.

    View this publication in the PUBMED database
  • 2013

    Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck.

    Keil F, Selzer E, Berghold A, Reinisch S, Kapp KS, De Vries A, Greil R, Bachtiary B, Tinchon C, Anderhuber W, Burian M, Kasparek AK, Elsäßer W, Kainz H, Riedl R, Kopp M, Kornek G.
    Eur J Cancer. 2013 Jan,49(2):352-9. doi: 10.1016/j.ejca.2012.08.004. Epub 2012 Sep 14.

    View this publication in the PUBMED database
  • 2013

    Mycophenolatmofetil und Azathioprin in der Schwangerschaft bei einer Patientin mit systemischem Lupus erythematodes.

    Psenak, O, Studnicka-Benke, A, Greil, R
    Rheuma plus. 2013, 12: 18-20.

    View this publication in the PUBMED database
  • 2013

    ASH 2012 update chronic lymphocytic leukemia—the best is yet to come

    Weiss, L, Melchardt, T, Greil, R, Hopfinger, G,
    Magazine of European Medical Oncology. 2013, Volume 6, Issue 3: 177-180.

    View this publication in the PUBMED database
  • 2013

    Systemische Therapie des prämenopausalen Mammakarzinoms

    Ressler Sigrun, Greil Richard
    Die Punkte. 2013.

    View this publication in the PUBMED database
  • 2013

    Aktuelle Diagnostik und Therapieoptionen bei aggressiven Lymphomen.

    Hopfinger, G, Greil, R
    Bremen, London, Boston: UniMed Verlag, 2013. (ISBN: 978-3-8374-1407-3)

    View this publication in the PUBMED database
  • 2013

    Two patients diagnosed with coexisting hematologic and oncologic BRAF V600E mutated malignancies. Which entity is really carrying the BRAF (V600E) mutation?

    Schlick, K, Troch, M, Placher-Sorko, G, Faber, V, Neureiter, D, Greil, R, Hopfinger, G
    ONKOLOGIE. 2013, 36: 168-169.

    View this publication in the PUBMED database
  • 2013

    Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: updated results from a retrospective matched-pair analysis

    Gampenrieder, SP, Romeder, F, Muss, C, Pircher, M, Ressler, S, Rinnerthaler, G, Bartsch, R, Sattlberger, C, Mlineritsch, B, Greil, R
    Anticancer Res. 2014 Jan,34(1):227-33.

    View this publication in the PUBMED database
  • 2013

    """ABCSG C-07 EXERCISE - Pilot study"": Endurance exercise to reduce the recurrence rate after adjuvant chemotherapy for colorectal cancer"

    Piringer, G, Fridrik, M, Fridrik, A, Zabernigg, A, Greil, R, Eisterer, W, Tschmelitsch, J, Lang, A, Gnant, M, Thaler, J
    ONKOLOGIE. 2013, 36: 72-72.

    View this publication in the PUBMED database
  • 2013

    Lapatinib plus Caelyx in patients with advanced or metastatic Her 2 positive breast cancer following failure of Trastuzumab therapy - A Phase II study of the Arbeitsgemeinschaft Medikamentose Tumortherapie

    Pircher, M, Mlineritsch, B, Fridrik, M, Dittrich, C, Lang, A, Petru, E, Weltermann, A, Thaler, J, Hufnagl, C, Gampenrieder, SP, Ressler, S, Rinnerthaler, G, Ulmer, H, Greil, R
    ONKOLOGIE. 2013, 36: 159-159.

    View this publication in the PUBMED database
  • 2013

    Updated report of the Austrian CML registry

    Schmidt, S, Burgstaller, S, Linkesch, W, Greil, R, Schlogl, E, Fridrik, M, Krieger, O, Petzer, A, Lang, A, Mitterer, M, Valent, P, Walder, A, Sliwa, T, Keil, F, Korger, M, Hausler, C, Woll, E, Oexle, H, Schnallinger, M, Pober, M, Rochau, U, Siebert, U, Thaler, J, Gastl, G
    ONKOLOGIE. 2013, 36: 63-63.

    View this publication in the PUBMED database
  • 2013

    MESENCHYMAL STEM CELLS RETAIN THEIR PRO-OLIGODENDROGENIC ACTIVITY DURING AGING: A RATIONALE FOR AUTOLOGOUS TRANSPLANTATION IN MULTIPLE SCLEROSIS

    Rivera, FJ, Wodnar, R, Feichtner, M, Oberbauer, E, Brachtl, G, Greil, R, Rohde, E, Franklin, RJM, Aigner, L
    GLIA. 2013, 61: S52-S52.

    View this publication in the PUBMED database
  • 2013

    CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism.

    Zucchetto A, Caldana C, Benedetti D, Tissino E, Rossi FM, Hutterer E, Pozzo F, Bomben R, Dal Bo M, D'Arena G, Zaja F, Pozzato G, Di Raimondo F, Hartmann TN, Rossi D, Gaidano G, Del Poeta G, Gattei V.
    Blood. 2013 Nov 7,122(19):3317-21. doi: 10.1182/blood-2013-06-507335. Epub 2013 Sep 25.

    View this publication in the PUBMED database
  • 2013

    [Autoimmune hemolysis accompanied by thrombopenia: consumption or myelodysplasia?].

    Melchardt, T, Weiss, L, Egle, A,
    Dtsch Med Wochenschr. 2013 Oct,138(41):2093-5. doi: 10.1055/s-0033-1349586. Epub 2013 Oct 1.

    View this publication in the PUBMED database
  • 2013

    Bid-ding for mercy: twisted killer in action.

    Egle A, Asslaber D, Villunger A, Pinon-Hofbauer J.
    Cell Death and Differentiation. 2013 Jul,20(7):847-9. doi: 10.1038/cdd.2013.40.

    View this publication in the PUBMED database
  • 2013

    p53 Efficiently Suppresses Tumor Development in the Complete Absence of Its Cell-Cycle Inhibitory and Proapoptotic Effectors p21, Puma, and Noxa.

    Valente LJ, Gray DH, Michalak EM, Pinon-Hofbauer J, Egle A, Scott CL, Janic A, Strasser A.
    Cell Rep. 2013 May 30,3(5):1339-45. doi: 10.1016/j.celrep.2013.04.012. Epub 2013 May 9.

    View this publication in the PUBMED database
  • 2013

    Protein Kinase C-?-Dependent Activation of NF-?B in Stromal Cells Is Indispensable for the Survival of Chronic Lymphocytic Leukemia B Cells In Vivo.

    Lutzny G, Kocher T, Schmidt-Supprian M, Rudelius M, Klein-Hitpass L, Finch AJ, Dürig J, Wagner M, Haferlach C, Kohlmann A, Schnittger S, Seifert M, Wanninger S, Zaborsky N, Oostendorp R, Ruland J, Leitges M, Kuhnt T, Schäfer Y, Lampl B, Peschel C, Egle A, Ringshausen I.
    Cancer Cell. 2013 Jan 14,23(1):77-92. doi: 10.1016/j.ccr.2012.12.003.

    View this publication in the PUBMED database
  • 2012

    Lysine residue at position 22 of the AID protein regulates its class switch activity.

    Geisberger R, Huemer M, Gassner FJ, Zaborsky N, Egle A, Greil R.
    PLoS One. 2012,7(2):e30667. doi: 10.1371/journal.pone.0030667. Epub 2012 Feb 20.

    View this publication in the PUBMED database
  • 2012

    Canonical and noncanonical Hedgehog/GLI signaling in hematological malignancies.

    Aberger F, Kern D, Greil R, Hartmann TN.
    Vitam Horm. 2012,88:25-54. doi: 10.1016/B978-0-12-394622-5.00002-X.

    View this publication in the PUBMED database
  • 2012

    Chemokine-dependent B cell-T cell interactions in chronic lymphocytic leukemia and multiple myeloma - targets for therapeutic intervention?

    Jöhrer K, Hofbauer SW, Zelle-Rieser C, Greil R, Hartmann TN.
    Expert Opin Biol Ther. 2012 Apr,12(4):425-41. doi: 10.1517/14712598.2012.664128. Epub 2012 Feb 15.

    View this publication in the PUBMED database
  • 2012

    Actinomycin D induces p53-independent cell death and prolongs survival in high-risk chronic lymphocytic leukemia.

    Merkel O, Wacht N, Sifft E, Melchardt T, Hamacher F, Kocher T, Denk U, Hofbauer JP, Egle A, Scheideler M, Schlederer M, Steurer M, Kenner L, Greil R.
    Leukemia. 2012 Dec,26(12):2508-16. doi: 10.1038/leu.2012.147. Epub 2012 Jun 1.

    View this publication in the PUBMED database
  • 2012

    Treatment of Aggressive B-Cell Lymphoma in the Elderly: The Influence of SNPs Affecting Pharmacodynamics Is Different Compared to Younger Patient

    Thomas Melchardt, Lukas Weiss, Clemens Hufnagl, Daniel Neureiter, Ralf Kemmerling, Patrick Morre, Ann Boekstegers, Georg Hopfinger, Richard Greil, Alexander Egle,
    Blood (ASH Annual Meeting Abstracts) 2012. 2012. #1613:

    View this publication in the PUBMED database
  • 2012

    Feasibility of anthracycline based treatment in unselected elderly DLBCL patients

    Melchardt, T, Weiss, L, Hufnagl, C, Neureiter, D, Kemmerling, R, Hopfinger, G, Greil, R, Egle, A
    ONKOLOGIE. 2012, 35: 86-87.

    View this publication in the PUBMED database
  • 2012

    Complications of 5-azacytidine: Three cases of severe colitis in a single center cohort

    Melchardt, T, Weiss, L, Pleyer, L, Steinkirchner, S, Greil, R, Egle, A
    ONKOLOGIE. 2012, 35: 149-149.

    View this publication in the PUBMED database
  • 2012

    Treatment of Aggressive B-Cell Lymphoma in the Elderly: The Influence of SNPs Affecting Pharmacodynamics Is Different Compared to Younger Patient

    Melchardt, T, Weiss, L, Hufnagl, C, Neureiter, D, Kemmerling, R, Morre, P, Boekstegers, A, Hopfinger, G, Greil, R, Egle, A
    BLOOD. 2012, 120(21):

    View this publication in the PUBMED database
  • 2012

    AOP2014, a Novel Peg-Proline-Interferon Alpha-2b with Improved Pharmacokinetic Properties, Is Safe and Well Tolerated and Shows Promising Efficacy in Patients with Polycythemia Vera (PV)

    Gisslinger, H, Kralovics, R, Gisslinger, B, Lechner, D, Buxhofer-Ausch, V, Strecker, K, Gastl, G, Willenbacher, E, Greil, R, Egle, A, Melchardt, T, Burgstaller, S, Schloegl, E, Tarmann, FJ, Zoerer, M, Klade, C, Zahriychuk, O, Thaler, J
    BLOOD. 2012, 120(21):

    View this publication in the PUBMED database
  • 2012

    Treating T-cell lymphoma: is there a light at the end of the tunnel?

    Hopfinger G, Merkel O, Melchardt T, Greil R.
    Memo - Magazine of European Medical Oncology. (2012) 5:174–177 DOI 10.1007/s12254-012-0013-4

    View this publication in the PUBMED database
  • 2012

    What paths are open for tackling increasing azole resistance in Aspergillus in the clinic?

    Auberger J, Greil R, Lass-Flörl C.
    Expert Rev Anti Infect Ther. 2012 Nov,10(11):1229-31. doi: 10.1586/eri.12.126.

    View this publication in the PUBMED database
  • 2012

    Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study.

    Thaler J, Karthaus M, Mineur L, Greil R, Letocha H, Hofheinz R, Fernebro E, Gamelin E, Baños A, Köhne CH.
    BMC Cancer. 2012 Sep 29,12:438. doi: 10.1186/1471-2407-12-438.

    View this publication in the PUBMED database
  • 2012

    Novel treatment avenues for peripheral T-cell lymphomas.

    Hopfinger G, Griessl R, Sifft E, Taylor N, Kenner L, Greil R, Merkel O.
    Expert Opin Drug Discov. 2012 Dec,7(12):1149-63. doi: 10.1517/17460441.2012.727392. Epub 2012 Sep 24.

    View this publication in the PUBMED database
  • 2012

    Effect of KRAS codon13 mutations in patients with advanced colorectal cancer (advanced CRC) under oxaliplatin containing chemotherapy. Results from a translational study of the AIO colorectal study group.

    Reinacher-Schick A, Schulmann K, Modest DP, Bruns N, Graeven U, Jaworska M, Greil R, Porschen R, Arnold D, Schmiegel W, Tannapfel A.
    BMC Cancer. 2012 Aug 9,12:349. doi: 10.1186/1471-2407-12-349.

    View this publication in the PUBMED database
  • 2012

    [Safety of immunosuppressants].

    Psenak O, Studnicka-Benke A, Greil R.
    Z Rheumatol. 2012 Jul,71(5):420-9. doi: 10.1007/s00393-012-0990-z.

    View this publication in the PUBMED database
  • 2012

    Influence of the American ODAC statement on Austrian bevacizumab prescribing practice for metastatic breast cancer.

    Preusser M, Fülöp G, Berghoff AS, Heinzl H, Steger GG, Greil R, Zielinski CC, Bartsch R.
    Oncologist. 2012,17(7):e13-7. doi: 10.1634/theoncologist.2012-0115. Epub 2012 Jun 27.

    View this publication in the PUBMED database
  • 2012

    Safety results from a phase III study (TURANDOT trial by CECOG) of first-line bevacizumab in combination with capecitabine or paclitaxel for HER-2-negative locally recurrent or metastatic breast cancer.

    Lang I, Inbar MJ, KahГЎn Z, Greil R, Beslija S, Stemmer SM, Kaufman B, Zvirbule Z, Steger GG, Messinger D, Brodowicz T, Zielinski C.
    Eur J Cancer. 2012 Nov,48(17):3140-9. doi: 10.1016/j.ejca.2012.04.022. Epub 2012 May 26.

    View this publication in the PUBMED database
  • 2012

    Continuous lenalidomide treatment for newly diagnosed multiple myeloma.

    Palumbo A, Hajek R, Delforge M, Kropff M, Petrucci MT, Catalano J, Gisslinger H, Wiktor-J?drzejczak W, Zodelava M, Weisel K, Cascavilla N, Iosava G, Cavo M, Kloczko J, BladГ© J, Beksac M, Spicka I, Plesner T, Radke J, Langer C, Ben Yehuda D, Corso A, et al.
    N Engl J Med. 2012 May 10,366(19):1759-69. doi: 10.1056/NEJMoa1112704.

    View this publication in the PUBMED database
  • 2012

    Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response.

    Jäger U, Fridrik M, Zeitlinger M, Heintel D, Hopfinger G, Burgstaller S, Mannhalter C, Oberaigner W, Porpaczy E, Skrabs C, Einberger C, Drach J, Raderer M, Gaiger A, Putman M, Greil R
    Haematologica. 2012 Sep,97(9):1431-8. Epub 2012 Apr 17.

    View this publication in the PUBMED database
  • 2012

    LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled multicenter multinational double-blinded phase II trial.

    Schimanski CC, Möhler M, Schön M, van Cutsem E, Greil R, Bechstein WO, Hegewisch-Becker S, von Wichert G, Vöhringer M, Heike M, Heinemann V, Peeters M, Kanzler S, Kasper S, Overkamp F, Schröder J, Seehofer D, Kullmann F, Linz B, Schmidtmann I, Smith-Machnow V, Gockel I, et al.
    BMC Cancer. 2012 Apr 11,12:144. doi: 10.1186/1471-2407-12-144.

    View this publication in the PUBMED database
  • 2012

    Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label phase 3 non-inferiority trial.

    Engert A, Haverkamp H, Kobe C, Markova J, Renner C, Ho A, Zijlstra J, Král Z, Fuchs M, Hallek M, Kanz L, Döhner H, Dörken B, Engel N, Topp M, Klutmann S, Amthauer H, Bockisch A, Kluge R, Kratochwil C, Schober O, Greil R, et al.
    Lancet. 2012 May 12,379(9828):1791-9. doi: 10.1016/S0140-6736(11)61940-5. Epub 2012 Apr 4.

    View this publication in the PUBMED database
  • 2012

    The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER).

    Aapro M, Molassiotis A, Dicato M, PelГЎez I, RodrГ­guez-Lescure ГЃ, Pastorelli D, Ma L, Burke T, Gu A, Gascon P, Roila F
    Ann Oncol. 2012 Aug,23(8):1986-92. Epub 2012 Mar 6.

    View this publication in the PUBMED database
  • 2012

    [Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (ÖGHO)].

    Pabinger I, Gastl G, Steurer M, Sormann S, Fillitz M, Friedl J, Geissler D, Geissler K, Greil R, Knöbl P, Kozek-Langenecker S, Krippl P, Kyrle P, Lang A, Linkesch W, Ludwig H, Müller M, Panzer S, Pittermann E, Thaler J, Weltermann A.
    Wien Klin Wochenschr. 2012 Feb,124(3-4):111-23. doi: 10.1007/s00508-012-0123-3. Epub 2012 Mar 3.

    View this publication in the PUBMED database
  • 2012

    First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: results of a prospective, randomized phase III study.

    Bergh J, Bondarenko IM, Lichinitser MR, Liljegren A, Greil R, Voytko NL, Makhson AN, Cortes J, Lortholary A, Bischoff J, Chan A, Delaloge S, Huang X, Kern KA, Giorgetti C.
    J Clin Oncol. 2012 Mar 20,30(9):921-9. doi: 10.1200/JCO.2011.35.7376. Epub 2012 Feb 13.

    View this publication in the PUBMED database
  • 2012

    Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group.

    Dubsky PC, Jakesz R, Mlineritsch B, Pöstlberger S, Samonigg H, Kwasny W, Tausch C, Stöger H, Haider K, Fitzal F, Singer CF, Stierer M, Sevelda P, Luschin-Ebengreuth G, Taucher S, Rudas M, Bartsch R, Steger GG, Greil R, Filipcic L, Gnant M.
    J Clin Oncol. 2012 Mar 1,30(7):722-8. doi: 10.1200/JCO.2011.36.8993. Epub 2012 Jan 23.

    View this publication in the PUBMED database
  • 2012

    Dose-intensification in early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD14 trial.

    von Tresckow B, PlГјtschow A, Fuchs M, Klimm B, Markova J, Lohri A, Kral Z, Greil R, Topp MS, Meissner J, Zijlstra JM, Soekler M, Stein H, Eich HT, Mueller RP, Diehl V, Borchmann P, Engert A.
    J Clin Oncol. 2012 Mar 20,30(9):907-13. doi: 10.1200/JCO.2011.38.5807. Epub 2012 Jan 23.

    View this publication in the PUBMED database
  • 2012

    Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial.

    Fätkenheuer G, Duvivier C, Rieger A, Durant J, Rey D, Schmidt W, Hill A, van Delft Y, Marks S
    J Antimicrob Chemother. 2012 Mar,67(3):685-90. doi: 10.1093/jac/dkr533. Epub 2011 Dec 29.

    View this publication in the PUBMED database
  • 2012

    Prognostic value of number of removed lymph nodes, number of involved lymph nodes and lymph node ratio in 7502 breast cancer patients enrolled onto trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG).

    Tausch C, Taucher S, Dubsky P, Seifert M, Reitsamer R, Kwasny W, Jakesz R, Fitzal F, Filipcic L, Fridrik M, Greil R, Gnant M.
    Ann Surg Oncol. 2012 Jun,19(6):1808-17. doi: 10.1245/s10434-011-2189-y. Epub 2011 Dec 30.

    View this publication in the PUBMED database
  • 2012

    Antimyeloma activity of the sesquiterpene lactone cnicin: impact on Pim-2 kinase as a novel therapeutic target.

    Jöhrer K, Obkircher M, Neureiter D, Parteli J, Zelle-Rieser C, Maizner E, Kern J, Hermann M, Hamacher F, Merkel O, Wacht N, Zidorn C, Scheideler M, Greil R.
    J Mol Med (Berl). 2012 Jun,90(6):681-93. doi: 10.1007/s00109-011-0848-x. Epub 2011 Dec 29.

    View this publication in the PUBMED database
  • 2012

    First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer.

    Köhne CH, Hofheinz R, Mineur L, Letocha H, Greil R, Thaler J, Fernebro E, Gamelin E, Decosta L, Karthaus M.
    J Cancer Res Clin Oncol. 2012 Jan,138(1):65-72. doi: 10.1007/s00432-011-1061-6. Epub 2011 Sep 30.

    View this publication in the PUBMED database
  • 2012

    Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: open questions.

    Valent P, Gastl G, Geissler K, Greil R, Hantschel O, Lang A, Linkesch W, Lion T, Petzer AL, Pittermann E, Pleyer L, Thaler J, Wolf D.
    Crit Rev Oncol Hematol. 2012 Jun,82(3):370-7. doi: 10.1016/j.critrevonc.2011.08.002. Epub 2011 Sep 7.

    View this publication in the PUBMED database
  • 2012

    An international expanded-access programme of everolimus: addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy.

    GrГјnwald V, Karakiewicz PI, Bavbek SE, Miller K, Machiels JP, Lee SH, Larkin J, Bono P, Rha SY, Castellano D, Blank CU, Knox JJ, Hawkins R, Anak O, Rosamilia M, Booth J, Pirotta N, Bodrogi I
    Eur J Cancer. 2012 Feb,48(3):324-32. doi: 10.1016/j.ejca.2011.06.054. Epub 2011 Jul 29.

    View this publication in the PUBMED database
  • 2012

    Treating T-cell lymphoma: is there a light at the end of the tunnel?

    Hopfinger, G, Merkel, O, Melchardt, T, Greil, R,
    Magazine of European Medical Oncology. 2012, 5 (3): 174-177.

    View this publication in the PUBMED database
  • 2012

    A 55-year-old woman with locally advanced rectal cancer and a resectable synchronous hepatic metastasis: a case report.

    Hohla, F, Mayer, P, Hutter, J, MeiГџnitzer, T, Greil, R,
    memo - Magazine of European Medical Oncology. 2012, 5 (4): 273-276.

    View this publication in the PUBMED database
  • 2012

    The role of biomarkers in the choice of therapy in triple negative breast cancer

    Mlineritsch B Ressler S Greil R
    memo - Magazine of European Medical Oncology. 2012, 5: 101-104.

    View this publication in the PUBMED database
  • 2012

    Bevacizumab (BEV) plus chemotherapy (CT) continued beyond first progression in patients with metastatic colorectal cancer (mCRC) previously treated with BEV plus CT: Results of a randomized phase III intergroup study (TML study).

    Arnold, D, Andre, T, Bennouna, J, Sastre, J, Osterlund, PJ, Greil, R, Van Cutsem, E, Von Moos, R, Reyes-Rivera, I, Bendahmane, B, Kubicka, S
    J CLIN ONCOL. 2012, 30(18):

    View this publication in the PUBMED database
  • 2012

    BIOMARKER (BM) RESULTS FROM THE PHASE III AVEREL TRIAL OF 1ST-LINE BEVACIZUMAB (BV), TRASTUZUMAB (H) plus DOCETAXEL (T) FOR HER2-POSITIVE LOCALLY RECURRENT/METASTATIC BREAST CANCER (LR/MBC)

    Gianni, L, Chan, A, Mansutti, M, Pivot, X, Greil, R, Provencher, L, Prot, S, Moore, N, Scherer, SJ, Pallaud, C
    ANN ONCOL. 2012, 23: 531-532.

    View this publication in the PUBMED database
  • 2012

    Influence of the American ODAC statement upon Austrian prescription practice of bevacizumab in metastatic breast cancer

    Preusser, M, Fulop, G, Berghoff, AS, Heinzl, H, Steger, GG, Greil, R, Zielinski, CC, Bartsch, R
    ONKOLOGIE. 2012, 35: 66-66. und erschienen unter: Oncologist. 2012,17(7):e13-7. doi: 10.1634/theoncologist.2012-0115. Epub 2012 Jun 27.

    View this publication in the PUBMED database
  • 2012

    Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: results of a randomised phase III intergroup study initiated by the AIO and AGMT (ML18147)

    Greil, R, Arnold, D, Hegewisch-Becker, S, Freier, W, Steffens, CC, Bertram, M, Schlichting, C, Andel, J, Taylor, M, Makrutzki, M, Kubicka, S
    ONKOLOGIE. 2012, 35: 254-254.

    View this publication in the PUBMED database
  • 2012

    IMPACT OF NUMBER OF PREVIOUS TREATMENT LINES AND PRE-TREATMENT WITH BORTEZOMIB OR LENALIDOMIDE ON EFFICACY OF BORTEZOMIB-BENDAMUSTINE-DEXAMETHASONE (BBD) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM)

    Ludwig, H, Kasparu, H, Leitgeb, C, Greil, R, Rauch, E, Linkesch, W, Zojer, N, Pour, L, Fillitz, M, Adam, Z
    ANN ONCOL. 2012, 23: 348-349.

    View this publication in the PUBMED database
  • 2012

    RITUXIMAB PLUS SUBCUTANEOUS CLADRIBINE IN PATIENTS WITH EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA OF THE MUCOSA ASSOCIATED TISSUE (MALT-LYMPHOMA): A PHASE II STUDY BY THE AGMT (ARBEITSGEMEINSCHAFT MEDIKAMENTOSE TUMORTHERAPIE)

    Troch, M, Kiesewetter, B, Willenbacher, W, Willenbacher, E, Zebisch, A, Linkesch, W, Fridrik, MA, Mullauer, L, Greil, R, Raderer, M
    ANN ONCOL. 2012, 23: 352-352.

    View this publication in the PUBMED database
  • 2012

    First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy

    dxxxAmore, F, Leppa, S, da Silva, MC, Relander, T, Brown, PD, Weidmann, E, Lauritzsen, GF, Pezzutto, A, Van Hoof, A, van Gelder, M, Doorduijn, JK, Wu, KL, Kluin-Nelemans, JC, Lugtenburg, PJ, Jankovska, M, Merup, M, Fagerli, UM, Walewski, J, Hagberg, H, Mariz, JM, Hansen, PB, Nosslinger, T, Janssens, A, Brandefors, L, Demuynck, H, Schaafsma, MR, Christiansen, I, Salek, D, Jyrkkio, S, Prochazka, V, Zijlstra, J, Bohmer, L, Greil, R, Stevens, W, Fijnheer, R, Kooy, MV, Grube, M, Hopfinger, G, Van den Neste, E, Jantunen, E, Trumper, L, Wulf, G, Altmann, B, Ziepert, M, Loeffler, M, Toldbod, H
    BLOOD. 2012, 120(21):

    View this publication in the PUBMED database
  • 2012

    Upgraded Cobas TaqMan version 2: hidden consequences at cohort level

    Taylor, N, Grabmeier-Pfistershammer, K, Oberkofler, H, Egle, A, Rieger, A, Ledergerber, B
    J INT AIDS SOC. 2012, 15: 109-109.

    View this publication in the PUBMED database
  • 2012

    PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas.

    Laimer D, Dolznig H, Kollmann K, Vesely PW, Schlederer M, Merkel O, Schiefer AI, Hassler MR, Heider S, Amenitsch L, Thallinger C, Staber PB, Simonitsch-Klupp I, Artaker M, Lagger S, Turner SD, Pileri S, Piccaluga PP, Valent P, Messana K, Landra I, Weichhart T, Knapp S, Shehata M, Todaro M, Sexl V, Höfler G, Piva R, Medico E, Ruggeri BA, Cheng M, Eferl R, Egger G, Penninger JM, Jaeger U, Moriggl R, Inghirami G, Kenner L.
    Nat Med. 2012 Nov,18(11):1699-704. doi: 10.1038/nm.2966. Epub 2012 Oct 14.

    View this publication in the PUBMED database
  • 2012

    Dendritic Cells Activated by IFN-?/STAT1 Express IL-31 Receptor and Release Proinflammatory Mediators upon IL-31 Treatment.

    Horejs-Hoeck J, Schwarz H, Lamprecht S, Maier E, Hainzl S, Schmittner M, Posselt G, Stoecklinger A, Hawranek T, Duschl A.
    J Immunol. 2012 Jun 1,188(11):5319-26. doi: 10.4049/jimmunol.1101044. Epub 2012 Apr 25.

    View this publication in the PUBMED database
  • 2011

    Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia.

    Gassner FJ, Weiss L, Geisberger R, Hofbauer JP, Egle A, Hartmann TN, Greil R, Tinhofer I.
    Cancer Immunol Immunother. 2011 Jan,60(1):75-85. doi: 10.1007/s00262-010-0920-3. Epub 2010 Sep 21.

    View this publication in the PUBMED database
  • 2011

    A Combination of Fludarabine/Rituximab with Escalating Doses of Lenalidomide in Previously Untreated Chronic Lymphocytic Leukemia (CLL): The REVLIRIT CLL5 AGMT Phase I/II Study, Clinical and Exploratory Analyses of Induction Results

    Egle, A, Steurer, M, Gassner, F, Geisberger, R, Melchardt, T, Weiss, L, Fridrik, MA, Thaler, J, Lang, A, Greil, R
    BLOOD. 2011, 118(21): 135-136.

    View this publication in the PUBMED database
  • 2011

    Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells.

    Brachtl G, Sahakyan K, Denk U, Girbl T, Alinger B, Hofbauer SW, Neureiter D, Hofbauer JP, Egle A, Greil R, Hartmann TN.
    PLoS One. 2011,6(8):e23758. doi: 10.1371/journal.pone.0023758. Epub 2011 Aug 18.

    View this publication in the PUBMED database
  • 2011

    CD44-hyaluronan interactions in the pathophysiology of chronic lymphocytic leukemia - regulation by cell activation

    Girbl, T, Asslaber, D, Brachtl, G, Denk, U, Weiss, L, Naor, D, Greil, R, Hartmann, TN
    ONKOLOGIE. 2011, 34: 140-140.

    View this publication in the PUBMED database
  • 2011

    Complete remission of Waldenström macroglobulinemia with azacitidine and rituximab.

    Weiss L, Melchardt T, Neureiter D, Kemmerling R, Moshir S, Pleyer L, Greil R, Egle A.
    J Clin Oncol. 2011 Aug 20,29(24):e696-8. doi: 10.1200/JCO.2011.35.8283. Epub 2011 Jul 5.

    View this publication in the PUBMED database
  • 2011

    Raltegravir in pregnancy: a case series presentation.

    Taylor N, Touzeau V, Geit M, Gisinger M, Egle A, Greil R, Rieger A, Zangerle R.
    Int J STD AIDS. 2011 Jun,22(6):358-60. doi: 10.1258/ijsa.2011.010469.

    View this publication in the PUBMED database
  • 2011

    Development of CLL in the TCL1 transgenic mouse model is associated with severe skewing of the T-cell compartment homologous to human CLL.

    Hofbauer JP, Heyder C, Denk U, Kocher T, Holler C, Trapin D, Asslaber D, Tinhofer I, Greil R, Egle A.
    Leukemia. 2011 Sep,25(9):1452-8. doi: 10.1038/leu.2011.111. Epub 2011 May 24.

    View this publication in the PUBMED database
  • 2011

    Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemia.

    Weiss L, Melchardt T, Egle A, Grabmer C, Greil R, Tinhofer I.
    Cancer. 2011 May 15,117(10):2163-9. doi: 10.1002/cncr.25752. Epub 2010 Nov 18.

    View this publication in the PUBMED database
  • 2011

    Treatment of invasive aspergillosis in cancer patients.

    Auberger, J, Russ, G, Greil, R, Egle, A,
    memo - Magazine of European Medical Oncology. 2011, 4 (4): 266-272.

    View this publication in the PUBMED database
  • 2011

    Activity of Azacitidine in 26 Unselected, Consecutive CMML Patients Included in the Austrian Azacitidine Registry (AAR) of the AGMT-Study Group

    Pleyer, L, Stauder, R, Burgstaller, S, Schreder, M, Tinchon, C, Pfeilstocker, M, Steinkirchner, S, Melchardt, T, Mitrovic, M, Girschikofsky, M, Lang, A, Krippl, P, Egle, A, Sliwa, T, Linkesch, W, Fridrik, MA, Greil, R
    BLOOD. 2011, 118(21): 747-747.

    View this publication in the PUBMED database
  • 2011

    Open-Label, Prospective, Multicentre, Phase I/II Study of AOP2014, a Novel PEG-Proline-Interferon Alpha-2b in Patients with Polycythemia Vera: Update from an Ongoing Study

    Gisslinger, H, Kralovics, R, Schoder, R, Gisslinger, B, Buxhofer-Ausch, V, Strecker, K, Wolf, D, Willenbacher, E, Greil, R, Egle, A, Melchardt, T, Burgstaller, S, Tarmann, FJ, Wachter, C, Zahriycick, O, Thaler, J
    BLOOD. 2011, 118(21): 762-762.

    View this publication in the PUBMED database
  • 2011

    Tumor load reduction and prolongation of overall-survival by actinomycin D in a murine model of high-risk chronic lymphocytic leukemia

    Wacht, N, Sifft, E, Melchardt, T, Hamacher, F, Denk, U, Pinon-Hofbauer, J, Egle, A, Kocher, T, Steurer, M, Greil, R, Merkel, O
    ONKOLOGIE. 2011, 34: 141-141.

    View this publication in the PUBMED database
  • 2011

    CLL CELLS INDUCE CLONAL T CELL SKEWING AND SUBSETSHIFTING IN THE MURINE TCL1 TRANSGENIC CHRONIC LYMPHOCYTIC LEUKEMIA MODEL

    Egle, A, Pinon-Hofbauer, J, Heyder, C, Denk, U, Kocher, T, Holler, C, Trapin, D, Asslaber, D, Tinhofer, I, Greil, R
    ANN ONCOL. 2011, 22: 144-144.

    View this publication in the PUBMED database
  • 2011

    Clonal Diversity of the T Cell Repertoire Predicts Disease Progression in Chronic Lymphocytic Leukaemia

    Holler, C, Zaborsky, N, Hofbauer, JP, Kocher, T, Trapin, D, Asslaber, D, Greil, R, Egle, A
    BLOOD. 2011, 118(21): 365-365.

    View this publication in the PUBMED database
  • 2011

    ASH Report. Novel agents in diffuse large B-cell lymphoma: A short update including ASH 2010.

    Melchardt T, Hofbauer SW, Greil R, Hopfinger G.
    Memo - Magazine of European Medical Oncology. 2011 June 1, 4(2): 120-123.

    View this publication in the PUBMED database
  • 2011

    Oxaliplatin, irinotecan and cetuximab in advanced gastric cancer. A multicenter phase II trial (Gastric-2) of the Arbeitsgemeinschaft Medikamentose Tumortherapie (AGMT).

    Wöll E, Greil R, Eisterer W, Bechter O, Fridrik MA, Grünberger B, Zabernigg A, Mayrbäurl B, Russ G, Dlaska M, Obrist P, Thaler J.
    Anticancer Res. 2011 Dec,31(12):4439-43.

    View this publication in the PUBMED database
  • 2011

    Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.

    Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwin J, Gray R, Pierce L, Whelan T, Wang Y, Peto R.
    Lancet. 2011 Nov 12,378(9804):1707-16. doi: 10.1016/S0140-6736(11)61629-2. Epub 2011 Oct 19. Review.

    View this publication in the PUBMED database
  • 2011

    Adjuvant sequencing of tamoxifen and anastrozole is superior to tamoxifen alone in postmenopausal women with low proliferating breast cancer.

    Bago-Horvath Z, Rudas M, Dubsky P, Jakesz R, Singer CF, Kemmerling R, Greil R, Jelen A, Böhm G, Jasarevic Z, Haid A, Gruber C, Pöstlberger S, Filipits M, Gnant M
    Clin Cancer Res. 2011 Dec 15,17(24):7828-34. doi: 10.1158/1078-0432.CCR-11-1846. Epub 2011 Oct 13.

    View this publication in the PUBMED database
  • 2011

    Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group.

    Borchmann P, Haverkamp H, Diehl V, Cerny T, Markova J, Ho AD, Eich HT, Mueller-Hermelink HK, Kanz L, Greil R, Rank A, Paulus U, Smardova L, Huber C, Dörken B, Nerl C, Krause SW, Mueller RP, Fuchs M, Engert A.
    J Clin Oncol. 2011 Nov 10,29(32):4234-42. doi: 10.1200/JCO.2010.33.9549. Epub 2011 Oct 11.

    View this publication in the PUBMED database
  • 2011

    A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors.

    Filipits M, Rudas M, Jakesz R, Dubsky P, Fitzal F, Singer CF, Dietze O, Greil R, Jelen A, Sevelda P, Freibauer C, Müller V, Jänicke F, Schmidt M, Kölbl H, Rody A, Kaufmann M, Schroth W, Brauch H, Schwab M, Fritz P, Weber KE, et al.
    PLoS One. 2011,6(8):e23758. doi: 10.1371/journal.pone.0023758. Epub 2011 Aug 18

    View this publication in the PUBMED database
  • 2011

    Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.

    Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, McGale P, Pan HC, Taylor C, Wang YC, Dowsett M, Ingle J, Peto R.
    Lancet. 2011 Aug 27,378(9793):771-84. doi: 10.1016/S0140-6736(11)60993-8. Epub 2011 Jul 28.

    View this publication in the PUBMED database
  • 2011

    Novel therapeutic options in anaplastic large cell lymphoma: molecular targets and immunological tools.

    Merkel O, Hamacher F, Sifft E, Kenner L, Greil R
    Mol Cancer Ther. 2011 Jul,10(7):1127-36. doi: 10.1158/1535-7163.MCT-11-0042. Epub 2011 Jun 28. Review.

    View this publication in the PUBMED database
  • 2011

    Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases.

    Lin NU, Eierman W, Greil R, Campone M, Kaufman B, Steplewski K, Lane SR, Zembryki D, Rubin SD, Winer EP.
    J Neurooncol. 2011 Dec,105(3):613-20. doi: 10.1007/s11060-011-0629-y. Epub 2011 Jun 26.

    View this publication in the PUBMED database
  • 2011

    Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.

    Gnant M, Mlineritsch B, Stoeger H, Luschin-Ebengreuth G, Heck D, Menzel C, Jakesz R, Seifert M, Hubalek M, Pristauz G, Bauernhofer T, Eidtmann H, Eiermann W, Steger G, Kwasny W, Dubsky P, Hochreiner G, Forsthuber EP, Fesl C, Greil R
    Lancet Oncol. 2011 Jul,12(7):631-41. doi: 10.1016/S1470-2045(11)70122-X. Epub 2011 Jun 5.

    View this publication in the PUBMED database
  • 2011

    Efficacy of temsirolimus after previous treatment with sunitinib, sorafenib or everolimus in advanced renal cell cancer.

    Grundbichler M, Mlineritsch B, Ressler S, Moik M, Kappacher A, Rosenlechner S, Greil R.
    Oncology. 2011,80(1-2):34-41. doi: 10.1159/000328086. Epub 2011 May 23.

    View this publication in the PUBMED database
  • 2011

    Combination therapy of lapatinib and Capecitabine for ErbB2-positive metastatic or locally advanced breast cancer: results from the Lapatinib Expanded Access Program (LEAP) in Central and Eastern Europe.

    Greil R, BorГ…ВЎtnar S, PetrГЎkovГЎ K, Marcou Y, Pikiel J, Wojtukiewicz MZ, Koza I, Steger GG, Linn M, Das Gupta A, Cwiertka K.
    Onkologie. 2011,34(5):233-8. doi: 10.1159/000327710. Epub 2011 Apr 26.

    View this publication in the PUBMED database
  • 2011

    Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial.

    Pfeiler G, Königsberg R, Fesl C, Mlineritsch B, Stoeger H, Singer CF, Pöstlberger S, Steger GG, Seifert M, Dubsky P, Taucher S, Samonigg H, Bjelic-Radisic V, Greil R, Marth C, Gnant M.
    J Clin Oncol. 2011 Jul 1,29(19):2653-9. doi: 10.1200/JCO.2010.33.2585. Epub 2011 May 9.

    View this publication in the PUBMED database
  • 2011

    Clinical outcome with bevacizumab in patients with recurrent high-grade glioma treated outside clinical trials.

    Hofer S, Elandt K, Greil R, Hottinger AF, Huber U, Lemke D, Marosi C, Ochsenbein A, Pichler J, Roelcke U, Weder P, Zander T, Wick W, Weller M.
    Acta Oncol. 2011 Jun,50(5):630-5. doi: 10.3109/0284186X.2011.572913. Epub 2011 Apr 18.

    View this publication in the PUBMED database
  • 2011

    Sentinel node biopsy after primary chemotherapy in breast cancer: a note of caution from results of ABCSG-14.

    Tausch C, Steger GG, Haid A, Jakesz R, Fridrik MA, Reitsamer R, Pöstlberger S, Lang A, Gnant M, Greil R.
    Breast J. 2011 May-Jun,17(3):230-8. doi: 10.1111/j.1524-4741.2011.01073.x. Epub 2011 Mar 31.

    View this publication in the PUBMED database
  • 2011

    Zoledronic acid for adjuvant use in patients with breast cancer.

    Ressler S, Mlineritsch B, Greil R.
    Expert Rev Anticancer Ther. 2011 Mar,11(3):333-49. doi: 10.1586/era.11.13.

    View this publication in the PUBMED database
  • 2011

    Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients.

    Fiegl M, Falkner F, Steurer M, Zojer N, Hopfinger G, Haslbauer F, Winder G, Voskova D, Andel J, Lang A, Brychtova Y, Mayer J, Greil R, Gastl G
    Ann Hematol. 2011 Sep,90(9):1083-91. doi: 10.1007/s00277-011-1192-5. Epub 2011 Feb 25.

    View this publication in the PUBMED database
  • 2011

    Preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with newly diagnosed primary operable cT₃NxM0 low rectal cancer: a phase II study.

    Ofner D, Devries AF, Schaberl-Moser R, Greil R, Rabl H, Tschmelitsch J, Zitt M, Kapp KS, Fastner G, Keil F, Eisterer W, Jäger R, Offner F, Gnant M, Thaler J
    Strahlenther Onkol. 2011 Feb,187(2):100-7. doi: 10.1007/s00066-010-2182-6. Epub 2011 Jan 21.

    View this publication in the PUBMED database
  • 2011

    Infusion reactions to the chimeric EGFR inhibitor cetuximab--change to the fully human anti-EGFR monoclonal antibody panitumumab is safe.

    Resch G, Schaberl-Moser R, Kier P, Kopetzky G, Scheithauer W, Sliwa T, Greil R, Nösslinger T, Mayrbäurl B, Thaler J.
    Ann Oncol. 2011 Feb,22(2):486-7. doi: 10.1093/annonc/mdq744. Epub 2011 Jan 13.

    View this publication in the PUBMED database
  • 2011

    Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma.

    Gökbuget N, Hartog CM, Bassan R, Derigs HG, Dombret H, Greil R, Hernández-Rivas JM, Huguet F, Intermesoli T, Jourdan E, Junghanss C, Leimer L, Moreno MJ, Reichle A, Ribera J, Schmid M, Serve H, Stelljes M, Stuhlmann R, Hoelzer D
    Haematologica. 2011 Feb,96(2):238-44. doi: 10.3324/haematol.2010.028092. Epub 2010 Oct 15.

    View this publication in the PUBMED database
  • 2011

    Bedeutung des RANK / RANK-Ligand Systems beim Mammakarzinom: Biologische Grundlagen.

    Ressler Sigrun, Mlineritsch Brigitte, Greil Richard
    Universum Innere Medizin. 2011.

    View this publication in the PUBMED database
  • 2011

    Bisphosphonate in der Therapie des Mammakarzinoms

    Ressler Sigrun, Mlineritsch Brigitte, Greil Richard
    MEDIUM. 2011. 3: 26-30.

    View this publication in the PUBMED database
  • 2011

    Parp Inhibitoren

    Ressler Sigrun, Mlineritsch Brigitte, Greil Richard
    Universum Innere Medizin. 2011.

    View this publication in the PUBMED database
  • 2011

    The oncogenic miR-17-92 cluster and miR-155 define ALK status in anaplastic large cell lymphoma

    Griessl, R, Hamacher, F, Sifft, E, Scheideler, M, Kenner, L, Greil, R, Merkel, O
    ONKOLOGIE. 2011, 34: 135-135.

    View this publication in the PUBMED database
  • 2011

    62-Month follow-up of ABCSG-12: Adjuvant endocrine therapy, alone or in combination with zoledronic acid, in premenopausal patients with endocrine-responsive early breast cancer

    Gnant, M, Mlineritsch, B, Stoeger, H, Luschin-Ebengreuth, G, Poestlberger, S, Steger, G, Jakesz, R, Singer, C, Eidtmann, H, Greil, R
    BONE. 2011, 48(1): S17-S17.

    View this publication in the PUBMED database
  • 2011

    Lower incidence of BCR-ABL mutations and improved molecular response kinetics in newly diagnosed CML patients treated with nilotinib compared with imatinib

    Muller, MC, le Coutre, P, Gattermann, N, Scheid, C, Al-Ali, HK, Ottmann, OG, Duyster, J, Blumenstengel, K, Brummendorf, TH, Greil, R, Chalandon, Y, Valent, P, Stegelmann, F, Kneba, M, Schafhausen, P, Saussele, S, Frank, O, Larson, RA, Saglio, G, Hochhaus, A, Lange, T
    ONKOLOGIE. 2011, 34: 266-266.

    View this publication in the PUBMED database
  • 2011

    DOSE-ESCALATION WITH BEACOPP ESCALATED IS SUPERIOR TO ABVD IN THE COMBINED-MODALITY TREATMENT OF EARLY UNFAVORABLE HODGKIN LYMPHOMA (HL): FINAL ANALYSIS OF THE GERMAN HODGKIN STUDY GROUP (GHSG) HD14 TRIAL

    Borchmann, P, Diehl, V, Plutschow, A, Von Tresckow, B, Markova, J, Hitz, F, Kra, Z, Greil, R, Topp, MS, Villalobos, M, Zijlstra, JM, Sokler, M, Fuchs, M, Engert, A
    ANN ONCOL. 2011, 22: 180-180.

    View this publication in the PUBMED database
  • 2011

    R-CHOP plus thalidomide for previously untreated patients with mantle cell lymphoma (AGMT NHL-11 trial)

    Drach, J, Hopfinger, G, Fridrik, M, Greil, R, Thaler, J, Willenbacher, W, Lang, A, Jager, U, Raderer, M
    ONKOLOGIE. 2011, 34: 75-75.

    View this publication in the PUBMED database
  • 2011

    Clinical aspects of 2009 pandemic influenza A (H1N1) virus infection in Austria.

    Poeppl, W, Hell, M, Herkner, H, Stoiser, B, Fritsche, G, Schurz-Bamieh, N, Poeppl, G, Gattringer, R, Jones, N, Maass, M, Egle, A, Burgmann, H,
    Infection. 2011 Aug,39(4):341-52. doi: 10.1007/s15010-011-0121-9. Epub 2011 May 5.

    View this publication in the PUBMED database
  • 2011

    Anaplastic large cell lymphoma: the current state of play from a European prospective as presented at the second annual meeting of the European Research Initiative on ALCL, 27-28 June 2011.

    Merkel O, Kenner L, Turner SD.
    Leukemia. Dec,25(12):1795-6. doi: 10.1038/leu.2011.295.

    View this publication in the PUBMED database
  • 2010

    VLA-4 and CD38 in chronic lymphocytic leukemia - more than prognostic markers?

    Brechtl, G, Denk, U, Pinon-Hofbauer, JD, Greil, R, Hartmann, TN
    ONKOLOGIE. 2010, 33: 201-202.

    View this publication in the PUBMED database
  • 2010

    The role of the VLA-4 integrin in adhesion and survival of chronic lymphocytic leukemia (CLL) cells

    Sahakyan, K, Hofbauer, S, Brachtl, G, Girbl, T, Henschler, R, Greil, R, Hartmann, TN
    ONKOLOGIE. 2010, 33: 201-201.

    View this publication in the PUBMED database
  • 2010

    The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients.

    Perkhofer S, Lass-Flörl C, Hell M, Russ G, Krause R, Hönigl M, Geltner C, Auberger J, Gastl G, Mitterbauer M, Willinger B, Knöbl P, Resch G, Waldner R, Makrai A, Hartmann G, Girschikofsky M, Greil R.
    Int J Antimicrob Agents. 2010 Dec,36(6):531-6. doi: 10.1016/j.ijantimicag.2010.08.010. Epub 2010 Oct 13.

    View this publication in the PUBMED database
  • 2010

    Modifying akt signaling in B-cell chronic lymphocytic leukemia cells.

    Hofbauer SW, Piñón JD, Brachtl G, Haginger L, Wang W, Jöhrer K, Tinhofer I, Hartmann TN, Greil R.
    Cancer Res. 2010 Sep 15,70(18):7336-44. doi: 10.1158/0008-5472.CAN-09-4411. Epub 2010 Sep 7.

    View this publication in the PUBMED database
  • 2010

    Inhibition of GLI, but not Smoothened induces apoptosis in chronic lymphocytic leukemia cells.

    Desch P, Asslaber D, Kern D, Schnidar H, Mangelberger D, Alinger B, Stoecher M, Hofbauer SW, Neureiter D, Tinhofer I, Aberger F, Hartmann TN, Greil R.
    Oncogene. 2010 Sep 2,29(35):4885-95. doi: 10.1038/onc.2010.243. Epub 2010 Jul 5.

    View this publication in the PUBMED database
  • 2010

    MicroRNAs as biomarkers for the diagnosis and prognosis of human cancer.

    Asslaber D, Pinon Hofbauer J, Greil R, Egle A.
    Journal of Nucleic Acids Investigations. 2010, Dec 1, 1(1): 76-80.

    View this publication in the PUBMED database
  • 2010

    An uncommon cause of anaemia: Sheehan's syndrome.

    Melchardt T, Namberger K, Weiss L, Egle A, Faber V, Greil R.
    Wien Klin Wochenschr. 2010 Dec,122(23-24):717-9. doi: 10.1007/s00508-010-1480-4. Epub 2010 Dec 7.

    View this publication in the PUBMED database
  • 2010

    Interdependent regulation of p53 and miR-34a in chronic lymphocytic leukemia.

    Merkel O, Asslaber D, PiГ±Гіn JD, Egle A, Greil R.
    Cell Cycle. 2010 Jul 15,9(14):2764-8. Epub 2010 Jul 3.

    View this publication in the PUBMED database
  • 2010

    microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia.

    Asslaber D, Piñón JD, Seyfried I, Desch P, Stöcher M, Tinhofer I, Egle A, Merkel O, Greil R.
    Blood. 2010 May 27,115(21):4191-7. doi: 10.1182/blood-2009-07-234823. Epub 2010 Jan 20.

    View this publication in the PUBMED database
  • 2010

    Enzastaurin kills human CLL cells regardless of clinical risk profile, but fails to prolong life in a murine CLL model

    Kocher, T, Pinon, HJ, Holler, C, Denk, U, Greil, R, Egle, A
    ONKOLOGIE. 2010, 33: 40-40.

    View this publication in the PUBMED database
  • 2010

    Final Analysis of Induction Treatment with Fludarabine, Cyclophosphamide Plus Rituximab (FCR) Followed by Fludarabine Plus Rituximab (FR) and Remission Maintenance Therapy with Rituximab In Previously Untreated B-Chronic Lymphocytic Leukemia (B-CLL): The Chairos AGMT CLL4/Roche ML18434 Study

    Egle, A, Weiss, L, Melchardt, T, Gunsilius, E, Petzer, AL, Fridrik, M, Lang, A, Krieger, O, Thaler, J, Greil, R
    BLOOD. 2010, 116(21): 593-594.

    View this publication in the PUBMED database
  • 2010

    Deletion of Puma and p21(Waf1) In Mice Deactivates p53-Induced Cell Death and Cell Cycle Arrest, but Protects Mice From Irradiation-Induced Lymphomagenesis by a Mechanism Involving Hemopoietic Stem Cell Quiescence

    Hofbauer, JP, Holler, C, Denk, U, Asslaber, D, Fastner, G, Labi, V, Villunger, A, Greil, R, Egle, A
    BLOOD. 2010, 116(21): 45-46.

    View this publication in the PUBMED database
  • 2010

    Neue Therapie in Sicht.

    Merkel O, Kenner L, Greil R
    SpringerMedizin. 22.09.2010

    View this publication in the PUBMED database
  • 2010

    Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.

    Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Correa C, McGale P, Taylor C, Wang Y, Clarke M, Davies C, Peto R, Bijker N, Solin L, Darby S.
    J Natl Cancer Inst Monogr. 2010,2010(41):162-77. doi: 10.1093/jncimonographs/lgq039.

    View this publication in the PUBMED database
  • 2010

    Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value.

    Michlmayr A, Bachleitner-Hofmann T, Baumann S, Marchetti-Deschmann M, Rech-Weichselbraun I, Burghuber C, Pluschnig U, Bartsch R, Graf A, Greil R, Allmaier G, Steger G, Gnant M, Bergmann M, Oehler R.
    Br J Cancer. 2010 Oct 12,103(8):1201-8. doi: 10.1038/sj.bjc.6605909. Epub 2010 Sep 28.

    View this publication in the PUBMED database
  • 2010

    Light chain-induced acute renal failure can be reversed by bortezomib-doxorubicin-dexamethasone in multiple myeloma: results of a phase II study.

    Ludwig H, Adam Z, Hajek R, Greil R, TГіthovГЎ E, Keil F, Autzinger EM, Thaler J, Gisslinger H, Lang A, Egyed M, Womastek I, Zojer N.
    J Clin Oncol. 2010 Oct 20,28(30):4635-41. doi: 10.1200/JCO.2010.28.1238. Epub 2010 Sep 7.

    View this publication in the PUBMED database
  • 2010

    Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.

    Engert A, Plütschow A, Eich HT, Lohri A, Dörken B, Borchmann P, Berger B, Greil R, Willborn KC, Wilhelm M, Debus J, Eble MJ, Sökler M, Ho A, Rank A, Ganser A, Trümper L, Bokemeyer C, Kirchner H, Schubert J, Král Z, Fuchs M, et al.
    N Engl J Med. 2010 Aug 12,363(7):640-52. doi: 10.1056/NEJMoa1000067.

    View this publication in the PUBMED database
  • 2010

    Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma.

    Merkel O, Hamacher F, Laimer D, Sifft E, Trajanoski Z, Scheideler M, Egger G, Hassler MR, Thallinger C, Schmatz A, Turner SD, Greil R, Kenner L.
    Proc Natl Acad Sci U S A. 2010 Sep 14,107(37):16228-33. doi: 10.1073/pnas.1009719107. Epub 2010 Aug 30.

    View this publication in the PUBMED database
  • 2010

    Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.

    Eich HT, Diehl V, Görgen H, Pabst T, Markova J, Debus J, Ho A, Dörken B, Rank A, Grosu AL, Wiegel T, Karstens JH, Greil R, Willich N, Schmidberger H, Döhner H, Borchmann P, Müller-Hermelink HK, Müller RP, Engert A.
    J Clin Oncol. 2010 Sep 20,28(27):4199-206. doi: 10.1200/JCO.2010.29.8018. Epub 2010 Aug 16.

    View this publication in the PUBMED database
  • 2010

    Evidence for the conversion of docetaxel into 7'-epidocetaxel in patients receiving Taxotere-based conventional chemotherapy.

    Czejka M, Greil R, Ulsperger E, Schnait H, Kienesberger K, Brumnik T, Farkouh A, Schierholz J.
    Int J Clin Pharmacol Ther. 2010 Jul,48(7):483-4.

    View this publication in the PUBMED database
  • 2010

    Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.

    Saglio G, Kim DW, Issaragrisil S, le Coutre P, Etienne G, Lobo C, Pasquini R, Clark RE, Hochhaus A, Hughes TP, Gallagher N, Hoenekopp A, Dong M, Haque A, Larson RA, Kantarjian HM
    N Engl J Med. 2010 Jun 17,362(24):2251-9. doi: 10.1056/NEJMoa0912614. Epub 2010 Jun 5.

    View this publication in the PUBMED database
  • 2010

    Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories.

    Fiegl M, Erdel M, Tinhofer I, Brychtova Y, Panovska A, Doubek M, Eigenberger K, Fonatsch C, Hopfinger G, MГјhlberger H, Zabernigg A, Falkner F, Gastl G, Mayer J, Greil R
    Ann Oncol. 2010 Dec,21(12):2410-9. doi: 10.1093/annonc/mdq236. Epub 2010 May 13.

    View this publication in the PUBMED database
  • 2010

    PLZF/ZBTB16, a glucocorticoid response gene in acute lymphoblastic leukemia interferes with glucocorticoid-induced apoptosis.

    Wasim M, Carlet M, Mansha M, Greil R, Ploner C, Trockenbacher A, Rainer J, Kofler R.
    J Steroid Biochem Mol Biol. 2010 Jun,120(4-5):218-27. doi: 10.1016/j.jsbmb.2010.04.019. Epub 2010 May 6.

    View this publication in the PUBMED database
  • 2010

    Dose-dense therapy improves survival in aggressive non-Hodgkin's lymphoma.

    Fridrik MA, Hausmaninger H, Lang A, Drach J, Krieger O, Geissler D, Michlmayr G, Ulsperger E, Chott A, Oberaigner W, Greil R.
    Ann Hematol. 2010 Mar,89(3):273-82. doi: 10.1007/s00277-009-0811-x. Epub 2009 Aug 20.

    View this publication in the PUBMED database
  • 2010

    Triple negative breast cancer

    Ressler S. Mlineritsch B Greil R
    memo - Magazine of European Medical Oncology. 2010, 3: 185-189.

    View this publication in the PUBMED database
  • 2010

    Short review – Management of Immune Thrombocytopenia in adults

    Lukas Weiss, Richard Greil,
    Magazine of European Medical Oncology. 2010, Volume 3, Issue 2: 69-72.

    View this publication in the PUBMED database
  • 2010

    Chronic Myeloid Neoplasias and Clonal Overlap Syndromes.

    Greil, R, Pleyer, L, Neureiter, D, Faber, V,
    2010.

    View this publication in the PUBMED database
  • 2010

    Rare Clonal Myeloid Diseases

    Melchardt T, Weiss L, Pleyer L, Neureiter D, Faber V, Greil R.
    In Greil R., Pleyer L., Neureiter D., Faber V. (Editors) , Chronic Myeloid Neoplasias and Clonal Overlap Syndromes. Wien New York: Springer (2010) , Springer, 2010. (ISBN 978-3-211-79891-1)

    View this publication in the PUBMED database
  • 2010

    Chronic Myelomonocytic Leukemia (CMML).

    Pleyer, L, Neureiter, D, Faber, V, Greil, R,
    In: Greil, R, Pleyer, L, Neureiter, D, Faber, V (Ed.) editors(s). Chronic Myeloid Neoplasias and Clonal Overlap Syndromes.. p. 223-234.

    View this publication in the PUBMED database
  • 2010

    Myelodysplastic Syndromes (MDS).

    Pleyer, L, Neureiter, D, Faber, V, Greil, R,
    In: Greil, R, Pleyer, L, Neureiter, D, Faber, V (Ed.) editors(s). Chronic Myeloid Neoplasias and Clonal Overlap Syndromes.. p. 153-222.

    View this publication in the PUBMED database
  • 2010

    Polycythemia Vera (PV).

    Pleyer, L, Neureiter, D, Greil, R,
    In: Greil, R, Pleyer, L, Neureiter, D, Faber, V (Ed.) editors(s). Chronic Myeloid Neoplasias and Clonal Overlap Syndromes.. p. 51-80.

    View this publication in the PUBMED database
  • 2010

    Bewegung und Krebs.

    Pleyer, L, Kappacher, A, Rosenlechner, S, Greil, R,
    In: Braumann, KM, Stiller, N (Ed.) editors(s). Bewegungstherapie bei internistischen Erkrankungen.. p. 223-240.

    View this publication in the PUBMED database
  • 2010

    De novo 'Classic' Paroxysmal Nocturnal Hemoglobinuria (PNH) (Marchiafava-Micheli Syndrome).

    Pleyer, L, Greil, R,
    In: Greil, R, Pleyer, L, Neureiter, D, Faber, V (Ed.) editors(s). Chronic Myeloid Neoplasias and Clonal Overlap Syndromes.. p. 259-280.

    View this publication in the PUBMED database
  • 2010

    Primary Myelofibrosis (PMF) [Previously Chronic Idiopathic Mylofibrosis (CIMF), Myelofibrosis with Myeloid Metaplasia (MMM), Agnogenic Myeloid Metaplasia (AMM)].

    Pleyer, L, Faber, V, Neureiter, D, Greil, R,
    In: Greil, R, Pleyer, L, Neureiter, D, Faber, V (Ed.) editors(s). Chronic Myeloid Neoplasias and Clonal Overlap Syndromes.. p. 81-116.

    View this publication in the PUBMED database
  • 2010

    Clonal Bone Marrow Failure Overlap Syndromes.

    Pleyer, L, Neureiter, D, Faber, V, Greil, R,
    In: Greil, R, Pleyer, L, Neureiter, D, Faber, V (Ed.) editors(s). Chronic Myeloid Neoplasias and Clonal Overlap Syndromes.. p. 281-288.

    View this publication in the PUBMED database
  • 2010

    Introduction to „Classic' Chronic Myeloproliferative Disoderes (CMPDs)- Molecular and Cellular Biology.

    Pleyer, L, Greil, R,
    In: Greil, R, Pleyer, L, Neureiter, D, Faber, V (Ed.) editors(s). Chronic Myeloid Neoplasias and Clonal Overlap Syndromes.. p. 1-13.

    View this publication in the PUBMED database
  • 2010

    Essential Thrombocythemia (ET).

    Pleyer, L, Faber, V, Neureiter, D, Greil, R
    In: Greil, R, Pleyer, L, Neureiter, D, Faber, V (Ed.) editors(s). Chronic Myeloid Neoplasias and Clonal Overlap Syndromes.. p. 14-50.

    View this publication in the PUBMED database
  • 2010

    ABCSG-24: EFFICACY OF ANTHRACYCLINE- AND TAXANE-BASED NEOADJUVANT THERAPY +/- CAPECITABINE (C) IN TRIPLE-NEGATIVE EARLY BREAST CANCER (TNBC)

    Steger, GG, Greil, R, Jakesz, R, Mlineritsch, B, Lang, A, Rudas, M, Marth, C, Stoeger, H, Singer, CF, Gnant, M
    ANN ONCOL. 2010, 21: 79-79.

    View this publication in the PUBMED database
  • 2010

    ADJUVANT ENDOCRINE THERAPY, ALONE OR IN COMBINATION WITH ZOLEDRONIC ACID (ZOL), IN PREMENOPAUSAL PATIENTS (PTS) WITH ENDOCRINE-RESPONSIVE EARLY BREAST CANCER (EBC): SUBGROUP ANALYSES OF ABCSG-12

    Gnant, M, Mlineritsch, B, Stoeger, H, Luschin-Ebengreuth, G, Poestlberger, S, Steger, GG, Jakesz, R, Singer, CF, Eidtmann, H, Greil, R
    ANN ONCOL. 2010, 21: 79-79.

    View this publication in the PUBMED database
  • 2010

    Non-pegylated liposomal doxorubicin in metastatic breast cancer (MBC) - Results from an Austrian post marketing surveillance programme

    Steger, GG, Mlineritsch, B, Bartsch, R, Pluschnig, U, Petru, E, Peintinger, F, Sevelda, P, Greil, R
    ONKOLOGIE. 2010, 33: 55-55.

    View this publication in the PUBMED database
  • 2010

    Antiapoptotic effects of p21 in arsenic trioxide induced apoptosis in CLL

    Sifft, E, Asslaber, D, Schweiggl, S, Hamacher, F, Greil, R, Merkel, O
    ONKOLOGIE. 2010, 33: 185-185.

    View this publication in the PUBMED database
  • 2010

    Targeting Pim-2, a novel survival protein of myeloma cells, kills malignant plasma cells

    Johrer, K, Obkircher, M, Neureiter, D, Parteli, J, Hamacher, F, Merkel, O, Wacht, N, Zidorn, C, Scheideler, M, Greil, R
    ONKOLOGIE. 2010, 33: 187-188.

    View this publication in the PUBMED database
  • 2010

    HETEROGENEOUS EXPRESSION PATTERN OF HEDGEHOG SIGNALLING PATHWAY IN HEMATOPOIESIS OF MYELODYSPLASTIC SYNDROME

    Neureiter, D, Kemmerling, R, Alinger, B, Kiesslich, T, Faber, V, Stocher, M, Pleyer, L, Greil, R, Dietz, O
    HAEMATOL-HEMATOL J. 2010, 95: 375-375.

    View this publication in the PUBMED database
  • 2010

    Role of miRNAs in ALK(+) and ALK(-) anaplastic large cell lymphoma

    Hamacher, F, Laimer, D, Scheideler, M, Trajanoski, Z, Egger, G, Kenner, L, Greil, R, Merkel, O
    ONKOLOGIE. 2010, 33: 209-209.

    View this publication in the PUBMED database
  • 2010

    Independent prognostic factors for response: updated results of the ABCSG-24 study evaluating the addition of capecitabine to epirubicin-docetaxel neoadjuvant therapy for early breast cancer (EBC)

    Steger, GG, Greil, R, Jakesz, R, Lang, A, Mlineritsch, B, Rudas, M, Marth, C, Stoeger, H, Singer, CF, Gnant, M
    EJC SUPPL. 2010, 8(3): 60-60.

    View this publication in the PUBMED database
  • 2010

    Dose-Escalation with BEACOPP Escalated Is Superior to ABVD In the Combined-Modality Treatment of Early Unfavorable Hodgkin Lymphoma: Final Analysis of the German Hodgkin Study Group (GHSG) HD14 Trial

    Engert, A, Borchmann, P, Pluetschow, A, von Tresckow, B, Markova, J, Hitz, F, Kral, Z, Greil, R, Topp, MS, Villalobos, M, Zijlstra, JM, Soekler, M, Stein, H, Eich, HT, Mueller, RP, Fuchs, M, Diehl, V
    BLOOD. 2010, 116(21): 336-336.

    View this publication in the PUBMED database
  • 2010

    Is Liposome Encapsulated Doxorubicin Able to Reduce the Cardiotoxicity of Doxorubicin In the Treatment of DLBCL? A Randomised Study by the Austrian Working Party of Medical Oncology (AGMT-Study NHL-14)

    Fridrik, M, Petzer, AL, Keil, F, Willenbacher, W, Jager, U, Lang, A, Andel, J, Krieger, O, Oberaigner, W, Greil, R
    BLOOD. 2010, 116(21): 736-737.

    View this publication in the PUBMED database
  • 2010

    Erforschung der Chronisch Lymphatischen Leukämie am LIMCR.

    Hartmann TN.
    Med.ium. 6/2010.

    View this publication in the PUBMED database
  • 2010

    ÖGHO-Frühjahrstagung: Chronische Lymphatische Leukämie, Adhäsionsmoleküle als mögliche therapeutische Ziele.

    Hartmann TN.
    JATROS Haematologie und Onkologie. 3/2010, Seite 63-65.

    View this publication in the PUBMED database
  • 2010

    CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B.

    Leick M, Catusse J, Follo M, Nibbs RJ, Hartmann TN, Veelken H, Burger M.
    mmunology. 2010 Apr,129(4):536-46. doi: 10.1111/j.1365-2567.2009.03209.x. Epub 2009 Dec 2.

    View this publication in the PUBMED database
  • 2010

    Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation.

    Labi V, Erlacher M, Krumschnabel G, Manzl C, Tzankov A, Pinon J, Egle A, Villunger A.
    Genes Dev. 2010 Aug 1,24(15):1602-7. doi: 10.1101/gad.1940210.

    View this publication in the PUBMED database
  • 2010

    Riding the 2-edged sword.

    Egle A.
    Blood. 2010 Jun 3,115(22):4325-6. doi: 10.1182/blood-2010-03-272211.

    View this publication in the PUBMED database
  • 2009

    Novel therapeutics approaches to chronic lymphocytic leukemia based on recent biological insights.

    Hartmann TN, Pleyer L, Desch P, Egle A, Greil R.
    Discov Med. 2009 Oct,8(42):157-64.

    View this publication in the PUBMED database
  • 2009

    Molecular and cellular mechanisms of CLL: novel therapeutic approaches.

    Pleyer L, Egle A, Hartmann TN, Greil R.
    Nat Rev Clin Oncol. 2009 Jul,6(7):405-18. doi: 10.1038/nrclinonc.2009.72. Epub 2009 Jun 2.

    View this publication in the PUBMED database
  • 2009

    Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow.

    Hartmann TN, Grabovsky V, Wang W, Desch P, Rubenzer G, Wollner S, Binsky I, Vallon-Eberhard A, Sapoznikov A, Burger M, Shachar I, Haran M, Honczarenko M, Greil R, Alon R.
    Cancer Res. 2009 Apr 1,69(7):3121-30. doi: 10.1158/0008-5472.CAN-08-4136. Epub 2009 Mar 17.

    View this publication in the PUBMED database
  • 2009

    Initial evaluation of the Roche COBAS TaqMan HIV-1 v2.0 assay for determining viral load in HIV-infected individuals.

    Taylor N, Schmid I, Egle A, Greil R, Patsch W, Oberkofler H.
    Antivir Ther. 2009,14(8):1189-93. doi: 10.3851/IMP1427.

    View this publication in the PUBMED database
  • 2009

    PKCbeta is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKCbeta as a therapeutic target in chronic lymphocytic leukemia.

    Holler C, PiГ±Гіn JD, Denk U, Heyder C, Hofbauer S, Greil R, Egle A.
    Blood. 2009 Mar 19,113(12):2791-4. doi: 10.1182/blood-2008-06-160713. Epub 2009 Jan 23.

    View this publication in the PUBMED database
  • 2009

    The REVLIRIT CLL5 AGMT Study - a Phase I/II Trial Combining Fludarabine/Rituximab with Escalating Doses of Lenalidomide Followed by Rituximab/Lenalidomide in Untreated Chronic Lymphocytic Leukemia (CLL): Results of a Planned Interim Analysis

    Egle, A, Steurer, M, Melchardt, T, Stoll, M, Greil, R
    BLOOD. 2009, 114(22): 1341-1342.

    View this publication in the PUBMED database
  • 2009

    The Inverse Correlation of Regulatory T Cells and Time to Initial Treatment in Chronic Lymphocytic B-Cell Leukemia

    Weiss, L, Melchardt, T, Grabmer, C, Egle, A, Tinhofer, I, Greil, R
    BLOOD. 2009, 114(22): 510-510.

    View this publication in the PUBMED database
  • 2009

    FINAL RESULTS OF ORAL FLUDARABINE WITH CONCOMITANT SUBCUTANEOUS ALEMTUZUMAB IN RELAPSED/REFRACTORY B-CHRONIC LYMPHOCYTIC LEUKAEMIA (B-CLL): THE FLUSALEM STUDY

    Egle, A, Melchardt, T, Pleyer, L, Tinhofer, I, Lang, A, Keil, F, Thaler, J, Gunsilius, E, Fridrik, M, Greil, R
    HAEMATOL-HEMATOL J. 2009, 94: 140-140.

    View this publication in the PUBMED database
  • 2009

    The Dark Side of the Moon - the Side Effects of Therapy in a Dynamic Era of Breast Cancer Management.

    Greil R.
    Breast Care (Basel). 2009,4(3):144-147. Epub 2009 Jun 26.

    View this publication in the PUBMED database
  • 2009

    Vincristine, idarubicin dexamethasone and thalidomide in scleromyxoedema.

    Laimer M, Namberger K, Massone C, Koller J, Emberger M, Pleyer L, Hintner H, Greil R.
    Acta Derm Venereol. 2009 Nov,89(6):631-5. doi: 10.2340/00015555-0731.

    View this publication in the PUBMED database
  • 2009

    Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy.

    Filipits M, Rudas M, Heinzl H, Jakesz R, Kubista E, Lax S, Schippinger W, Dietze O, Greil R, Stiglbauer W, Kwasny W, Nader A, Stierer M, Gnant MF
    Clin Cancer Res. 2009 Sep 15,15(18):5888-94. doi: 10.1158/1078-0432.CCR-09-0728. Epub 2009 Sep 1.

    View this publication in the PUBMED database
  • 2009

    Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?

    Gnant M, Dubsky P, Fitzal F, Blaha P, Schoppmann S, Steger G, Marth C, Samonigg H, HГјttner K, Fohler H, Ruecklinger E, Jakesz R, Greil R
    Clin Breast Cancer. 2009 Jun,9 Suppl 1:S18-27. doi: 10.3816/CBC.2009.s.002. Review.

    View this publication in the PUBMED database
  • 2009

    Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3.

    Van Cutsem E, Labianca R, Bodoky G, Barone C, Aranda E, Nordlinger B, Topham C, Tabernero J, AndrГ© T, Sobrero AF, Mini E, Greil R, Di Costanzo F, Collette L, Cisar L, Zhang X, Khayat D, Bokemeyer C, Roth AD, Cunningham D.
    J Clin Oncol. 2009 Jul 1,27(19):3117-25. doi: 10.1200/JCO.2008.21.6663. Epub 2009 May 18.

    View this publication in the PUBMED database
  • 2009

    Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer.

    Baselga J, Semiglazov V, van Dam P, Manikhas A, Bellet M, Mayordomo J, Campone M, Kubista E, Greil R, Bianchi G, Steinseifer J, Molloy B, Tokaji E, Gardner H, Phillips P, Stumm M, Lane HA, Dixon JM, Jonat W, Rugo HS.
    J Clin Oncol. 2009 Jun 1,27(16):2630-7. doi: 10.1200/JCO.2008.18.8391. Epub 2009 Apr 20.

    View this publication in the PUBMED database
  • 2009

    Neoadjuvant bevacizumab, docetaxel and capecitabine combination therapy for HER2/neu-negative invasive breast cancer: Efficacy and safety in a phase II pilot study.

    Greil R, Moik M, Reitsamer R, Ressler S, Stoll M, Namberger K, Menzel C, Mlineritsch B.
    Eur J Surg Oncol. 2009 Oct,35(10):1048-54. doi: 10.1016/j.ejso.2009.01.014. Epub 2009 Feb 27.

    View this publication in the PUBMED database
  • 2009

    Difference in the relative distribution of CD4+ T-cell subsets in B-CLL with mutated and unmutated immunoglobulin (Ig) VH genes: implication for the course of disease.

    Tinhofer I, Weiss L, Gassner F, Rubenzer G, Holler C, Greil R.
    J Immunother. 2009 Apr,32(3):302-9. doi: 10.1097/CJI.0b013e318197b5e4.

    View this publication in the PUBMED database
  • 2009

    Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer.

    Lin NU, DiГ©ras V, Paul D, Lossignol D, Christodoulou C, Stemmler HJ, RochГ© H, Liu MC, Greil R, Ciruelos E, Loibl S, Gori S, Wardley A, Yardley D, Brufsky A, Blum JL, Rubin SD, Dharan B, Steplewski K, Zembryki D, Oliva C, Roychowdhury D, et al.
    Clin Cancer Res. 2009 Feb 15,15(4):1452-9. doi: 10.1158/1078-0432.CCR-08-1080.

    View this publication in the PUBMED database
  • 2009

    Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

    Gnant M, Mlineritsch B, Schippinger W, Luschin-Ebengreuth G, Pöstlberger S, Menzel C, Jakesz R, Seifert M, Hubalek M, Bjelic-Radisic V, Samonigg H, Tausch C, Eidtmann H, Steger G, Kwasny W, Dubsky P, Fridrik M, Fitzal F, Stierer M, Rücklinger E, Greil R
    N Engl J Med. 2009 Feb 12,360(7):679-91. doi: 10.1056/NEJMoa0806285. Erratum in: N Engl J Med. 2009 May 28,360(22):2379.

    View this publication in the PUBMED database
  • 2009

    Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer.

    Mlineritsch B, Schabel-Moser R, Andel J, Fridrik M, Moik M, Mayer P, Russ G, Rass C, Greil R
    Onkologie. 2009 Feb,32(1-2):18-24. doi: 10.1159/000180915. Epub 2009 Jan 20.

    View this publication in the PUBMED database
  • 2009

    Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma.

    Ludwig H, Hajek R, TГіthovГЎ E, Drach J, Adam Z, Labar B, Egyed M, Spicka I, Gisslinger H, Greil R, Kuhn I, Zojer N, Hinke A.
    Blood. 2009 Apr 9,113(15):3435-42. doi: 10.1182/blood-2008-07-169565. Epub 2008 Oct 27.

    View this publication in the PUBMED database
  • 2009

    Hodgkin lymphoma in Tyrol-a population-based study.

    Fong D, Steurer M, Greil R, Gunsilius E, Spizzo G, Gastl G, Tzankov A.
    Ann Hematol. 2009 May,88(5):449-56. doi: 10.1007/s00277-008-0618-1. Epub 2008 Oct 10.

    View this publication in the PUBMED database
  • 2009

    The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cells.

    Nevo I, Sagi-Assif O, Meshel T, Ben-Baruch A, Jöhrer K, Greil R, Trejo LE, Kharenko O, Feinmesser M, Yron I, Witz IP.
    Cancer Lett. 2009 Jan 8,273(1):127-39. doi: 10.1016/j.canlet.2008.07.029. Epub 2008 Sep 7.

    View this publication in the PUBMED database
  • 2009

    REVERSAL OF ACUTE RENAL IMPAIRMENT BY BORTEZOMIB-DOXORUBICIN-DEXAMETHASONE IN MULTIPLE MYELOMA. RESULTS FROM AN PHASE II STUDY

    Ludwig, H, Adam, Z, Greil, R, Tothova, E, Keil, F, Zojer, N, Thaler, J, Gisslinger, H, Egyed, M, Lang, A
    HAEMATOL-HEMATOL J. 2009, 94: 154-154.

    View this publication in the PUBMED database
  • 2009

    A randomized phase III study comparing epirubicin, docetaxel, and capecitabine (EDC) to epirubicin and docetaxel (ED) as neoadjuvant treatment for early breast cancer - first results of the Austrian Breast and Colorectal Cancer Study Group-Trial 24 (ABCSG-24)

    Steger, GG, Greil, R, Jakesz, R, Lang, A, Mlineritsch, B, Melbinger-Zeinitzer, E, Martin, C, Samonigg, H, Kubista, E, Gnant, M
    EJC SUPPL. 2009, 7(3): 3-3.

    View this publication in the PUBMED database
  • 2009

    NUMBER NEEDED TO TREAT (NNT) AS A MEASURE OF ZOLEDRONIC ACID (ZOL) EFFICACY IN PATIENTS WITH HORMONE-RESPONSIVE EARLY BREAST CANCER (BC) IN THE AUSTRIAN BREAST AND COLORECTAL CANCER STUDY GROUP (ABCSG)-12 TRIAL

    Gnant, M, Mlineritsch, B, Schippinger, W, Luschin-Ebengreuth, G, Steger, GG, Bjelic-Radisic, V, Jakesz, R, Kubista, E, Marth, C, Greil, R
    ANN ONCOL. 2009, 20: 30-30.

    View this publication in the PUBMED database
  • 2009

    Bevacizumab (Bev) combined with either capecitabine (X) or weekly paclitaxel (Pac) as first-line therapy for HER2-negative locally recurrent or metastatic breast cancer (LR/MBC): the CECOG phase III TURANDOT trial

    Lang, I, Inbar, M, Steger, G, Greil, R, Zvirbule, Z, Beslija, S, Kahan, Z, Taskova, V, Kaufmann, B, Zielinski, CC
    EJC SUPPL. 2009, 7(2): 277-278.

    View this publication in the PUBMED database
  • 2009

    Pharmacogenetic (CYP2D6) and gene expression profiles (HOXB13/IL17BR and molecular grade index) for prediction of adjuvant endocrine therapy benefit in the ABCSG 8 trial.

    Goetz, M, Ames, M, Gnant, M, Filpits, M, Jakesz, R, Greil, R, Marth, C, Samonigg, H, Suman, V, Safgren, S, Kuffel, M, Weinshilboum, R, Erlander, M, Ma, XJ, Ingle, J
    CANCER RES. 2009, 69(2): 77S-77S.

    View this publication in the PUBMED database
  • 2009

    The number needed to treat (NNT) as a measure of drug efficacy: the case of zoledronic acid for early hormone-responsive breast cancer in the ABCSG-12 trial

    Gnant, M, Mlineritsch, B, Schippinger, W, Luschin-Ebengreuth, G, Steger, G, Bjelic-Radisic, V, Jakesz, R, Kubista, E, Marth, C, Greil, R
    CANCER RES. 2009, 69(2): 191S-191S.

    View this publication in the PUBMED database
  • 2009

    Number needed to treat (NNT) as a drug efficacy measure: Zoledronic acid (ZOL) for early hormone-responsive breast cancer in the ABCSG-12 trial

    Gnant, M, Mlineritsch, B, Schippinger, W, Luschin-Ebengreuth, G, Steger, G, Bjelic-Radisic, V, Jakesz, R, Kubista, E, Marth, C, Greil, R
    BREAST. 2009, 18: S59-S59.

    View this publication in the PUBMED database
  • 2009

    ADDITION OF ZOLEDRONIC ACID (ZOL) TO ADJUVANT ENDOCRINE THERAPY IMPROVES DISEASE-FREE (DFS) AND RECURRENCE-FREE SURVIVAL (RFS) IN PREMENOPAUSAL WOMEN WITH HORMONE-RESPONSIVE EARLY BREAST CANCER (HREBC): MULTIVARIATE ANALYSES OF THE AUSTRIAN BREAST AND COLORECTAL CANCER STUDY GROUP 12 (ABCSG-12) TRIAL

    Gnant, M, Mlineritsch, B, Schippinger, W, Luschin-Ebengreuth, G, Poestlberger, S, Menzel, C, Jakesz, R, Kubista, E, Marth, C, Greil, R
    ANN ONCOL. 2009, 20: 30-30.

    View this publication in the PUBMED database
  • 2009

    Neoadjuvant chemoradiation therapy with capecitabine (X) plus cetuximab (C), and external beam radiotherapy (RT) in locally advanced rectal cancer (LARC): ABCSG trial R03

    Eisterer, WM, De Vries, A, Oefner, D, Greil, R, Rabl, H, Tschmelitsch, J, Schmid, R, Kapp, K, Zehentmayr, F, Thaler, J
    J CLIN ONCOL. 2009, 27(15):

    View this publication in the PUBMED database
  • 2009

    Final Results of ABCSG-24, a Randomized Phase III Study Comparing Epirubicin, Docetaxel, and Capecitabine (EDC) to Epirubicin and Docetaxel (ED) as Neoadjuvant Treatment for Early Breast Cancer and Comparing ED/EDC plus Trastuzumab (T) to ED/EDC as Neoadjuvant Treatment for Early HER-2 Positive Breast Cancer

    Steger, GG, Greil, R, Jakesz, R, Lang, A, Mlineritsch, B, Melbinger-Zeinitzer, E, Marth, C, Samonigg, H, Kubista, E, Gnant, M
    CANCER RES. 2009, 69(24): 564S-564S.

    View this publication in the PUBMED database
  • 2008

    Minimal Residual Disease (MRD) and T/NK Cell Dynamics during Fludarabine, Cyclophosphamide Plus Rituximab (FCR) Followed by Fludarabine Plus Rituximab (FR) and Remission Maintenance Therapy with Rituximab in Previously Untreated B-Chronic Lymphocytic Leukemia (B-CLL): Riskfactor Stratification in the Chairos Study.

    Egle, A, Weiss, L, Gassner, F, Russ, G, Pleyer, L, Gunsilius, E, Tinhofer, I, Thaler, J, Petzer, AL, Greil, R
    BLOOD. 2008, 112(11): 1089-1089.

    View this publication in the PUBMED database
  • 2008

    T Cell Dynamics during the Pretumor and Tumor Phase in the Murine Tcll Transgenic Chronic Lymphocytic Leukemia Model

    Egle, A, Pinon, JD, Heyder, C, Holler, C, Denk, U, Tinhofer, I, Greil, R
    BLOOD. 2008, 112(11): 1078-1078.

    View this publication in the PUBMED database
  • 2008

    Is Chemoendocrine Treatment without Alternative?

    Greil R.
    Breast Care (Basel). 2008,3(4):231-235. Epub 2008 Aug 22.

    View this publication in the PUBMED database
  • 2008

    Differential diagnostic challenge of chronic neutrophilic leukemia in a patient with prolonged leukocytosis.

    Neureiter D, Kemmerling R, Ocker M, Seidlhofer C, Faber V, Stöcher M, Greil R, Dietze O.
    J Hematop. 2008 Jul,1(1):23-7. doi: 10.1007/s12308-008-0004-x. Epub 2008 Apr 19.

    View this publication in the PUBMED database
  • 2008

    Diagnostic algorithms, monitoring prognostication and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platform.

    Valent P, Lion T, Wolf D, Sillaber C, Agis H, Petzer A, Lang A, Kalhs P, Geissler D, Greil R, Linkesch W, Burgstaller S, Thaler J, Gastl G.
    Wien Klin Wochenschr. 2008,120(21-22):697-709. doi: 10.1007/s00508-008-1100-8.

    View this publication in the PUBMED database
  • 2008

    Biweekly oxaliplatin and irinotecan chemotherapy in advanced gastric cancer. A first-line multicenter phase II trial of the Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT).

    Wöll E, Kühr T, Eisterer W, Gattringer K, Greil R, Zabernigg A, Hilbe W, Thaler J.
    Anticancer Res. 2008 Sep-Oct,28(5B):2901-5.

    View this publication in the PUBMED database
  • 2008

    Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.

    San Miguel JF, Schlag R, Khuageva NK, Dimopoulos MA, Shpilberg O, Kropff M, Spicka I, Petrucci MT, Palumbo A, Samoilova OS, Dmoszynska A, Abdulkadyrov KM, Schots R, Jiang B, Mateos MV, Anderson KC, Esseltine DL, Liu K, Cakana A, van de Velde H, Richardson PG
    N Engl J Med. 2008 Aug 28,359(9):906-17. doi: 10.1056/NEJMoa0801479.

    View this publication in the PUBMED database
  • 2008

    SNP309 as predictor for sensitivity of CLL cells to the MDM2 inhibitor nutlin-3a.

    Seyfried I, Hofbauer S, Stoecher M, Greil R, Tinhofer I.
    Blood. 2008 Sep 1,112(5):2168, author reply 2169. doi: 10.1182/blood-2008-05-158634.

    View this publication in the PUBMED database
  • 2008

    Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy.

    Gnant M, Mlineritsch B, Luschin-Ebengreuth G, Kainberger F, Kässmann H, Piswanger-Sölkner JC, Seifert M, Ploner F, Menzel C, Dubsky P, Fitzal F, Bjelic-Radisic V, Steger G, Greil R, Marth C, Kubista E, Samonigg H, Wohlmuth P, Mittlböck M, Jakesz R
    Lancet Oncol. 2008 Sep,9(9):840-9. doi: 10.1016/S1470-2045(08)70204-3. Epub 2008 Aug 19.

    View this publication in the PUBMED database
  • 2008

    The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer.

    Bartsch R, Mlineritsch B, Gnant M, Niernberger T, Pluschnig U, Greil R, Wenzel C, Sevelda P, Thaler J, Rudas M, Pober M, Zielinski CC, Steger GG
    Breast Cancer Res Treat. 2009 May,115(2):373-80. doi: 10.1007/s10549-008-0132-0. Epub 2008 Jul 26.

    View this publication in the PUBMED database
  • 2008

    Chemotherapy in gastric cancer.

    Wöll E, Devries A, Eisterer W, Hejna M, Keil F, Stein H, Zacherl J, Greil R.
    Anticancer Res. 2008 Mar-Apr,28(2B):1213-9.

    View this publication in the PUBMED database
  • 2008

    MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.

    Gryshchenko I, Hofbauer S, Stoecher M, Daniel PT, Steurer M, Gaiger A, Eigenberger K, Greil R, Tinhofer I.
    J Clin Oncol. 2008 May 10,26(14):2252-7. doi: 10.1200/JCO.2007.11.5212.

    View this publication in the PUBMED database
  • 2008

    Hematopoietic growth factors: ESMO recommendations for the applications.

    Greil R, Psenak O, Roila F
    Ann Oncol. 2008 May,19 Suppl 2:ii116-8. doi: 10.1093/annonc/mdn107.

    View this publication in the PUBMED database
  • 2008

    Erythropoietins in cancer patients: ESMO recommendations for use.

    Greil R, Thödtman R, Roila F
    Ann Oncol. 2008 May,19 Suppl 2:ii113-5. doi: 10.1093/annonc/mdn106.

    View this publication in the PUBMED database
  • 2008

    Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.

    Dubsky P, Sevelda P, Jakesz R, Hausmaninger H, Samonigg H, Seifert M, Denison U, Mlineritsch B, Steger G, Kwasny W, Stöger H, Bartsch R, Stierer M, Taucher S, Fridrik M, Schippinger W, Greil R, Pötter R, Gnant M
    Clin Cancer Res. 2008 Apr 1,14(7):2082-7. doi: 10.1158/1078-0432.CCR-07-2068.

    View this publication in the PUBMED database
  • 2008

    Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy.

    Rudas M, Lehnert M, Huynh A, Jakesz R, Singer C, Lax S, Schippinger W, Dietze O, Greil R, Stiglbauer W, Kwasny W, Grill R, Stierer M, Gnant MF, Filipits M
    Clin Cancer Res. 2008 Mar 15,14(6):1767-74. doi: 10.1158/1078-0432.CCR-07-4122.

    View this publication in the PUBMED database
  • 2008

    Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min: a randomized, open-label study.

    von Moos R, Caspar CB, ThГјrlimann B, Angst R, Inauen R, Greil R, Bergstrom B, Schmieding K, Pecherstorfer M.
    Ann Oncol. 2008 Jul,19(7):1266-70. doi: 10.1093/annonc/mdn038. Epub 2008 Mar 11.

    View this publication in the PUBMED database
  • 2008

    Combined pegylated liposomal doxorubicin and bortezomib is highly effective in patients with recurrent or refractory multiple myeloma who received prior thalidomide/lenalidomide therapy.

    Sonneveld P, Hajek R, Nagler A, Spencer A, BladГ© J, Robak T, Zhuang SH, Harousseau JL, Orlowski RZ
    Cancer. 2008 Apr 1,112(7):1529-37. doi: 10.1002/cncr.23326.

    View this publication in the PUBMED database
  • 2008

    Arsenic trioxide induces apoptosis preferentially in B-CLL cells of patients with unfavourable prognostic factors including del17p13.

    Merkel O, Heyder C, Asslaber D, Hamacher F, Tinhofer I, Holler C, Stöcher M, Prokesch A, Papak C, Scheideler M, Trajanoski Z, Greil R.
    J Mol Med (Berl). 2008 May,86(5):541-52. doi: 10.1007/s00109-008-0314-6. Epub 2008 Feb 23.

    View this publication in the PUBMED database
  • 2008

    Tumour-immune cell interactions modulated by chemokines.

    Jöhrer K, Pleyer L, Olivier A, Maizner E, Zelle-Rieser C, Greil R.
    Expert Opin Biol Ther. 2008 Mar,8(3):269-90. doi: 10.1517/14712598.8.3.269 .

    View this publication in the PUBMED database
  • 2008

    Oxaliplatin in combination with 5-fluorouracil/leucovorin or capecitabine in elderly patients with metastatic colorectal cancer.

    Arkenau HT, Graeven U, Kubicka S, Grothey A, Englisch-Fritz C, Kretzschmar A, Greil R, Freier W, Seufferlein T, Hinke A, Schmoll HJ, Schmiegel W, Porschen R
    Clin Colorectal Cancer. 2008 Jan,7(1):60-4.

    View this publication in the PUBMED database
  • 2008

    A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines.

    Schmid P, KГјhnhardt D, Kiewe P, Lehenbauer-Dehm S, Schippinger W, Greil R, Lange W, Preiss J, Niederle N, Brossart P, Freier W, KГјmmel S, Van de Velde H, Regierer A, Possinger K.
    Ann Oncol. 2008 May,19(5):871-6. doi: 10.1093/annonc/mdm569. Epub 2008 Jan 21.

    View this publication in the PUBMED database
  • 2008

    Exemestane as primary systemic treatment for hormone receptor positive post-menopausal breast cancer patients: a phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-17).

    Mlineritsch B, Tausch C, Singer C, Luschin-Ebengreuth G, Jakesz R, Ploner F, Stierer M, Melbinger E, Menzel C, Urbania A, Fridrik M, Steger G, Wohlmuth P, Gnant M, Greil R
    Breast Cancer Res Treat. 2008 Nov,112(1):203-13. Epub 2007 Dec 22.

    View this publication in the PUBMED database
  • 2008

    The potential risk of neoadjuvant chemotherapy in breast cancer patients--results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07).

    Taucher S, Steger GG, Jakesz R, Tausch C, Wette V, Schippinger W, Kwasny W, Reiner G, Greil R, Dubsky P, Poestlberger S, Tschmelitsch J, Samonigg H, Gnant M
    Breast Cancer Res Treat. 2008 Nov,112(2):309-16. Epub 2007 Dec 14.

    View this publication in the PUBMED database
  • 2008

    Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platform

    Valent, P, Lion, T, Wolf, D, Sillaber, C, Agis, H, Petzer, A, Lang, A, Kalhs, P, Geissler, D, Greil, R, Linkesch, W, Burgstaller, S, Thaler, J, Gastl, G
    WIEN KLIN WOCHENSCHR. 2008, 120(21-22): 697-709.

    View this publication in the PUBMED database
  • 2008

    ZOLEDRONIC ACID (ZOL) IMPROVES DISEASE-FREE (DFS) AND RECURRENCE-FREE SURVIVAL (RFS) IN PREMENOPAUSAL WOMEN WITH EARLY BREAST CANCER (ERBC) RECEIVING ADJUVANT ENDOCRINE THERAPY: MULTIVARIATE ANALYSIS OF EFFICACY DATA FROM THE AUSTRIAN BREAST AND COLORECTAL CANCER STUDY GROUP (ABCSG)-12

    Gnant, M, Mlineritsch, B, Schippinger, W, Luschin-Ebengreuth, G, Steger, GG, Bjelic-Radisic, V, Jakesz, R, Kubista, E, Marth, C, Greil, R
    ANN ONCOL. 2008, 19: 44-44.

    View this publication in the PUBMED database
  • 2008

    MULTIPLE MYELOMA - CHEMOKINE NETWORK: CCL27/CTACK - A NEW PLAYER IN MYELOMA PROGRESSION

    Olivier, A, Unger, M, Maizner, E, Neureiter, D, Greil, R, Johrer, K
    ANTICANCER RES. 2008, 28(5C): 3429-3429.

    View this publication in the PUBMED database
  • 2008

    R-CHOP plus THALIDOMIDE FOR PREVIOUSLY UNTREATED MANTLE CELL LYMPHOMA

    Drach, W, Hopfinger, G, Fridrik, M, Greil, R, Thaler, J, Keil, F, Lang, A, Jaeger, U, Raderer, M
    HAEMATOL-HEMATOL J. 2008, 93: 394-395.

    View this publication in the PUBMED database
  • 2008

    Twelve-year retrospective analysis of lung cancer-The TYROL Study: Daily routine in 1,424 patients (1995-2006)

    Fiegl, M, Hilbe, W, Auberger, J, Schmid, T, Auberger, T, Tzankov, A, Sterlacci, W, Denz, H, Jamnig, H, Greil, R
    J CLIN ONCOL. 2008, 26(15):

    View this publication in the PUBMED database
  • 2008

    The single nucleotide polymorphism MDM2-SNP309 influences sensitivity of B-CLL cells to the non-genotoxic activator of the p53 pathway Nutlin-3a

    Tinhofer, I, Seyfried, I, Stoecher, M, Hofbauer, S, Daniel, PT, Greil, R
    J CLIN ONCOL. 2008, 26(15):

    View this publication in the PUBMED database
  • 2008

    The Austrian Fulvestrant Registry: Results from a prospective observation of fulvestrant in postmenopausal patients

    Bartsch, R, Mlineritsch, B, Gnant, M, Niernberger, T, Pluschnig, U, Greil, R, Pober, M, Sevelda, P, Thaler, J, Steger, GG
    J CLIN ONCOL. 2008, 26(15):

    View this publication in the PUBMED database
  • 2008

    Adjuvant ovarian suppression combined with tamoxifen or anastrozole, alone or in combination with zoledronic acid, in premenopausal women with hormone-responsive, stage I and II breast cancer: First efficacy results from ABCSG-12

    Gnant, M, Mlineritsch, B, Schippinger, W, Luschin-Ebengreuth, G, Poestlberger, S, Menzel, C, Jakesz, R, Kubista, E, Marth, C, Greil, R
    J CLIN ONCOL. 2008, 26(15):

    View this publication in the PUBMED database
  • 2008

    R-CHOP plus thalidomide for previously untreated mantle cell lymphoma

    Drach, J, Hopfinger, G, Fridrik, M, Greil, R, Thaler, J, Keil, F, Lang, A, Jaeger, U, Raderer, M
    ANN ONCOL. 2008, 19: 214-215.

    View this publication in the PUBMED database
  • 2008

    IMMUNOMODULATORY CAPACITY OF MYELOMA-DERIVED CHEMOKINE CCL27

    Johrer, K, Olivier, A, Unger, M, Maizner, E, Neureiter, D, Greil, R
    ANTICANCER RES. 2008, 28(5C): 3336-3337.

    View this publication in the PUBMED database
  • 2008

    A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells.

    Hartmann TN, Grabovsky V, Pasvolsky R, Shulman Z, Buss EC, Spiegel A, Nagler A, Lapidot T, Thelen M, Alon R.
    J Leukoc Biol. 2008 Oct,84(4):1130-40. doi: 10.1189/jlb.0208088. Epub 2008 Jul 24.

    View this publication in the PUBMED database
  • 2008

    Bim and Bmf in tissue homeostasis and malignant disease.

    PiГ±on JD, Labi V, Egle A, Villunger A.
    Oncogene. 2008 Dec,27 Suppl 1:S41-52. doi: 10.1038/onc.2009.42.

    View this publication in the PUBMED database
  • 2007

    Planned first efficacy and safety analysis of de-intensified induction with fludarabine, cyclophosphamide plus rituximab (FCR) followed by fludarabine plus rituximab (FR) and remission maintenance therapy with rituximab in previously untreated B-chronic lymphocytic leukemia (B-CLL): The chairos study

    Egle, A, Weiss, L, Russ, G, Thoedtmann, R, Pleyer, L, Gastl, G, Thaler, J, Petzer, A, Tinhofer, I, Greil, R
    BLOOD. 2007, 110(11): 609A-609A.

    View this publication in the PUBMED database
  • 2007

    Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.

    Jakesz R, Greil R, Gnant M, Schmid M, Kwasny W, Kubista E, Mlineritsch B, Tausch C, Stierer M, Hofbauer F, Renner K, Dadak C, RГјcklinger E, Samonigg H
    J Natl Cancer Inst. 2007 Dec 19,99(24):1845-53. Epub 2007 Dec 11. Erratum in: J Natl Cancer Inst. 2008 Feb 6,100(3):226.

    View this publication in the PUBMED database
  • 2007

    A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer.

    Schippinger W, Samonigg H, Schaberl-Moser R, Greil R, Thödtmann R, Tschmelitsch J, Jagoditsch M, Steger GG, Jakesz R, Herbst F, Hofbauer F, Rabl H, Wohlmuth P, Gnant M, Thaler J
    Br J Cancer. 2007 Oct 22,97(8):1021-7. Epub 2007 Sep 25.

    View this publication in the PUBMED database
  • 2007

    Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO Colorectal Study Group.

    Porschen R, Arkenau HT, Kubicka S, Greil R, Seufferlein T, Freier W, Kretzschmar A, Graeven U, Grothey A, Hinke A, Schmiegel W, Schmoll HJ
    J Clin Oncol. 2007 Sep 20,25(27):4217-23. Epub 2007 Jun 4.

    View this publication in the PUBMED database
  • 2007

    Pathologic complete response with six compared with three cycles of neoadjuvant epirubicin plus docetaxel and granulocyte colony-stimulating factor in operable breast cancer: results of ABCSG-14.

    Steger GG, Galid A, Gnant M, Mlineritsch B, Lang A, Tausch C, Rudas M, Greil R, Wenzel C, Singer CF, Haid A, Pöstlberger S, Samonigg H, Luschin-Ebengreuth G, Kwasny W, Klug E, Kubista E, Menzel C, Jakesz R
    J Clin Oncol. 2007 May 20,25(15):2012-8.

    View this publication in the PUBMED database
  • 2007

    [Expert recommendations 2006 on the rationale for second-line therapy for non-small cell bronchial neoplasms].

    Hilbe W, Aigner K, Dittrich C, Eckmayr J, Fiegl M, Flicker M, Forstner B, Greil R, Jamnig H, Krajnik G, Lang A, Mohn-Staudner A, Schinko H, Studnicka M, Pirker R, Ploner F, Rothmund J, Schiller L, Zabernigg A, Zöchbauer-Müller S.
    Wien Klin Wochenschr. 2007,119(7-8):259-66.

    View this publication in the PUBMED database
  • 2007

    Massive infiltration of bone marrow in colon carcinoma after treatment with activated protein C.

    Pleyer L, Went P, Russ G, Prinz E, Faber V, Röwert HJ, Karlbauer R, Greil R.
    Wien Klin Wochenschr. 2007,119(7-8):254-8.

    View this publication in the PUBMED database
  • 2007

    Hematopoietic growth factors: ESMO recommendations for the application.

    ESMO Guidelines Working Group, Greil R, Psenak O.
    Ann Oncol. 2007 Apr,18 Suppl 2:ii89-91.

    View this publication in the PUBMED database
  • 2007

    Erythropoietins in cancer patients: ESMO recommendations for use.

    ESMO Guidelines Working Group, Greil R, Thödtmann R.
    Ann Oncol. 2007 Apr,18 Suppl 2:ii86-8.

    View this publication in the PUBMED database
  • 2007

    Is it time to consider neoadjuvant treatment as the standard of care in oesophageal cancer?

    Greil R, Stein HJ.
    Lancet Oncol. 2007 Mar,8(3):189-90.

    View this publication in the PUBMED database
  • 2007

    Fulvestrant ('Faslodex') in heavily pretreated postmenopausal patients with advanced breast cancer: single centre clinical experience from the compassionate use programme.

    Mlineritsch B, Psenak O, Mayer P, Moik M, Namberger K, Hauser-Kronberger C, Greil R.
    Breast Cancer Res Treat. 2007 Nov,106(1):105-12. Epub 2007 Feb 13.

    View this publication in the PUBMED database
  • 2007

    The Role of Imaging in Malignant Lymphoma: A Critical View on PET Scanning in Current Clinical Practice

    Namberger, K, Greil, R,
    Imaging decisions (Berlin, Germany). 2007, 10(4): 22-31.

    View this publication in the PUBMED database
  • 2007

    A new sesquiterpene lactone sulfate from Reichardia gaditana (Asteraceae)

    Zidorn, C, Ellmerer, EP, Heller, W, Johrer, K, Frommberger, M, Greil, R, Guggenberger, M, Ongania, KH, Stuppner, H
    Z NATURFORSCH B. 2007, 62(1): 132-134.

    View this publication in the PUBMED database
  • 2007

    Entwicklungen und Perspektiven in der Behandlung der Lymphatischen Neoplasien.

    Pleyer, L, Desch, P, Greil, R,
    In: Greil, R (Ed.) editors(s). Lymphoproliferative Erkrankungen.. p. 139-155.

    View this publication in the PUBMED database
  • 2007

    Regulation of apoptosis.

    Pleyer, L, Tinhofer, I, Greil, R,
    In: Hakan Mellstedt DSDBRG (Ed.) editors(s). ESMO Handbook of principles of translational Research.. p. 67-69.

    View this publication in the PUBMED database
  • 2007

    Morbus Hodgkin.

    Greil, R,
    In: Greil, R (Ed.) editors(s). Lymphoproliferative Erkrankungen..

    View this publication in the PUBMED database
  • 2007

    Therapy of antibody-mediated factor VIII deficiency by immunosuppressive therapy containing cyclophosphamide, dexamethasone and rituximab: A case report

    Thoedtmann, R, Rosenlechner, S, Unger, J, Patsch, W, Greil, R
    HAEMATOL-HEMATOL J. 2007, 92: 546-546.

    View this publication in the PUBMED database
  • 2007

    MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukaemia but can be preferentially targeted by the MDM2 inhibitor Nutlin-3a

    Tinhofer, I, Gryshchenko, I, Stoecher, M, Hofbauer, S, Daniel, PT, Greil, R
    EJC SUPPL. 2007, 5(4): 347-347.

    View this publication in the PUBMED database
  • 2007

    Incidence and other aspects of myelodysplastic syndrome in the Austrian federal state Salzburg

    Kemmerling, R, Neuretter, D, Faber, V, Stocher, M, Greil, R, Dietze, O
    PATHOL RES PRACT. 2007, 203(5): 392-392.

    View this publication in the PUBMED database
  • 2007

    Zell- und Molekularbiologie.

    Tinhofer I.
    in Lymphoproliferative Erkrankungen R.Greil Uni-Med Science, Seite 29 - 41

    View this publication in the PUBMED database
  • 2007

    Mitochondrial phosphate-carrier deficiency: a novel disorder of oxidative phosphorylation.

    Mayr JA, Merkel O, Kohlwein SD, Gebhardt BR, Böhles H, Fötschl U, Koch J, Jaksch M, Lochmüller H, Horvath R, Freisinger P, Sperl W.
    American Journal of Human Genetics. 2007 Mar,80(3):478-84. Epub 2007 Jan 10.

    View this publication in the PUBMED database
  • 2006

    The effect of IgVH mutational status on the induction of apoptosis by rituximab in patients with heavily pretreated B-cell chronic lymphocytic leukemia: evidence from a clinical phase I/II trial.

    Tinhofer I, Steurer M, Leitinger G, Rumpold H, Egle A, Erdel M, Greil R.
    Haematologica. 2006 Sep,91(9):1291-3.

    View this publication in the PUBMED database
  • 2006

    Expression levels of CD38 in T cells predict course of disease in male patients with B-chronic lymphocytic leukemia.

    Tinhofer I, Rubenzer G, Holler C, Hofstaetter E, Stoecher M, Egle A, Steurer M, Greil R.
    Blood. 2006 Nov 1,108(9):2950-6. Epub 2006 Jul 6.

    View this publication in the PUBMED database
  • 2006

    Planned first safety and efficacy analysis of oral fludarabine combined with subcutaneous alemtuzumab in 2(nd) line therapy of B-chronic lymphocytic leukaemia (B-CLL): The FLUSALEM study.

    Egle, A, Tinhofer, I, Russ, G, Rass, C, Greil, R
    BLOOD. 2006, 108(11): 336B-336B.

    View this publication in the PUBMED database
  • 2006

    Routine clinical use of alemtuzumab in patients with heavily pretreated B-cell chronic lymphocytic leukemia: a nation-wide retrospective study in Austria.

    Fiegl M, Falkner A, Hopfinger G, Brugger S, Zabernigg A, Bauer F, Haslbauer F, Demirtas D, Grossschmidt P, Tatzreiter G, Gastl G, Greil R
    Cancer. 2006 Nov 15,107(10):2408-16.

    View this publication in the PUBMED database
  • 2006

    Extensive organizing pneumonia during chemo-immunotherapy containing rituximab and G-CSF in a patient with diffuse large B-cell lymphoma: case report and review of the literature.

    Mian M, Rass C, Hutarew G, Kofler B, Fiegl M, Greil R.
    Leuk Lymphoma. 2006 Aug,47(8):1683-5.

    View this publication in the PUBMED database
  • 2006

    Purine antagonists for chronic lymphocytic leukaemia.

    Steurer M, Pall G, Richards S, Schwarzer G, Bohlius J, Greil R.
    Cochrane Database Syst Rev. 2006 Jul 19,(3):CD004270.

    View this publication in the PUBMED database
  • 2006

    IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses.

    Falkensammer C, Jöhrer K, Gander H, Ramoner R, Putz T, Rahm A, Greil R, Bartsch G, Thurnher M.
    Cancer Immunol Immunother. 2006 Oct,55(10):1228-37. Epub 2006 Jan 28.

    View this publication in the PUBMED database
  • 2006

    Single-agent purine analogues for the treatment of chronic lymphocytic leukaemia: a systematic review and meta-analysis.

    Steurer M, Pall G, Richards S, Schwarzer G, Bohlius J, Greil R
    Cancer Treat Rev. 2006 Aug,32(5):377-89. Epub 2006 Jun 21. Review.

    View this publication in the PUBMED database
  • 2006

    Diffuse large B-cell lymphoma as a second, clonally unrelated lymphoproliferative disease in a patient with IgM monoclonal gammopathy of undetermined significance (MGUS) and concomitant polycythemia vera rubra.

    Mian M, Psenak O, Greil R, Fiegl M, Tzankov A.
    Leuk Lymphoma. 2006 May,47(5):940-3. No abstract available.

    View this publication in the PUBMED database
  • 2006

    A role of TRAIL in killing osteoblasts by myeloma cells.

    Tinhofer I, Biedermann R, Krismer M, Crazzolara R, Greil R.
    FASEB J. 2006 Apr,20(6):759-61. Epub 2006 Jan 25.

    View this publication in the PUBMED database
  • 2006

    Adjuvant treatment with trastuzumab in clinical practice outside clinical studies

    Senn, HJ, Thurlimann, B, von Minckwitz, G, Herrmann, R, Jakesz, R, Gnant, M, Greil, R
    BREAST CARE. 2006, 1(2): 96-101.

    View this publication in the PUBMED database
  • 2006

    Clinical practice aromatase inhibitors: Upfront, switch or extended?

    Greil, R, Jonat, W, Maass, N, Kaufmann, M, Ortmann, O, Possinger, K, Steger, G
    BREAST CARE. 2006, 1(1): 37-43.

    View this publication in the PUBMED database
  • 2006

    The still long and winding road to neoadjuvant sytemic therapy as the standard of care in breast cancer

    Greil, R
    BREAST CARE. 2006, 1(6): 352-357.

    View this publication in the PUBMED database
  • 2006

    A role of TRAIL in killing osteoblasts by myeloma cells

    Tinhofer, I, Biedermann, R, Krismer, M, Crazzolara, R, Greil, R
    FASEB J. 2006 Apr,20(6):759-61. Epub 2006 Jan 25.

    View this publication in the PUBMED database
  • 2006

    Lymphoproliferative Erkrankungen.

    Greil, R,
    2006.

    View this publication in the PUBMED database
  • 2006

    Wie sterben wir? Wie schön ist der Tod? Wie teuer ist der Tod? - Die Palliativmedizin im Spannungsfeld der Ressourcenallokation

    Greil, R,
    In: Fischer, M, Zänker, KS, editors(s). Medizin- und Bioethik. (ISBN: 978-3-631-54744-1 )

    View this publication in the PUBMED database
  • 2006

    Systemic application of granulocyte-colony stimulating factor and stem cell factor exacerbates excitotoxic brain injury in newborn mice.

    Keller M, Simbruner G, Gorna A, Urbanek M, Tinhofer I, Griesmaier E, Sarkozy G, Schwendimann L, Gressens P.
    Pediatric Research. 2006 Apr, 59 (4 Pt 1): 549-53.

    View this publication in the PUBMED database
  • 2005

    Expression levels of CD38 in tumor cells and T-cells are of prognostic value in B-CLL

    Tinhofer, I, Rubenzer, G, Egle, A, Greil, R
    BLOOD. 2005, 106(11): 347A-347A.

    View this publication in the PUBMED database
  • 2005

    1,10-Epoxyhypocretenolides from the Azorean Endemic Leontodon rigens (Asteraceae)

    Zidorn C, Ellmerer EP, Konwalinka G, Ongania KH, Schwaha R, Greil R, Jöhrer K, Perry NB, Stuppner H
    Letters in Organic Chemistry. Volume 2, Number 5, August 2005 , pp. 461-464(4).

    View this publication in the PUBMED database
  • 2005

    Continuous prednisolone versus conventional prednisolone with VMCP-interferon-alpha2b as first-line chemotherapy in elderly patients with multiple myeloma.

    Ludwig H, Spicka I, Klener P, Greil R, Adam Z, Gisslinger H, TarkovГЎcs G, Linkesch W, Maniatis A, Morant R, Drach J, Kuhn I, Schuster J, Hinke A.
    Br J Haematol. 2005 Nov,131(3):329-37.

    View this publication in the PUBMED database
  • 2005

    Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.

    Jakesz R, Jonat W, Gnant M, Mittlboeck M, Greil R, Tausch C, Hilfrich J, Kwasny W, Menzel C, Samonigg H, Seifert M, Gademann G, Kaufmann M, Wolfgang J
    Lancet. 2005 Aug 6-12,366(9484):455-62.

    View this publication in the PUBMED database
  • 2005

    ESMO recommendations for the application of hematopoietic growth factors.

    Greil R, Jost LM
    Ann Oncol. 2005,16 Suppl 1:i80-2. No abstract available.

    View this publication in the PUBMED database
  • 2005

    ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of chronic lymphocytic leukemia.

    Hallek M, Stahel RA, Greil R
    Ann Oncol. 2005,16 Suppl 1:i50-1. No abstract available.

    View this publication in the PUBMED database
  • 2005

    ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patients.

    Fey MF, Greil R, Jost LM
    Ann Oncol. 2005,16 Suppl 1:i48-9. No abstract available.

    View this publication in the PUBMED database
  • 2005

    ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of multiple myeloma.

    Harrouseau JL, Greil R, Kloke O
    Ann Oncol. 2005,16 Suppl 1:i48-9. No abstract available.

    View this publication in the PUBMED database
  • 2005

    Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinoma.

    Jöhrer K, Zelle-Rieser C, Perathoner A, Moser P, Hager M, Ramoner R, Gander H, Höltl L, Bartsch G, Greil R, Thurnher M.
    Clin Cancer Res. 2005 Apr 1,11(7):2459-65.

    View this publication in the PUBMED database
  • 2005

    Polyacetylenes from the Apiaceae vegetables carrot, celery fennel parsley and parsnip and their cytotoxic activities.

    Zidorn C, Jöhrer K, Ganzera M, Schubert B, Sigmund EM, Mader J, Greil R, Ellmerer EP, Stuppner H.
    J Agric Food Chem. 2005 Apr 6,53(7):2518-23.

    View this publication in the PUBMED database
  • 2005

    Long-term results of dose density therapy in patients with aggressive lymphoma.

    Fridrik MA, Hausmaninger H, Linkesch W, Greil R, Krieger O, Baldinger C, Klocker J, Pont J, Oberaigner W.
    Ann Hematol. 2005 Apr,84(4):217-22. Epub 2004 Nov 6.

    View this publication in the PUBMED database
  • 2005

    ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patients

    Fey, MF, Greil, R, Jost, LM
    Ann Oncol. 2005,16 Suppl 1:i48-9.

    View this publication in the PUBMED database
  • 2005

    Chemotherapie im Alter

    Greil, R, Faber, V,
    In: Likar, R, Bernatzky, G, Pipam, W, Janig, H, Sadjak, A, editors(s). Lebensqualität im Alter. Springer, p. 57-264. (ISBN: 978-3-211-21197-7)

    View this publication in the PUBMED database
  • 2005

    Purine antagonists for chronic lymphocytic leukemia: Results of a comprehensive meta-analysis

    Steurer, M, Pall, G, Richards, S, Schwarzer, G, Bohlius, J, Greil, R
    ANN ONCOL. 2005, 16: 203-204.

    View this publication in the PUBMED database
  • 2005

    Alemtuzumab is effective in patients with advanced, pretreated B-cell chronic lymphocytic leukemia: A nationwide study of routine use in Austria

    Fiegl, M, Falkner, A, Hopfinger, G, Brugger, S, Zabernigg, A, Haslbauer, F, Andel, J, Thaler, J, Fridrik, M, Bauer, F, Mian, M, Tatzreiter, G, Zoier, N, Demirtas, D, Postner, G, Auberger, J, Gastl, G, Greil, R
    BLOOD. 2005, 106(11): 833A-833A.

    View this publication in the PUBMED database
  • 2005

    PKC delta is involved in signal attenuation in CD3+ T cells.

    Gruber T, Barsig J, Pfeifhofer C, Ghaffari-Tabrizi N, Tinhofer I, Leitges M, Baier G.
    Immunology Letters. 2005 Jan 31,96(2): 291-3.

    View this publication in the PUBMED database
  • 2004

    Is higher income and educational status associated with poorer outcome in patients with Hodgkin's disease?

    Holzner B, Fischhofer M, Kemmler G, Kopp M, Sperner-Unterweger B, Krugmann J, Dirnhofer S, Greil R.
    Eur J Haematol. 2004 Nov,73(5):318-24.

    View this publication in the PUBMED database
  • 2004

    Biomarkers in non-small cell lung cancer prevention.

    Hilbe W, Dirnhofer S, Greil R, Wöll E.
    Eur J Cancer Prev. 2004 Oct,13(5):425-36.

    View this publication in the PUBMED database
  • 2004

    Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia.

    Eisterer W, Bechter O, Söderberg O, Nilsson K, Terol M, Greil R, Thaler J, Herold M, Finke L, Günthert U, Montserrat E, Stauder R.
    Leuk Res. 2004 Oct,28(10):1043-51.

    View this publication in the PUBMED database
  • 2004

    Normative data for functional assessment of cancer therapy--general scale and its use for the interpretation of quality of life scores in cancer survivors.

    Holzner B, Kemmler G, Cella D, De Paoli C, Meraner V, Kopp M, Greil R, Fleischhacker WW, Sperner-Unterweger B.
    Acta Oncol. 2004,43(2):153-60.

    View this publication in the PUBMED database
  • 2004

    Quality of life of patients with chronic lymphocytic leukemia: results of a longitudinal investigation over 1 yr.

    Holzner B, Kemmler G, Kopp M, Nguyen-Van-Tam D, Sperner-Unterweger B, Greil R.
    Eur J Haematol. 2004 Jun,72(6):381-9.

    View this publication in the PUBMED database
  • 2004

    Unfavourable prognosis of patients with trisomy 18q21 detected by fluorescence in situ hybridisation in t(11,18) negative, surgically resected gastrointestinal B cell lymphomas.

    Krugmann J, Tzankov A, Dirnhofer S, Fend F, Greil R, Siebert R, Erdel M.
    J Clin Pathol. 2004 Apr,57(4):360-4.

    View this publication in the PUBMED database
  • 2004

    Transendothelial migration of myeloma cells is increased by tumor necrosis factor (TNF)-alpha via TNF receptor 2 and autocrine up-regulation of MCP-1.

    Jöhrer K, Janke K, Krugmann J, Fiegl M, Greil R.
    Clin Cancer Res. 2004 Mar 15,10(6):1901-10.

    View this publication in the PUBMED database
  • 2004

    Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial.

    Sieber M, Tesch H, Pfistner B, Rueffer U, Paulus U, Munker R, Hermann R, Doelken G, Koch P, Oertel J, Roller S, Worst P, Bischof H, Glunz A, Greil R, von Kalle K, Schalk KP, Hasenclever D, Brosteanu O, Duehmke E, Georgii A, Engert A, et al.
    Ann Oncol. 2004 Feb,15(2):276-82.

    View this publication in the PUBMED database
  • 2004

    Treatment of advanced Hodgkinxxxs disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkinxxxs Lymphoma Study Group HD6 trial

    Sieber, M, Tesch, H, Pfistner, B, Rueffer, U, Paulus, U, Munker, R, Hermann, R, Doelken, G, Koch, P, Oertel, J, Roller, S, Worst, P, Bischof, H, Glunz, A, Greil, R, von Kalle, K, Schalk, KP, Hasenclever, D, Brosteanu, O, Duehmke, E, Georgii, A, Engert, A, Loeffler, M, Diehl, V
    ANN ONCOL. 2004, 15(2): 276-282.

    View this publication in the PUBMED database
  • 2003

    Tuning the rheostat of the myelopoietic system via Fas and TRAIL.

    Greil R, Anether G, Johrer K, Tinhofer I.
    Crit Rev Immunol. 2003,23(4):301-22.

    View this publication in the PUBMED database
  • 2003

    Tracking death dealing by Fas and TRAIL in lymphatic neoplastic disorders: pathways, targets and therapeutic tools.

    Greil R, Anether G, Johrer K, Tinhofer I.
    J Leukoc Biol. 2003 Sep,74(3):311-30.

    View this publication in the PUBMED database
  • 2003

    Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.

    Krugmann J, Tzankov A, Gschwendtner A, Fischhofer M, Greil R, Fend F, Dirnhofer S.
    Mod Pathol. 2003 Jun,16(6):566-73.

    View this publication in the PUBMED database
  • 2003

    Prognostic significance of CD20 expression in classical Hodgkin lymphoma: a clinicopathological study of 119 cases.

    Tzankov A, Krugmann J, Fend F, Fischhofer M, Greil R, Dirnhofer S.
    Clin Cancer Res. 2003 Apr,9(4):1381-6.

    View this publication in the PUBMED database
  • 2003

    A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML).

    Kühr T, Burgstaller S, Apfelbeck U, Linkesch W, Seewann H, Fridrik M, Michlmayr G, Krieger O, Lutz D, Lin W, Pont J, Köck L, Abbrederis K, Baldinger C, Buder R, Geissler D, Hausmaninger H, Lang A, Zabernigg A, Duba C, Hilbe W, Eisterer W, et al.
    Leuk Res. 2003 May,27(5):405-11.

    View this publication in the PUBMED database
  • 2003

    Tetrocarcin-A--induced ER stress mediates apoptosis in B-CLL cells via a Bcl-2--independent pathway.

    Anether G, Tinhofer I, Senfter M, Greil R.
    Blood. 2003 Jun 1,101(11):4561-8. Epub 2003 Jan 30.

    View this publication in the PUBMED database
  • 2002

    Splenectomy versus medical treatment for idiopathic thrombocytopenic purpura.

    Gadenstätter M, Lamprecht B, Klingler A, Wetscher GJ, Greil R, Schmid T.
    Am J Surg. 2002 Dec,184(6):606-9, discussion 609-10.

    View this publication in the PUBMED database
  • 2002

    Histone deacetylase inhibitors potently repress CXCR4 chemokine receptor expression and function in acute lymphoblastic leukaemia.

    Crazzolara R, Jöhrer K, Johnstone RW, Greil R, Kofler R, Meister B, Bernhard D.
    Br J Haematol. 2002 Dec,119(4):965-9.

    View this publication in the PUBMED database
  • 2002

    Diffuse large B-cell lymphoma with infiltration-associated peripheral neuropathy and paraneoplastic myopathy with a prolonged course over seven years.

    Fiegl M, Muigg A, Smekal A, Krugmannd J, Dirnhofer S, Greil R.
    Leuk Lymphoma. 2002 Aug,43(8):1687-90.

    View this publication in the PUBMED database
  • 2002

    Intravascular large B-cell lymphoma with a fulminant clinical course: a case report with definite diagnosis post mortem.

    Fiegl M, Greil R, Pechlaner C, Krugmann J, Dirnhofer S.
    Ann Oncol. 2002 Sep,13(9):1503-6.

    View this publication in the PUBMED database
  • 2002

    The impact of hemoglobin levels on fatigue and quality of life in cancer patients.

    Holzner B, Kemmler G, Greil R, Kopp M, Zeimet A, Raderer M, Hejna M, Zöchbauer S, Krajnik G, Huber H, Fleischhacker WW, Sperner-Unterweger B.
    Ann Oncol. 2002 Jun,13(6):965-73.

    View this publication in the PUBMED database
  • 2002

    Monoclonal gammopathy of undetermined significance.

    Fiegl M, Greil R.
    N Engl J Med. 2002 Jun 27,346(26):2087-8, author reply 2087-8.

    View this publication in the PUBMED database
  • 2002

    Multidimensional scaling as a tool for analysing quality of life data.

    Kemmler G, Holzner B, Kopp M, DГјnser M, Greil R, Hahn E, Sperner-Unterweger B.
    Qual Life Res. 2002 May,11(3):223-33.

    View this publication in the PUBMED database
  • 2002

    Stressful death of T-ALL tumor cells after treatment with the anti-tumor agent Tetrocarcin-A.

    Tinhofer I, Anether G, Senfter M, Pfaller K, Bernhard D, Hara M, Greil R.
    FASEB J. 2002 Aug,16(10):1295-7. Epub 2002 Jun 7.

    View this publication in the PUBMED database
  • 2002

    The role of soluble CD23 in distinguishing stable and progressive forms of B-chronic lymphocytic leukemia.

    Schwarzmeier JD, Shehata M, Hilgarth M, Marschitz I, Louda N, Hubmann R, Greil R.
    Leuk Lymphoma. 2002 Mar,43(3):549-54.

    View this publication in the PUBMED database
  • 2002

    Interleukin-15 as a potential costimulatory cytokine in CD154 gene therapy of chronic lymphocytic leukemia.

    Anether G, Marschitz I, Tinhofer I, Greil R.
    Blood. 2002 Jan 15,99(2):722-3.

    View this publication in the PUBMED database
  • 2002

    Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.

    Sieber M, Tesch H, Pfistner B, Rueffer U, Lathan B, Brosteanu O, Paulus U, Koch T, Pfreundschuh M, Loeffler M, Engert A, Josting A, Wolf J, Hasenclever D, Franklin J, Duehmke E, Georgii A, Schalk KP, Kirchner H, Doelken G, Munker R, Koch P, et al.
    J Clin Oncol. 2002 Jan 15,20(2):476-84.

    View this publication in the PUBMED database
  • 2001

    Stepping up treatment with Rituxan (R) (rituximab, Mabthera (R)) for CLL patients with advanced stage of disease relapsing after or refractory to conventional chemotherapy.

    Greil, R, Steurer, M, Egle, A, Stauder, R, Anether, G, Ulmer, L, Tinhofer, I, Gastl, G
    BLOOD. 2001, 98(11): 289B-290B.

    View this publication in the PUBMED database
  • 2001

    Dose escalation of ara-c may improve response rates in a subgroup of chronic myeloid leukemia patients with poor response to interferon-alpha and low-dose ara-C.

    Hilbe W, Kühr T, Apfelbeck U, Fridrik M, Seewann H, Stöger M, Linkesch W, Pont J, Baldinger C, Hartner E, Bernhart M, Geissler D, Krieger O, Lang A, Lin W, Ludwig H, Duba C, Greil R, Gast G, Thaler J.
    Leuk Lymphoma. 2001 Nov-Dec,42(6):1283-8.

    View this publication in the PUBMED database
  • 2001

    Epstein-Barr virus-associated extranodal NK/T-cell lymphoma, nasal type of the hypopharynx in a renal allograft recipient: case report and review of literature.

    Stadlmann S, Fend F, Moser P, Obrist P, Greil R, Dirnhofer S.
    Hum Pathol. 2001 Nov,32(11):1264-8.

    View this publication in the PUBMED database
  • 2001

    Quality of life measurement in oncology--a matter of the assessment instrument?

    Holzner B, Kemmler G, Sperner-Unterweger B, Kopp M, DГјnser M, Margreiter R, Marschitz I, Nachbaur D, Fleischhacker WW, Greil R.
    Eur J Cancer. 2001 Dec,37(18):2349-56.

    View this publication in the PUBMED database
  • 2001

    Inhibition of histone deacetylase activity enhances Fas receptor-mediated apoptosis in leukemic lymphoblasts.

    Bernhard D, Skvortsov S, Tinhofer I, HГјbl H, Greil R, Csordas A, Kofler R.
    Cell Death Differ. 2001 Oct,8(10):1014-21.

    View this publication in the PUBMED database
  • 2001

    Primary gastrointestinal B-cell lymphoma. A clincopathological and immunohistochemical study of 61 cases with an evaluation of prognostic parameters.

    Krugmann J, Dirnhofer S, Gschwendtner A, Berresheim U, Greil R, Krugmann K, Fend F.
    Pathol Res Pract. 2001,197(6):385-93.

    View this publication in the PUBMED database
  • 2001

    Resveratrol, a tumor-suppressive compound from grapes induces apoptosis via a novel mitochondrial pathway controlled by Bcl-2.

    Tinhofer I, Bernhard D, Senfter M, Anether G, Loeffler M, Kroemer G, Kofler R, Csordas A, Greil R.
    FASEB J. 2001 Jul,15(9):1613-5.

    View this publication in the PUBMED database
  • 2001

    Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: long-term results of a randomized trial of radiotherapy alone.

    DГјhmke E, Franklin J, Pfreundschuh M, Sehlen S, Willich N, RГјhl U, MГјller RP, Lukas P, Atzinger A, Paulus U, Lathan B, RГјffer U, Sieber M, Wolf J, Engert A, Georgii A, Staar S, Herrmann R, Beykirch M, Kirchner H, Emminger A, Greil R, et al.
    J Clin Oncol. 2001 Jun 1,19(11):2905-14.

    View this publication in the PUBMED database
  • 2000

    Analysis of Bcl-2 protein expression in chronic lymphocytic leukemia. A comparison of three semiquantitation techniques.

    Marschitz I, Tinhofer I, Hittmair A, Egle A, Kos M, Greil R.
    Am J Clin Pathol. 2000 Feb,113(2):219-29.

    View this publication in the PUBMED database
  • 2000

    Expression of functional interleukin-15 receptor and autocrine production of interleukin-15 as mechanisms of tumor propagation in multiple myeloma.

    Tinhofer I, Marschitz I, Henn T, Egle A, Greil R.
    Blood. 2000 Jan 15,95(2):610-8.

    View this publication in the PUBMED database
  • 2000

    Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells.

    Bernhard D, Tinhofer I, Tonko M, HГјbl H, Ausserlechner MJ, Greil R, Kofler R, Csordas A.
    Cell Death Differ. 2000 Sep,7(9):834-42.

    View this publication in the PUBMED database
  • 2000

    Vinorelbine-gemcitabine in advanced non-small-cell lung cancer (NSCLC): an AASLC phase II trial. Austrian Association for the Study of Lung Cancer.

    Krajnik G, Mohn-Staudner A, Thaler J, Greil R, Schmeikal S, Marhold F, Deutsch J, Preiss P, Malayeri R, Schäfer-Prokop C, Wein W, Huber H, Pirker R.
    Ann Oncol. 2000 Aug,11(8):993-8.

    View this publication in the PUBMED database
  • 2000

    Gastric cancer cell lines lack Fas ligand (FasL) expression but kill T cells via a FasL independent pathway.

    Tinhofer I, Wykypiel H, Marschitz I, Henn T, Greil R.
    Gut. 2000 May,46(5):738-40.

    View this publication in the PUBMED database
  • 1999

    Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.

    Kemmler G, Holzner B, Kopp M, DГјnser M, Margreiter R, Greil R, Sperner-Unterweger B.
    J Clin Oncol. 1999 Sep,17(9):2932-40.

    View this publication in the PUBMED database
  • 1999

    Synergistic action of protein kinase C theta and calcineurin is sufficient for Fas ligand expression and induction of a crmA-sensitive apoptosis pathway in Jurkat T cells.

    Villunger A, Ghaffari-Tabrizi N, Tinhofer I, Krumböck N, Bauer B, Schneider T, Kasibhatla S, Greil R, Baier-Bitterlich G, Uberall F, Green DR, Baier G.
    Eur J Immunol. 1999 Nov,29(11):3549-61.

    View this publication in the PUBMED database
  • 1999

    Thymic Hodgkin's disease--a histological and immunohistochemical study of three cases.

    Krugmann J, Feichtinger H, Greil R, Fend F.
    Pathol Res Pract. 1999,195(10):681-7.

    View this publication in the PUBMED database
  • 1999

    Retrospective assessment of quality of life and treatment outcome in patients with Hodgkin's disease from 1969 to 1994.

    Greil R, Holzner B, Kemmler G, Kopp M, Buchowski A, Oberaigner W, Fritsch E, Dirnhofer S, Rueffer U, Diehl V, Sperner-Unterweger B.
    Eur J Cancer. 1999 May,35(5):698-706.

    View this publication in the PUBMED database
  • 1999

    Cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) versus cyclophosphamide, epirubicin, vincristine, prednisolone, ifosfamide, VP-16, methotrexate, dexamethasone (CEOP/IMVP-Dexa) for aggressive non-Hodgkinxxxs lymphoma. A multicenter randomized trial of the Austrian working party medical oncology.

    Fridrik, MA, Hausmaninger, H, Greil, R, Lang, A, Drach, J, Fortelny, A, Krieger, O, Lin, W
    BLOOD. 1999, 94(10): 261B-261B.

    View this publication in the PUBMED database
  • 1998

    On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.

    Greil R, Egle A, Villunger A.
    Leuk Lymphoma. 1998 Nov,31(5-6):477-90.

    View this publication in the PUBMED database
  • 1998

    Functional granulocyte/macrophage colony stimulating factor receptor is constitutively expressed on neoplastic plasma cells and mediates tumour cell longevity.

    Villunger A, Egle A, Kos M, Egle D, Tinhofer I, Henn T, Uberall F, Maly K, Greil R.
    Br J Haematol. 1998 Sep,102(4):1069-80.

    View this publication in the PUBMED database
  • 1998

    Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand+ tumor cells in B chronic lymphocytic leukemia.

    Tinhofer I, Marschitz I, Kos M, Henn T, Egle A, Villunger A, Greil R.
    Blood. 1998 Jun 1,91(11):4273-81.

    View this publication in the PUBMED database
  • 1998

    Inversion of CD4(+)/CD8(+) ratio in B chronic lymphocytic leukemia correlates with differential sensitivity of CD4(+) and CD8(+) T lymphocytes to the killing efficacy of Fas (APO-1/CD95) ligand(+) tumor cells.

    Tinhofer, I, Marschitz, I, Kos, M, Henn, T, Egle, A, Villunger, A, Greil, R
    BLOOD. 1998, 92(10): 271B-271B.

    View this publication in the PUBMED database
  • 1998

    Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC): a phase I trial.

    Krajnik G, Wein W, Greil R, Marhold F, Mohn-Staudner A, Kummer F, Malayeri R, Zöchbauer-Müller S, Huber H, Pirker R.
    Eur J Cancer. 1998 Nov,34(12):1977-80.

    View this publication in the PUBMED database
  • 1998

    Interferon-alpha for the treatment of elderly patients with chronic myeloid leukaemia.

    Hilbe W, Apfelbeck U, Fridrik M, Bernhart M, Niessner H, Abbrederis K, Michlmayr G, Pont J, Linkesch W, Hausmaninger H, Arneitz K, Baldinger C, Duba C, Eisterer W, Greil R, Konwalinka G, Niederwieser D, Gastl G, Thaler J.
    Leuk Res. 1998 Oct,22(10):881-6.

    View this publication in the PUBMED database
  • 1998

    Leg ulcers associated with long-term hydroxyurea therapy.

    Weinlich G, Schuler G, Greil R, Kofler H, Fritsch P.
    J Am Acad Dermatol. 1998 Aug,39(2 Pt 2):372-4.

    View this publication in the PUBMED database
  • 1998

    Prognosis and management strategies of lymphatic neoplasias in the elderly. II. Hodgkin's disease.

    Greil R.
    Oncology. 1998 Jul-Aug,55(4):265-75.

    View this publication in the PUBMED database
  • 1998

    Prognosis and management strategies of lymphatic neoplasias in the elderly. I. Aggressive non-Hodgkin's lymphomas.

    Greil R.
    Oncology. 1998 May-Jun,55(3):189-217.

    View this publication in the PUBMED database
  • 1998

    Urticaria pigmentosa: a clinical, hematopathologic and serologic study of 30 adults.

    Topar G, Staudacher C, Geisen F, Gabl C, Fend F, Herold M, Greil R, Fritsch P, Sepp N.
    Am J Clin Pathol. 1998 Mar,109(3):279-85.

    View this publication in the PUBMED database
  • 1997

    Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells.

    Villunger A, Egle A, Kos M, Hartmann BL, Geley S, Kofler R, Greil R.
    Cancer Res. 1997 Aug 15,57(16):3331-4.

    View this publication in the PUBMED database
  • 1997

    The interleukin 1beta-converting enzyme inhibitor CrmA prevents Apo1/Fas- but not glucocorticoid-induced poly(ADP-ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cells.

    Geley S, Hartmann BL, Kapelari K, Egle A, Villunger A, Heidacher D, Greil R, Auer B, Kofler R.
    FEBS Lett. 1997 Jan 27,402(1):36-40.

    View this publication in the PUBMED database
  • 1997

    Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillance.

    Villunger A, Egle A, Marschitz I, Kos M, Böck G, Ludwig H, Geley S, Kofler R, Greil R.
    Blood. 1997 Jul 1,90(1):12-20.

    View this publication in the PUBMED database
  • 1997

    Expression of Apo-1/Fas (CD95), Bcl-2 Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional status.

    Egle A, Villunger A, Marschitz I, Kos M, Hittmair A, Lukas P, GrГјnewald K, Greil R.
    Br J Haematol. 1997 May,97(2):418-28.

    View this publication in the PUBMED database
  • 1997

    Fas (Apo-1/CD95) - Ligand expression on neoplastic plasma cells and its role for the expansion of the neoplastic clone.

    Greil, R, Villunger, A, Egle, A, Marschitz, L, Kos, M, Bock, G, Ludwig, H, Geley, S, Kofler, R
    BLOOD. 1997, 90(10): 1578-1578.

    View this publication in the PUBMED database
  • 1997

    Fas (Apo-1/CD95) - Ligand expression on neoplastic plasma cells and its role for the expansion of the neoplastic clone.

    Fridrik MA, Greil R, Hausmaninger H, Krieger O, Oppitz P, Stöger M, Klocker J, Neubauer M, Helm W, Pont J, Fazeny B, Hudec M, Simonitsch I, Radaszkiewicz T.
    Ann Hematol. 1997 Oct,75(4):135-40.

    View this publication in the PUBMED database
  • 1997

    Cytokine priming of the granulocyte respiratory burst in myelodysplastic syndromes.

    Zabernigg A, Hilbe W, Eisterer W, Greil R, Ludescher C, Thaler J.
    Leuk Lymphoma. 1997 Sep,27(1-2):137-43.

    View this publication in the PUBMED database
  • 1997

    Interferon-alpha-2C and LD ara-C for the treatment of patients with CML: results of the Austrian multi-center phase II study.

    Thaler J, Hilbe W, Apfelbeck U, Linkesch W, Sill H, Seewann H, Pont J, Bernhart M, Stöger M, Niessner H, Abbrederis K, Geissler D, Hausmaninger H, Lin W, Ludwig H, Lang A, Duba C, Fluckinger T, Greil R, Grünewald K, Konwalinka G, Niederwieser D, et al.
    Leuk Res. 1997 Jan,21(1):75-80.

    View this publication in the PUBMED database
  • 1996

    Modulation of Apo-1/Fas (CD95)-induced programmed cell death in myeloma cells by interferon-alpha 2.

    Egle A, Villunger A, Kos M, Böck G, Gruber J, Auer B, Greil R.
    Eur J Immunol. 1996 Dec,26(12):3119-26.

    View this publication in the PUBMED database
  • 1996

    IL-10 serum levels in B-cell chronic lymphocytic leukaemia.

    Egle A, Marschitz I, Posch B, Herold M, Greil R.
    Br J Haematol. 1996 Jul,94(1):211-2.

    View this publication in the PUBMED database
  • 1996

    2',2'-Difluorodeoxycytidine (gemcitabine) induces apoptosis in myeloma cell lines resistant to steroids and 2-chlorodeoxyadenosine (2-CdA).

    Gruber J, Geisen F, Sgonc R, Egle A, Villunger A, Boeck G, Konwalinka G, Greil R.
    Stem Cells. 1996 May,14(3):351-62.

    View this publication in the PUBMED database
  • 1996

    Constituents of autocrine IL-6 loops in myeloma cell lines and their targeting for suppression of neoplastic growth by antibody strategies.

    Villunger A, Egle A, Kos M, Hittmair A, Maly K, Greil R.
    Int J Cancer. 1996 Feb 8,65(4):498-505.

    View this publication in the PUBMED database
  • 1995

    Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response.

    Cazzola M, Messinger D, Battistel V, Bron D, Cimino R, Enller-Ziegler L, Essers U, Greil R, Grossi A, Jäger G, LeMevel A, Najman A, Silingardi V, Spriano M, van Hoof A, Ehmer B.
    Blood. 1995 Dec 15,86(12):4446-53.

    View this publication in the PUBMED database
  • 1995

    Gastric malt lymphoma with crystalline immunoglobulin inclusions and secondary immunoblastic lymphoma in a cervical lymph node.

    Fend F, Gabl C, Hittmair A, Greil R, Feichtinger H.
    Pathol Res Pract. 1995 Oct,191(10):1053-8.

    View this publication in the PUBMED database
  • 1995

    Necrotizing vasculitis associated with hepatitis C virus infection: successful treatment of vasculitis with interferon-alpha despite persistence of mixed cryoglobulinemia.

    Sepp NT, Umlauft F, Illersperger B, GrГјnewald K, Schuler G, Greil R, Vogel W.
    Dermatology. 1995,191(1):43-5.

    View this publication in the PUBMED database
  • 1995

    Multimodal therapy in life-threatening cerebral lupus erythematosus: the benefit of cerebrospinal fluid pheresis.

    Pfausler B, Bösch S, Grubwieser G, Vollert H, Greil R, Hagn C, Schmutzhard E.
    Int Arch Allergy Immunol. 1995 Aug,107(4):592-4.

    View this publication in the PUBMED database
  • 1994

    Apoptosis and therapy of malignant diseases of the hematopoietic system.

    Gruber J, Greil R.
    Int Arch Allergy Immunol. 1994 Dec,105(4):368-73.

    View this publication in the PUBMED database
  • 1993

    Extensive meningeal involvement as the primary manifestation of a systemic small lymphocytic lymphoma: favourable outcome after neuraxial irradiation without chemotherapy.

    Soucek D, Ransmayr G, Twerdy K, Zwierzina H, Greil R, Fritsch E, Maier H, Pallua A, Gerstenbrand F.
    Br J Haematol. 1993 Apr,83(4):674-5.

    View this publication in the PUBMED database
  • 1992

    Investigation of nuclear c-MYC oncoprotein expression in human hematopoiesis: suitability of a rapid and reliable semiquantitative evaluation system.

    Greil R, Fasching B, Weger A, Loidl P.
    Lab Invest. 1992 Feb,66(2):251-60.

    View this publication in the PUBMED database
  • 1992

    Differential expression of c-myc-mRNA and c-MYC-protein during terminal neoplastic B-cell differentiation.

    Greil R, Loidl P, Fasching B, Huber H.
    Curr Top Microbiol Immunol. 1992,182:215-21.

    View this publication in the PUBMED database
  • 1991

    Expression of the c-myc proto-oncogene in multiple myeloma and chronic lymphocytic leukemia: an in situ analysis.

    Greil R, Fasching B, Loidl P, Huber H.
    Blood. 1991 Jul 1,78(1):180-91.

    View this publication in the PUBMED database
  • 1991

    [Urticarial vasculitis as a symptom of Muckle-Wells syndrome?].

    Grassegger A, Greil R, Feichtinger J, Fritsch P, Hintner H.
    Hautarzt. 1991 Feb,42(2):116-9.

    View this publication in the PUBMED database
  • 1990

    Monoclonal antibody B-ly7: a sensitive marker for detection of minimal residual disease in hairy cell leukemia.

    Thaler J, Dietze O, Faber V, Greil R, Gastl G, Denz H, Ho AD, Huber H.
    Leukemia. 1990 Mar,4(3):170-6.

    View this publication in the PUBMED database
  • 1990

    [Cytologic molecular detection of oncogene expression: possibilities and prospects in hemato-oncology].

    Greil R, Fasching B, Huber H.
    Acta Med Austriaca. 1990,17(1):6-10.

    View this publication in the PUBMED database
  • 1990

    A monoclonal antibody directed against the human intercellular adhesion molecule (ICAM-1) modulates the release of tumor necrosis factor-alpha, interferon-gamma and interleukin 1.

    Geissler D, Gaggl S, Möst J, Greil R, Herold M, Dietrich M.
    Eur J Immunol. 1990 Dec,20(12):2591-6.

    View this publication in the PUBMED database
  • 1989

    Immunohistological assessment of bone marrow biopsies from patients with hairy cell leukemia: changes following treatment with alpha-2-interferon and deoxycoformycin.

    Thaler J, Denz H, Dietze O, Gastl G, Ho AD, Gattringer C, Greil R, Lechleitner M, Huber C, Huber H.
    Leuk Res. 1989,13(5):377-83.

    View this publication in the PUBMED database
  • 1989

    Expression of leucocyte function-associated antigen-1 and 7F7-antigen, an adhesion molecule related to intercellular adhesion molecule-1 (ICAM-1) in non-Hodgkin lymphomas and leukaemias: possible influence on growth pattern and leukaemic behaviour.

    Stauder R, Greil R, Schulz TF, Thaler J, Gattringer C, Radaskiewicz T, Dierich MP, Huber H.
    Clin Exp Immunol. 1989 Aug,77(2):234-8.

    View this publication in the PUBMED database
  • 1989

    In situ hybridization for the detection of low copy numbers of c-abl oncogene mRNA in lymphoma cells: technical approach and comparison with results with anti-oncoprotein antibodies.

    Greil R, Fasching B, Huber H.
    Lab Invest. 1989 Apr,60(4):574-82.

    View this publication in the PUBMED database
  • 1989

    Immunohistology for quantification of normal bone marrow lymphocyte subsets.

    Thaler J, Greil R, Dietze O, Huber H.
    Br J Haematol. 1989 Dec,73(4):576-7.

    View this publication in the PUBMED database
  • 1988

    Importance of an 85 kDa membrane glycoprotein for a variety of cell-cell interactions.

    Schulz TF, Vogetseder W, Mitterer M, Neumayer HP, Myones BL, Stauder R, Greil R, Böck G, Feichtinger H, Huber H, et al.
    Mol Immunol. 1988 Nov,25(11):1053-61.

    View this publication in the PUBMED database
  • 1986

    [Studies of immunologic markers in malignant lymphomas: diagnostic and prognostic relevance].

    Huber H, Thaler J, Greil R, Gattringer C, Radaszkiewicz T.
    Onkologie. 1986 Apr,9(2):108-13.

    View this publication in the PUBMED database
  • 1986

    In situ quantification of T-cell subsets, NK-like cells and macrophages in Hodgkin's disease: quantity and quality of infiltration density depends on histopathological subtypes.

    Gattringer G, Greil R, Radaszkiewicz T, Huber H.
    Blut. 1986 Jul,53(1):49-58.

    View this publication in the PUBMED database
  • 1986

    Growth fraction of tumour cells and infiltration density with natural killer-like (HNK1+) cells in non-Hodgkin lymphomas.

    Greil R, Gattringer C, Knapp W, Huber H.
    Br J Haematol. 1986 Feb,62(2):293-300.

    View this publication in the PUBMED database
  • 1986

    Receptors for the third component of complement: their association with maturation stage in non-Hodgkin lymphomas (NHL) and their possible implication with the development of follicular structures.

    Greil R, Gattringer C, Schulz T, Knapp W, Radaskiewicz T, Dierich MP, Huber H.
    Clin Exp Immunol. 1986 May,64(2):423-31.

    View this publication in the PUBMED database
  • 1985

    [Rhabdomyolysis as a late complication of anesthesia--a case of malignant hyperthermia?].

    Greil R, Gattringer C, Abbrederis K.
    Wien Klin Wochenschr. 1985 Nov 8,97(21):813-6.

    View this publication in the PUBMED database
  • 1985

    [Infiltration pattern of immunocompetent lymphocytes in the tissue of malignant non-Hodgkin's lymphoma: relationship to histological and clinical parameters].

    Gattringer C, Radaszkiewicz T, Greil R, Pfaller W, Huber H.
    Wien Klin Wochenschr. 1985 Mar 1,97(5):258-63.

    View this publication in the PUBMED database